id	sid	tid	token	lemma	pos
ajlm-1807	1	1	abstract	abstract	ADJ
ajlm-1807	1	2	introduction	introduction	NOUN
ajlm-1807	1	3	methods	method	NOUN
ajlm-1807	1	4	results	result	VERB
ajlm-1807	1	5	discussion	discussion	NOUN
ajlm-1807	1	6	conclusion	conclusion	NOUN
ajlm-1807	1	7	acknowledgements	acknowledgement	NOUN
ajlm-1807	1	8	references	reference	NOUN
ajlm-1807	1	9	about	about	ADP
ajlm-1807	1	10	the	the	DET
ajlm-1807	1	11	author(s	author(s	NOUN
ajlm-1807	1	12	)	)	PUNCT
ajlm-1807	1	13	oluwalana	oluwalana	PROPN
ajlm-1807	1	14	t.	t.	PROPN
ajlm-1807	1	15	oyekale	oyekale	PROPN
ajlm-1807	1	16	department	department	PROPN
ajlm-1807	1	17	of	of	ADP
ajlm-1807	1	18	medical	medical	ADJ
ajlm-1807	1	19	microbiology	microbiology	NOUN
ajlm-1807	1	20	and	and	CCONJ
ajlm-1807	1	21	parasitology	parasitology	NOUN
ajlm-1807	1	22	,	,	PUNCT
ajlm-1807	1	23	faculty	faculty	NOUN
ajlm-1807	1	24	of	of	ADP
ajlm-1807	1	25	medicine	medicine	NOUN
ajlm-1807	1	26	and	and	CCONJ
ajlm-1807	1	27	health	health	NOUN
ajlm-1807	1	28	sciences	sciences	PROPN
ajlm-1807	1	29	,	,	PUNCT
ajlm-1807	1	30	afe	afe	PROPN
ajlm-1807	1	31	babalola	babalola	PROPN
ajlm-1807	1	32	university	university	PROPN
ajlm-1807	1	33	,	,	PUNCT
ajlm-1807	1	34	ado	ado	NOUN
ajlm-1807	1	35	ekiti	ekiti	PROPN
ajlm-1807	1	36	,	,	PUNCT
ajlm-1807	1	37	nigeria	nigeria	PROPN
ajlm-1807	1	38	department	department	PROPN
ajlm-1807	1	39	of	of	ADP
ajlm-1807	1	40	medical	medical	ADJ
ajlm-1807	1	41	microbiology	microbiology	NOUN
ajlm-1807	1	42	and	and	CCONJ
ajlm-1807	1	43	parasitology	parasitology	NOUN
ajlm-1807	1	44	,	,	PUNCT
ajlm-1807	1	45	federal	federal	ADJ
ajlm-1807	1	46	teaching	teaching	NOUN
ajlm-1807	1	47	hospital	hospital	NOUN
ajlm-1807	1	48	,	,	PUNCT
ajlm-1807	1	49	ido	ido	NOUN
ajlm-1807	1	50	-	-	PUNCT
ajlm-1807	1	51	ekiti	ekiti	PROPN
ajlm-1807	1	52	,	,	PUNCT
ajlm-1807	1	53	nigeria	nigeria	PROPN
ajlm-1807	1	54	bola	bola	PROPN
ajlm-1807	1	55	o.	o.	PROPN
ajlm-1807	1	56	ojo	ojo	PROPN
ajlm-1807	1	57	department	department	PROPN
ajlm-1807	1	58	of	of	ADP
ajlm-1807	1	59	medical	medical	ADJ
ajlm-1807	1	60	microbiology	microbiology	NOUN
ajlm-1807	1	61	and	and	CCONJ
ajlm-1807	1	62	parasitology	parasitology	NOUN
ajlm-1807	1	63	,	,	PUNCT
ajlm-1807	1	64	federal	federal	ADJ
ajlm-1807	1	65	teaching	teaching	NOUN
ajlm-1807	1	66	hospital	hospital	NOUN
ajlm-1807	1	67	,	,	PUNCT
ajlm-1807	1	68	ido	ido	NOUN
ajlm-1807	1	69	-	-	PUNCT
ajlm-1807	1	70	ekiti	ekiti	PROPN
ajlm-1807	1	71	,	,	PUNCT
ajlm-1807	1	72	nigeria	nigeria	PROPN
ajlm-1807	1	73	adewale	adewale	PROPN
ajlm-1807	1	74	t.	t.	PROPN
ajlm-1807	1	75	olajide	olajide	PROPN
ajlm-1807	1	76	department	department	PROPN
ajlm-1807	1	77	of	of	ADP
ajlm-1807	1	78	surgery	surgery	NOUN
ajlm-1807	1	79	,	,	PUNCT
ajlm-1807	1	80	faculty	faculty	NOUN
ajlm-1807	1	81	of	of	ADP
ajlm-1807	1	82	medicine	medicine	NOUN
ajlm-1807	1	83	and	and	CCONJ
ajlm-1807	1	84	health	health	NOUN
ajlm-1807	1	85	sciences	sciences	PROPN
ajlm-1807	1	86	,	,	PUNCT
ajlm-1807	1	87	afe	afe	PROPN
ajlm-1807	1	88	babalola	babalola	PROPN
ajlm-1807	1	89	university	university	PROPN
ajlm-1807	1	90	,	,	PUNCT
ajlm-1807	1	91	ado	ado	NOUN
ajlm-1807	1	92	ekiti	ekiti	PROPN
ajlm-1807	1	93	,	,	PUNCT
ajlm-1807	1	94	nigeria	nigeria	PROPN
ajlm-1807	1	95	department	department	PROPN
ajlm-1807	1	96	of	of	ADP
ajlm-1807	1	97	surgery	surgery	NOUN
ajlm-1807	1	98	,	,	PUNCT
ajlm-1807	1	99	federal	federal	ADJ
ajlm-1807	1	100	teaching	teaching	NOUN
ajlm-1807	1	101	hospital	hospital	NOUN
ajlm-1807	1	102	,	,	PUNCT
ajlm-1807	1	103	ido	ido	NOUN
ajlm-1807	1	104	-	-	PUNCT
ajlm-1807	1	105	ekiti	ekiti	PROPN
ajlm-1807	1	106	,	,	PUNCT
ajlm-1807	1	107	nigeria	nigeria	PROPN
ajlm-1807	1	108	oluwatoyin	oluwatoyin	PROPN
ajlm-1807	1	109	i.	i.	PROPN
ajlm-1807	1	110	oyekale	oyekale	PROPN
ajlm-1807	1	111	department	department	PROPN
ajlm-1807	1	112	of	of	ADP
ajlm-1807	1	113	radiology	radiology	NOUN
ajlm-1807	1	114	,	,	PUNCT
ajlm-1807	1	115	federal	federal	ADJ
ajlm-1807	1	116	teaching	teaching	NOUN
ajlm-1807	1	117	hospital	hospital	NOUN
ajlm-1807	1	118	,	,	PUNCT
ajlm-1807	1	119	ido	ido	NOUN
ajlm-1807	1	120	-	-	PUNCT
ajlm-1807	1	121	ekiti	ekiti	PROPN
ajlm-1807	1	122	,	,	PUNCT
ajlm-1807	1	123	nigeria	nigeria	PROPN
ajlm-1807	1	124	citation	citation	PROPN
ajlm-1807	1	125	oyekale	oyekale	PROPN
ajlm-1807	1	126	ot	ot	INTJ
ajlm-1807	1	127	,	,	PUNCT
ajlm-1807	1	128	ojo	ojo	PROPN
ajlm-1807	1	129	bo	bo	PROPN
ajlm-1807	1	130	,	,	PUNCT
ajlm-1807	1	131	olajide	olajide	ADV
ajlm-1807	1	132	at	at	ADP
ajlm-1807	1	133	,	,	PUNCT
ajlm-1807	1	134	oyekale	oyekale	PROPN
ajlm-1807	1	135	oi	oi	PROPN
ajlm-1807	1	136	.	.	PROPN
ajlm-1807	1	137	bacteriological	bacteriological	PROPN
ajlm-1807	1	138	profile	profile	NOUN
ajlm-1807	1	139	and	and	CCONJ
ajlm-1807	1	140	antibiogram	antibiogram	NUM
ajlm-1807	1	141	of	of	ADP
ajlm-1807	1	142	blood	blood	NOUN
ajlm-1807	1	143	culture	culture	NOUN
ajlm-1807	1	144	isolates	isolate	NOUN
ajlm-1807	1	145	from	from	ADP
ajlm-1807	1	146	bloodstream	bloodstream	NOUN
ajlm-1807	1	147	infections	infection	NOUN
ajlm-1807	1	148	in	in	ADP
ajlm-1807	1	149	a	a	DET
ajlm-1807	1	150	rural	rural	ADJ
ajlm-1807	1	151	tertiary	tertiary	ADJ
ajlm-1807	1	152	hospital	hospital	NOUN
ajlm-1807	1	153	in	in	ADP
ajlm-1807	1	154	nigeria	nigeria	PROPN
ajlm-1807	1	155	.	.	PUNCT
ajlm-1807	2	1	afr	afr	PROPN
ajlm-1807	2	2	j	j	PROPN
ajlm-1807	2	3	lab	lab	PROPN
ajlm-1807	2	4	med	med	PROPN
ajlm-1807	2	5	.	.	PUNCT
ajlm-1807	3	1	2022;11(1	2022;11(1	NUM
ajlm-1807	3	2	)	)	PUNCT
ajlm-1807	3	3	,	,	PUNCT
ajlm-1807	4	1	a1807	a1807	PROPN
ajlm-1807	4	2	.	.	PUNCT
ajlm-1807	4	3	https://doi.org/10.4102/ajlm.v11i1.1807	https://doi.org/10.4102/ajlm.v11i1.1807	AUX
ajlm-1807	4	4	original	original	ADJ
ajlm-1807	4	5	research	research	NOUN
ajlm-1807	4	6	bacteriological	bacteriological	ADJ
ajlm-1807	4	7	profile	profile	NOUN
ajlm-1807	4	8	and	and	CCONJ
ajlm-1807	4	9	antibiogram	antibiogram	NUM
ajlm-1807	4	10	of	of	ADP
ajlm-1807	4	11	blood	blood	NOUN
ajlm-1807	4	12	culture	culture	NOUN
ajlm-1807	4	13	isolates	isolate	NOUN
ajlm-1807	4	14	from	from	ADP
ajlm-1807	4	15	bloodstream	bloodstream	NOUN
ajlm-1807	4	16	infections	infection	NOUN
ajlm-1807	4	17	in	in	ADP
ajlm-1807	4	18	a	a	DET
ajlm-1807	4	19	rural	rural	ADJ
ajlm-1807	4	20	tertiary	tertiary	ADJ
ajlm-1807	4	21	hospital	hospital	NOUN
ajlm-1807	4	22	in	in	ADP
ajlm-1807	4	23	nigeria	nigeria	PROPN
ajlm-1807	4	24	oluwalana	oluwalana	PROPN
ajlm-1807	4	25	t.	t.	PROPN
ajlm-1807	4	26	oyekale	oyekale	PROPN
ajlm-1807	4	27	,	,	PUNCT
ajlm-1807	4	28	bola	bola	PROPN
ajlm-1807	4	29	o.	o.	PROPN
ajlm-1807	4	30	ojo	ojo	PROPN
ajlm-1807	4	31	,	,	PUNCT
ajlm-1807	4	32	adewale	adewale	PROPN
ajlm-1807	4	33	t.	t.	PROPN
ajlm-1807	4	34	olajide	olajide	PROPN
ajlm-1807	4	35	,	,	PUNCT
ajlm-1807	4	36	oluwatoyin	oluwatoyin	PROPN
ajlm-1807	4	37	i.	i.	PROPN
ajlm-1807	4	38	oyekale	oyekale	PROPN
ajlm-1807	4	39	received	receive	VERB
ajlm-1807	4	40	:	:	PUNCT
ajlm-1807	4	41	01	01	NUM
ajlm-1807	4	42	dec	dec	PROPN
ajlm-1807	4	43	.	.	PROPN
ajlm-1807	4	44	2021	2021	NUM
ajlm-1807	4	45	;	;	PUNCT
ajlm-1807	4	46	accepted	accept	VERB
ajlm-1807	4	47	:	:	PUNCT
ajlm-1807	4	48	25	25	NUM
ajlm-1807	4	49	may	may	PROPN
ajlm-1807	4	50	2022	2022	NUM
ajlm-1807	4	51	;	;	PUNCT
ajlm-1807	4	52	published	publish	VERB
ajlm-1807	4	53	:	:	PUNCT
ajlm-1807	4	54	24	24	NUM
ajlm-1807	4	55	aug	aug	PROPN
ajlm-1807	4	56	.	.	PROPN
ajlm-1807	4	57	2022	2022	NUM
ajlm-1807	4	58	copyright	copyright	NOUN
ajlm-1807	4	59	:	:	PUNCT
ajlm-1807	4	60	©	©	PROPN
ajlm-1807	4	61	2022	2022	NUM
ajlm-1807	4	62	.	.	PUNCT
ajlm-1807	5	1	the	the	DET
ajlm-1807	5	2	author(s	author(s	PROPN
ajlm-1807	5	3	)	)	PUNCT
ajlm-1807	5	4	.	.	PUNCT
ajlm-1807	6	1	licensee	licensee	NOUN
ajlm-1807	6	2	:	:	PUNCT
ajlm-1807	6	3	aosis	aosis	NOUN
ajlm-1807	6	4	.	.	PUNCT
ajlm-1807	7	1	this	this	PRON
ajlm-1807	7	2	is	be	AUX
ajlm-1807	7	3	an	an	DET
ajlm-1807	7	4	open	open	ADJ
ajlm-1807	7	5	access	access	NOUN
ajlm-1807	7	6	article	article	NOUN
ajlm-1807	7	7	distributed	distribute	VERB
ajlm-1807	7	8	under	under	ADP
ajlm-1807	7	9	the	the	DET
ajlm-1807	7	10	terms	term	NOUN
ajlm-1807	7	11	of	of	ADP
ajlm-1807	7	12	the	the	DET
ajlm-1807	7	13	creative	creative	ADJ
ajlm-1807	7	14	commons	common	NOUN
ajlm-1807	7	15	attribution	attribution	NOUN
ajlm-1807	7	16	license	license	NOUN
ajlm-1807	7	17	,	,	PUNCT
ajlm-1807	7	18	which	which	PRON
ajlm-1807	7	19	permits	permit	VERB
ajlm-1807	7	20	unrestricted	unrestricted	ADJ
ajlm-1807	7	21	use	use	NOUN
ajlm-1807	7	22	,	,	PUNCT
ajlm-1807	7	23	distribution	distribution	NOUN
ajlm-1807	7	24	,	,	PUNCT
ajlm-1807	7	25	and	and	CCONJ
ajlm-1807	7	26	reproduction	reproduction	NOUN
ajlm-1807	7	27	in	in	ADP
ajlm-1807	7	28	any	any	DET
ajlm-1807	7	29	medium	medium	NOUN
ajlm-1807	7	30	,	,	PUNCT
ajlm-1807	7	31	provided	provide	VERB
ajlm-1807	7	32	the	the	DET
ajlm-1807	7	33	original	original	ADJ
ajlm-1807	7	34	work	work	NOUN
ajlm-1807	7	35	is	be	AUX
ajlm-1807	7	36	properly	properly	ADV
ajlm-1807	7	37	cited	cite	VERB
ajlm-1807	7	38	.	.	PUNCT
ajlm-1807	8	1	abstract	abstract	ADJ
ajlm-1807	8	2	background	background	NOUN
ajlm-1807	8	3	:	:	PUNCT
ajlm-1807	8	4	bloodstream	bloodstream	NOUN
ajlm-1807	8	5	infections	infection	NOUN
ajlm-1807	8	6	(	(	PUNCT
ajlm-1807	8	7	bsis	bsis	NOUN
ajlm-1807	8	8	)	)	PUNCT
ajlm-1807	8	9	are	be	AUX
ajlm-1807	8	10	a	a	DET
ajlm-1807	8	11	cause	cause	NOUN
ajlm-1807	8	12	of	of	ADP
ajlm-1807	8	13	significant	significant	ADJ
ajlm-1807	8	14	morbidity	morbidity	NOUN
ajlm-1807	8	15	and	and	CCONJ
ajlm-1807	8	16	mortality	mortality	NOUN
ajlm-1807	8	17	requiring	require	VERB
ajlm-1807	8	18	urgent	urgent	ADJ
ajlm-1807	8	19	antibiotic	antibiotic	ADJ
ajlm-1807	8	20	treatment	treatment	NOUN
ajlm-1807	8	21	.	.	PUNCT
ajlm-1807	9	1	however	however	ADV
ajlm-1807	9	2	,	,	PUNCT
ajlm-1807	9	3	there	there	PRON
ajlm-1807	9	4	is	be	VERB
ajlm-1807	9	5	widespread	widespread	ADJ
ajlm-1807	9	6	antibiotic	antibiotic	ADJ
ajlm-1807	9	7	-	-	PUNCT
ajlm-1807	9	8	resistance	resistance	NOUN
ajlm-1807	9	9	from	from	ADP
ajlm-1807	9	10	the	the	DET
ajlm-1807	9	11	bacterial	bacterial	ADJ
ajlm-1807	9	12	causes	cause	NOUN
ajlm-1807	9	13	,	,	PUNCT
ajlm-1807	9	14	necessitating	necessitate	VERB
ajlm-1807	9	15	regular	regular	ADJ
ajlm-1807	9	16	surveillance	surveillance	NOUN
ajlm-1807	9	17	for	for	ADP
ajlm-1807	9	18	drug	drug	NOUN
ajlm-1807	9	19	-	-	PUNCT
ajlm-1807	9	20	resistant	resistant	ADJ
ajlm-1807	9	21	bacteria	bacteria	NOUN
ajlm-1807	9	22	and	and	CCONJ
ajlm-1807	9	23	their	their	PRON
ajlm-1807	9	24	antibiograms	antibiogram	NOUN
ajlm-1807	9	25	.	.	PUNCT
ajlm-1807	10	1	objective	objective	NOUN
ajlm-1807	10	2	:	:	PUNCT
ajlm-1807	10	3	this	this	DET
ajlm-1807	10	4	study	study	NOUN
ajlm-1807	10	5	isolated	isolate	VERB
ajlm-1807	10	6	and	and	CCONJ
ajlm-1807	10	7	identified	identify	VERB
ajlm-1807	10	8	various	various	ADJ
ajlm-1807	10	9	bacterial	bacterial	ADJ
ajlm-1807	10	10	causes	cause	NOUN
ajlm-1807	10	11	of	of	ADP
ajlm-1807	10	12	bsis	bsis	NOUN
ajlm-1807	10	13	,	,	PUNCT
ajlm-1807	10	14	determined	determine	VERB
ajlm-1807	10	15	their	their	PRON
ajlm-1807	10	16	antibiotic	antibiotic	ADJ
ajlm-1807	10	17	susceptibility	susceptibility	NOUN
ajlm-1807	10	18	patterns	pattern	NOUN
ajlm-1807	10	19	,	,	PUNCT
ajlm-1807	10	20	and	and	CCONJ
ajlm-1807	10	21	determined	determine	VERB
ajlm-1807	10	22	the	the	DET
ajlm-1807	10	23	best	good	ADJ
ajlm-1807	10	24	empirical	empirical	ADJ
ajlm-1807	10	25	treatment	treatment	NOUN
ajlm-1807	10	26	for	for	ADP
ajlm-1807	10	27	cases	case	NOUN
ajlm-1807	10	28	of	of	ADP
ajlm-1807	10	29	bsi	bsi	NOUN
ajlm-1807	10	30	in	in	ADP
ajlm-1807	10	31	the	the	DET
ajlm-1807	10	32	setting	setting	NOUN
ajlm-1807	10	33	.	.	PUNCT
ajlm-1807	11	1	methods	method	NOUN
ajlm-1807	11	2	:	:	PUNCT
ajlm-1807	11	3	a	a	DET
ajlm-1807	11	4	cross	cross	ADJ
ajlm-1807	11	5	-	-	ADJ
ajlm-1807	11	6	sectional	sectional	ADJ
ajlm-1807	11	7	study	study	NOUN
ajlm-1807	11	8	was	be	AUX
ajlm-1807	11	9	carried	carry	VERB
ajlm-1807	11	10	out	out	ADP
ajlm-1807	11	11	at	at	ADP
ajlm-1807	11	12	the	the	DET
ajlm-1807	11	13	federal	federal	ADJ
ajlm-1807	11	14	teaching	teaching	NOUN
ajlm-1807	11	15	hospital	hospital	NOUN
ajlm-1807	11	16	,	,	PUNCT
ajlm-1807	11	17	ido	ido	NOUN
ajlm-1807	11	18	-	-	PUNCT
ajlm-1807	11	19	ekiti	ekiti	PROPN
ajlm-1807	11	20	,	,	PUNCT
ajlm-1807	11	21	nigeria	nigeria	PROPN
ajlm-1807	11	22	between	between	ADP
ajlm-1807	11	23	june	june	PROPN
ajlm-1807	11	24	2020	2020	NUM
ajlm-1807	11	25	and	and	CCONJ
ajlm-1807	11	26	february	february	PROPN
ajlm-1807	11	27	2021	2021	NUM
ajlm-1807	11	28	on	on	ADP
ajlm-1807	11	29	177	177	NUM
ajlm-1807	11	30	blood	blood	NOUN
ajlm-1807	11	31	culture	culture	NOUN
ajlm-1807	11	32	samples	sample	NOUN
ajlm-1807	11	33	from	from	ADP
ajlm-1807	11	34	cases	case	NOUN
ajlm-1807	11	35	of	of	ADP
ajlm-1807	11	36	bsi	bsi	PROPN
ajlm-1807	11	37	.	.	PUNCT
ajlm-1807	12	1	identification	identification	NOUN
ajlm-1807	12	2	of	of	ADP
ajlm-1807	12	3	isolated	isolated	ADJ
ajlm-1807	12	4	bacteria	bacteria	NOUN
ajlm-1807	12	5	and	and	CCONJ
ajlm-1807	12	6	antibiotic	antibiotic	ADJ
ajlm-1807	12	7	susceptibility	susceptibility	NOUN
ajlm-1807	12	8	testing	testing	NOUN
ajlm-1807	12	9	of	of	ADP
ajlm-1807	12	10	the	the	DET
ajlm-1807	12	11	isolates	isolate	NOUN
ajlm-1807	12	12	were	be	AUX
ajlm-1807	12	13	carried	carry	VERB
ajlm-1807	12	14	out	out	ADP
ajlm-1807	12	15	following	follow	VERB
ajlm-1807	12	16	the	the	DET
ajlm-1807	12	17	standard	standard	ADJ
ajlm-1807	12	18	protocol	protocol	NOUN
ajlm-1807	12	19	.	.	PUNCT
ajlm-1807	13	1	results	result	NOUN
ajlm-1807	13	2	:	:	PUNCT
ajlm-1807	13	3	culture	culture	NOUN
ajlm-1807	13	4	positivity	positivity	NOUN
ajlm-1807	13	5	in	in	ADP
ajlm-1807	13	6	this	this	DET
ajlm-1807	13	7	study	study	NOUN
ajlm-1807	13	8	was	be	AUX
ajlm-1807	13	9	19.2	19.2	NUM
ajlm-1807	13	10	%	%	NOUN
ajlm-1807	13	11	.	.	PUNCT
ajlm-1807	14	1	no	no	DET
ajlm-1807	14	2	significant	significant	ADJ
ajlm-1807	14	3	difference	difference	NOUN
ajlm-1807	14	4	was	be	AUX
ajlm-1807	14	5	seen	see	VERB
ajlm-1807	14	6	in	in	ADP
ajlm-1807	14	7	culture	culture	NOUN
ajlm-1807	14	8	positivity	positivity	NOUN
ajlm-1807	14	9	between	between	ADP
ajlm-1807	14	10	male	male	ADJ
ajlm-1807	14	11	and	and	CCONJ
ajlm-1807	14	12	female	female	ADJ
ajlm-1807	14	13	participants	participant	NOUN
ajlm-1807	14	14	(	(	PUNCT
ajlm-1807	14	15	p	p	X
ajlm-1807	14	16	=	=	NOUN
ajlm-1807	14	17	0.97	0.97	NUM
ajlm-1807	14	18	)	)	PUNCT
ajlm-1807	14	19	.	.	PUNCT
ajlm-1807	15	1	gram	gram	NOUN
ajlm-1807	15	2	-	-	PUNCT
ajlm-1807	15	3	negative	negative	ADJ
ajlm-1807	15	4	enteric	enteric	ADJ
ajlm-1807	15	5	bacteria	bacteria	NOUN
ajlm-1807	15	6	were	be	AUX
ajlm-1807	15	7	predominantly	predominantly	ADV
ajlm-1807	15	8	isolated	isolate	VERB
ajlm-1807	15	9	(	(	PUNCT
ajlm-1807	15	10	67.6	67.6	NUM
ajlm-1807	15	11	%	%	NOUN
ajlm-1807	15	12	)	)	PUNCT
ajlm-1807	15	13	,	,	PUNCT
ajlm-1807	15	14	including	include	VERB
ajlm-1807	15	15	escherichia	escherichia	NOUN
ajlm-1807	15	16	coli	coli	NOUN
ajlm-1807	15	17	(	(	PUNCT
ajlm-1807	15	18	29.4	29.4	NUM
ajlm-1807	15	19	%	%	NOUN
ajlm-1807	15	20	)	)	PUNCT
ajlm-1807	15	21	and	and	CCONJ
ajlm-1807	15	22	klebsiella	klebsiella	PROPN
ajlm-1807	15	23	aerogenes	aerogenes	PROPN
ajlm-1807	15	24	(	(	PUNCT
ajlm-1807	15	25	20.6	20.6	NUM
ajlm-1807	15	26	%	%	NOUN
ajlm-1807	15	27	)	)	PUNCT
ajlm-1807	15	28	.	.	PUNCT
ajlm-1807	16	1	staphylococcus	staphylococcus	NOUN
ajlm-1807	16	2	aureus	aureus	PROPN
ajlm-1807	16	3	was	be	AUX
ajlm-1807	16	4	the	the	DET
ajlm-1807	16	5	most	most	ADV
ajlm-1807	16	6	common	common	ADJ
ajlm-1807	16	7	gram	gram	NOUN
ajlm-1807	16	8	-	-	PUNCT
ajlm-1807	16	9	positive	positive	ADJ
ajlm-1807	16	10	bacterium	bacterium	NOUN
ajlm-1807	16	11	isolated	isolate	VERB
ajlm-1807	16	12	(	(	PUNCT
ajlm-1807	16	13	23.5	23.5	NUM
ajlm-1807	16	14	%	%	NOUN
ajlm-1807	16	15	)	)	PUNCT
ajlm-1807	16	16	.	.	PUNCT
ajlm-1807	17	1	three	three	NUM
ajlm-1807	17	2	(	(	PUNCT
ajlm-1807	17	3	37.5	37.5	NUM
ajlm-1807	17	4	%	%	NOUN
ajlm-1807	17	5	)	)	PUNCT
ajlm-1807	17	6	s.	s.	PROPN
ajlm-1807	17	7	aureus	aureus	PROPN
ajlm-1807	17	8	isolates	isolate	NOUN
ajlm-1807	17	9	were	be	AUX
ajlm-1807	17	10	methicillin	methicillin	NOUN
ajlm-1807	17	11	-	-	PUNCT
ajlm-1807	17	12	resistant	resistant	ADJ
ajlm-1807	17	13	.	.	PUNCT
ajlm-1807	18	1	all	all	DET
ajlm-1807	18	2	isolates	isolate	NOUN
ajlm-1807	18	3	were	be	AUX
ajlm-1807	18	4	sensitive	sensitive	ADJ
ajlm-1807	18	5	to	to	ADP
ajlm-1807	18	6	meropenem	meropenem	PROPN
ajlm-1807	18	7	,	,	PUNCT
ajlm-1807	18	8	and	and	CCONJ
ajlm-1807	18	9	97.1	97.1	NUM
ajlm-1807	18	10	%	%	NOUN
ajlm-1807	18	11	were	be	AUX
ajlm-1807	18	12	sensitive	sensitive	ADJ
ajlm-1807	18	13	to	to	ADP
ajlm-1807	18	14	imipenem	imipenem	PROPN
ajlm-1807	18	15	;	;	PUNCT
ajlm-1807	18	16	other	other	ADJ
ajlm-1807	18	17	sensitivity	sensitivity	NOUN
ajlm-1807	18	18	patterns	pattern	NOUN
ajlm-1807	18	19	were	be	AUX
ajlm-1807	18	20	:	:	PUNCT
ajlm-1807	18	21	ceftazidime	ceftazidime	NOUN
ajlm-1807	18	22	(	(	PUNCT
ajlm-1807	18	23	85.3	85.3	NUM
ajlm-1807	18	24	%	%	NOUN
ajlm-1807	18	25	)	)	PUNCT
ajlm-1807	18	26	,	,	PUNCT
ajlm-1807	18	27	ciprofloxacin	ciprofloxacin	NOUN
ajlm-1807	18	28	(	(	PUNCT
ajlm-1807	18	29	79.4	79.4	NUM
ajlm-1807	18	30	%	%	NOUN
ajlm-1807	18	31	)	)	PUNCT
ajlm-1807	18	32	,	,	PUNCT
ajlm-1807	18	33	ofloxacin	ofloxacin	PROPN
ajlm-1807	18	34	(	(	PUNCT
ajlm-1807	18	35	79.4	79.4	NUM
ajlm-1807	18	36	%	%	NOUN
ajlm-1807	18	37	)	)	PUNCT
ajlm-1807	18	38	,	,	PUNCT
ajlm-1807	18	39	and	and	CCONJ
ajlm-1807	18	40	gentamicin	gentamicin	NOUN
ajlm-1807	18	41	(	(	PUNCT
ajlm-1807	18	42	76.5	76.5	NUM
ajlm-1807	18	43	%	%	NOUN
ajlm-1807	18	44	)	)	PUNCT
ajlm-1807	18	45	.	.	PUNCT
ajlm-1807	19	1	there	there	PRON
ajlm-1807	19	2	was	be	VERB
ajlm-1807	19	3	low	low	ADJ
ajlm-1807	19	4	sensitivity	sensitivity	NOUN
ajlm-1807	19	5	to	to	PART
ajlm-1807	19	6	ampicillin	ampicillin	NOUN
ajlm-1807	19	7	(	(	PUNCT
ajlm-1807	19	8	32.4	32.4	NUM
ajlm-1807	19	9	%	%	NOUN
ajlm-1807	19	10	)	)	PUNCT
ajlm-1807	19	11	and	and	CCONJ
ajlm-1807	19	12	cotrimoxazole	cotrimoxazole	NOUN
ajlm-1807	19	13	(	(	PUNCT
ajlm-1807	19	14	38.2	38.2	NUM
ajlm-1807	19	15	%	%	NOUN
ajlm-1807	19	16	)	)	PUNCT
ajlm-1807	19	17	.	.	PUNCT
ajlm-1807	20	1	all	all	DET
ajlm-1807	20	2	gram	gram	NOUN
ajlm-1807	20	3	-	-	PUNCT
ajlm-1807	20	4	positive	positive	ADJ
ajlm-1807	20	5	isolates	isolate	NOUN
ajlm-1807	20	6	,	,	PUNCT
ajlm-1807	20	7	including	include	VERB
ajlm-1807	20	8	methicillin	methicillin	NOUN
ajlm-1807	20	9	-	-	PUNCT
ajlm-1807	20	10	resistant	resistant	ADJ
ajlm-1807	20	11	s.	s.	PROPN
ajlm-1807	20	12	aureus	aureus	PROPN
ajlm-1807	20	13	,	,	PUNCT
ajlm-1807	20	14	were	be	AUX
ajlm-1807	20	15	sensitive	sensitive	ADJ
ajlm-1807	20	16	to	to	ADP
ajlm-1807	20	17	vancomycin	vancomycin	PROPN
ajlm-1807	20	18	.	.	PUNCT
ajlm-1807	21	1	conclusion	conclusion	NOUN
ajlm-1807	21	2	:	:	PUNCT
ajlm-1807	21	3	regular	regular	ADJ
ajlm-1807	21	4	surveillance	surveillance	NOUN
ajlm-1807	21	5	of	of	ADP
ajlm-1807	21	6	isolate	isolate	NOUN
ajlm-1807	21	7	sensitivity	sensitivity	NOUN
ajlm-1807	21	8	patterns	pattern	NOUN
ajlm-1807	21	9	,	,	PUNCT
ajlm-1807	21	10	formulation	formulation	NOUN
ajlm-1807	21	11	of	of	ADP
ajlm-1807	21	12	hospital	hospital	NOUN
ajlm-1807	21	13	antibiotic	antibiotic	ADJ
ajlm-1807	21	14	policies	policy	NOUN
ajlm-1807	21	15	based	base	VERB
ajlm-1807	21	16	on	on	ADP
ajlm-1807	21	17	existing	exist	VERB
ajlm-1807	21	18	data	datum	NOUN
ajlm-1807	21	19	and	and	CCONJ
ajlm-1807	21	20	compliance	compliance	NOUN
ajlm-1807	21	21	with	with	ADP
ajlm-1807	21	22	treatment	treatment	NOUN
ajlm-1807	21	23	guidelines	guideline	NOUN
ajlm-1807	21	24	will	will	AUX
ajlm-1807	21	25	promote	promote	VERB
ajlm-1807	21	26	rational	rational	ADJ
ajlm-1807	21	27	antibiotic	antibiotic	ADJ
ajlm-1807	21	28	use	use	NOUN
ajlm-1807	21	29	and	and	CCONJ
ajlm-1807	21	30	reduce	reduce	VERB
ajlm-1807	21	31	resistance	resistance	NOUN
ajlm-1807	21	32	among	among	ADP
ajlm-1807	21	33	bacteria	bacteria	NOUN
ajlm-1807	21	34	.	.	PUNCT
ajlm-1807	22	1	keywords	keyword	NOUN
ajlm-1807	22	2	:	:	PUNCT
ajlm-1807	22	3	antibiotic	antibiotic	ADJ
ajlm-1807	22	4	-	-	PUNCT
ajlm-1807	22	5	resistance	resistance	NOUN
ajlm-1807	22	6	;	;	PUNCT
ajlm-1807	22	7	antibiotic	antibiotic	ADJ
ajlm-1807	22	8	sensitivity	sensitivity	NOUN
ajlm-1807	22	9	;	;	PUNCT
ajlm-1807	22	10	bacterial	bacterial	ADJ
ajlm-1807	22	11	isolates	isolate	NOUN
ajlm-1807	22	12	;	;	PUNCT
ajlm-1807	22	13	blood	blood	NOUN
ajlm-1807	22	14	culture	culture	NOUN
ajlm-1807	22	15	;	;	PUNCT
ajlm-1807	22	16	bloodstream	bloodstream	NOUN
ajlm-1807	22	17	infections	infection	NOUN
ajlm-1807	22	18	.	.	PUNCT
ajlm-1807	23	1	introduction	introduction	NOUN
ajlm-1807	23	2	bloodstream	bloodstream	NOUN
ajlm-1807	23	3	infections	infection	NOUN
ajlm-1807	23	4	(	(	PUNCT
ajlm-1807	23	5	bsis	bsis	NOUN
ajlm-1807	23	6	)	)	PUNCT
ajlm-1807	23	7	,	,	PUNCT
ajlm-1807	23	8	which	which	PRON
ajlm-1807	23	9	range	range	VERB
ajlm-1807	23	10	from	from	ADP
ajlm-1807	23	11	self	self	NOUN
ajlm-1807	23	12	-	-	PUNCT
ajlm-1807	23	13	limiting	limit	VERB
ajlm-1807	23	14	bacteraemia	bacteraemia	NOUN
ajlm-1807	23	15	to	to	ADP
ajlm-1807	23	16	an	an	DET
ajlm-1807	23	17	outright	outright	ADJ
ajlm-1807	23	18	life	life	NOUN
ajlm-1807	23	19	-	-	PUNCT
ajlm-1807	23	20	threatening	threaten	VERB
ajlm-1807	23	21	septicaemia	septicaemia	NOUN
ajlm-1807	23	22	,	,	PUNCT
ajlm-1807	23	23	are	be	AUX
ajlm-1807	23	24	some	some	PRON
ajlm-1807	23	25	of	of	ADP
ajlm-1807	23	26	the	the	DET
ajlm-1807	23	27	most	most	ADV
ajlm-1807	23	28	common	common	ADJ
ajlm-1807	23	29	healthcare	healthcare	NOUN
ajlm-1807	23	30	-	-	PUNCT
ajlm-1807	23	31	associated	associate	VERB
ajlm-1807	23	32	infections	infection	NOUN
ajlm-1807	23	33	globally.1	globally.1	NOUN
ajlm-1807	23	34	bacteraemia	bacteraemia	NOUN
ajlm-1807	23	35	is	be	AUX
ajlm-1807	23	36	simply	simply	ADV
ajlm-1807	23	37	described	describe	VERB
ajlm-1807	23	38	as	as	ADP
ajlm-1807	23	39	the	the	DET
ajlm-1807	23	40	presence	presence	NOUN
ajlm-1807	23	41	of	of	ADP
ajlm-1807	23	42	viable	viable	ADJ
ajlm-1807	23	43	bacteria	bacteria	NOUN
ajlm-1807	23	44	in	in	ADP
ajlm-1807	23	45	the	the	DET
ajlm-1807	23	46	blood	blood	NOUN
ajlm-1807	23	47	,	,	PUNCT
ajlm-1807	23	48	while	while	SCONJ
ajlm-1807	23	49	septicaemia	septicaemia	NOUN
ajlm-1807	23	50	connotes	connote	VERB
ajlm-1807	23	51	systemic	systemic	ADJ
ajlm-1807	23	52	manifestations	manifestation	NOUN
ajlm-1807	23	53	caused	cause	VERB
ajlm-1807	23	54	by	by	ADP
ajlm-1807	23	55	bacteria	bacteria	NOUN
ajlm-1807	23	56	or	or	CCONJ
ajlm-1807	23	57	their	their	PRON
ajlm-1807	23	58	toxins	toxin	NOUN
ajlm-1807	23	59	in	in	ADP
ajlm-1807	23	60	blood	blood	NOUN
ajlm-1807	23	61	.	.	PUNCT
ajlm-1807	24	1	septicaemia	septicaemia	NOUN
ajlm-1807	24	2	constitutes	constitute	VERB
ajlm-1807	24	3	a	a	DET
ajlm-1807	24	4	significant	significant	ADJ
ajlm-1807	24	5	cause	cause	NOUN
ajlm-1807	24	6	of	of	ADP
ajlm-1807	24	7	morbidity	morbidity	NOUN
ajlm-1807	24	8	and	and	CCONJ
ajlm-1807	24	9	mortality	mortality	NOUN
ajlm-1807	24	10	,	,	PUNCT
ajlm-1807	24	11	requiring	require	VERB
ajlm-1807	24	12	prompt	prompt	ADJ
ajlm-1807	24	13	assessment	assessment	NOUN
ajlm-1807	24	14	,	,	PUNCT
ajlm-1807	24	15	diagnosis	diagnosis	NOUN
ajlm-1807	24	16	,	,	PUNCT
ajlm-1807	24	17	and	and	CCONJ
ajlm-1807	24	18	antibiotic	antibiotic	ADJ
ajlm-1807	24	19	treatment	treatment	NOUN
ajlm-1807	24	20	.	.	PUNCT
ajlm-1807	25	1	bloodstream	bloodstream	NOUN
ajlm-1807	25	2	infections	infection	NOUN
ajlm-1807	25	3	account	account	VERB
ajlm-1807	25	4	for	for	ADP
ajlm-1807	25	5	up	up	ADP
ajlm-1807	25	6	to	to	PART
ajlm-1807	25	7	9	9	NUM
ajlm-1807	25	8	%	%	NOUN
ajlm-1807	25	9	–	–	PUNCT
ajlm-1807	25	10	11	11	NUM
ajlm-1807	25	11	%	%	NOUN
ajlm-1807	25	12	of	of	ADP
ajlm-1807	25	13	hospital	hospital	NOUN
ajlm-1807	25	14	-	-	PUNCT
ajlm-1807	25	15	acquired	acquire	VERB
ajlm-1807	25	16	infections	infection	NOUN
ajlm-1807	25	17	in	in	ADP
ajlm-1807	25	18	the	the	DET
ajlm-1807	25	19	developed	develop	VERB
ajlm-1807	25	20	countries	country	NOUN
ajlm-1807	25	21	of	of	ADP
ajlm-1807	25	22	europe	europe	PROPN
ajlm-1807	25	23	and	and	CCONJ
ajlm-1807	25	24	the	the	DET
ajlm-1807	25	25	united	united	PROPN
ajlm-1807	25	26	states	states	PROPN
ajlm-1807	25	27	,	,	PUNCT
ajlm-1807	25	28	while	while	SCONJ
ajlm-1807	25	29	higher	high	ADJ
ajlm-1807	25	30	prevalence	prevalence	NOUN
ajlm-1807	25	31	of	of	ADP
ajlm-1807	25	32	up	up	ADP
ajlm-1807	25	33	to	to	PART
ajlm-1807	25	34	19	19	NUM
ajlm-1807	25	35	%	%	NOUN
ajlm-1807	25	36	has	have	AUX
ajlm-1807	25	37	been	be	AUX
ajlm-1807	25	38	recorded	record	VERB
ajlm-1807	25	39	from	from	ADP
ajlm-1807	25	40	lowand	lowand	ADJ
ajlm-1807	25	41	middle	middle	ADJ
ajlm-1807	25	42	-	-	PUNCT
ajlm-1807	25	43	income	income	NOUN
ajlm-1807	25	44	countries	country	NOUN
ajlm-1807	25	45	of	of	ADP
ajlm-1807	25	46	the	the	DET
ajlm-1807	25	47	world.2,3	world.2,3	PROPN
ajlm-1807	25	48	a	a	DET
ajlm-1807	25	49	european	european	ADJ
ajlm-1807	25	50	study	study	NOUN
ajlm-1807	25	51	had	have	AUX
ajlm-1807	25	52	estimated	estimate	VERB
ajlm-1807	25	53	that	that	SCONJ
ajlm-1807	25	54	bsi	bsi	PROPN
ajlm-1807	25	55	patients	patient	NOUN
ajlm-1807	25	56	spend	spend	VERB
ajlm-1807	25	57	an	an	DET
ajlm-1807	25	58	additional	additional	ADJ
ajlm-1807	25	59	6.0–11.5	6.0–11.5	NUM
ajlm-1807	25	60	days	day	NOUN
ajlm-1807	25	61	in	in	ADP
ajlm-1807	25	62	hospital	hospital	NOUN
ajlm-1807	25	63	compared	compare	VERB
ajlm-1807	25	64	to	to	ADP
ajlm-1807	25	65	other	other	ADJ
ajlm-1807	25	66	patients	patient	NOUN
ajlm-1807	25	67	and	and	CCONJ
ajlm-1807	25	68	the	the	DET
ajlm-1807	25	69	cost	cost	NOUN
ajlm-1807	25	70	of	of	ADP
ajlm-1807	25	71	management	management	NOUN
ajlm-1807	25	72	associated	associate	VERB
ajlm-1807	25	73	with	with	ADP
ajlm-1807	25	74	bsi	bsi	PROPN
ajlm-1807	25	75	ranges	range	VERB
ajlm-1807	25	76	from	from	ADP
ajlm-1807	25	77	$	$	SYM
ajlm-1807	25	78	8000	8000	NUM
ajlm-1807	25	79	united	united	PROPN
ajlm-1807	25	80	states	states	PROPN
ajlm-1807	25	81	dollars	dollar	NOUN
ajlm-1807	25	82	(	(	PUNCT
ajlm-1807	25	83	usd	usd	NOUN
ajlm-1807	25	84	)	)	PUNCT
ajlm-1807	25	85	to	to	ADP
ajlm-1807	25	86	$	$	SYM
ajlm-1807	25	87	56	56	NUM
ajlm-1807	25	88	000	000	NUM
ajlm-1807	25	89	usd.4	usd.4	NOUN
ajlm-1807	25	90	the	the	DET
ajlm-1807	25	91	risk	risk	NOUN
ajlm-1807	25	92	factors	factor	NOUN
ajlm-1807	25	93	for	for	ADP
ajlm-1807	25	94	bsis	bsis	NOUN
ajlm-1807	25	95	include	include	VERB
ajlm-1807	25	96	the	the	DET
ajlm-1807	25	97	use	use	NOUN
ajlm-1807	25	98	of	of	ADP
ajlm-1807	25	99	healthcare	healthcare	NOUN
ajlm-1807	25	100	devices	device	NOUN
ajlm-1807	25	101	such	such	ADJ
ajlm-1807	25	102	as	as	ADP
ajlm-1807	25	103	:	:	PUNCT
ajlm-1807	25	104	peripheral	peripheral	ADJ
ajlm-1807	25	105	and	and	CCONJ
ajlm-1807	25	106	central	central	ADJ
ajlm-1807	25	107	venous	venous	ADJ
ajlm-1807	25	108	catheters	catheter	NOUN
ajlm-1807	25	109	on	on	ADP
ajlm-1807	25	110	patients	patient	NOUN
ajlm-1807	25	111	;	;	PUNCT
ajlm-1807	25	112	age	age	NOUN
ajlm-1807	25	113	(	(	PUNCT
ajlm-1807	25	114	elderly	elderly	ADJ
ajlm-1807	25	115	patient	patient	NOUN
ajlm-1807	25	116	,	,	PUNCT
ajlm-1807	25	117	neonates	neonate	NOUN
ajlm-1807	25	118	)	)	PUNCT
ajlm-1807	25	119	;	;	PUNCT
ajlm-1807	25	120	and	and	CCONJ
ajlm-1807	25	121	premorbid	premorbid	PROPN
ajlm-1807	25	122	medical	medical	ADJ
ajlm-1807	25	123	conditions	condition	NOUN
ajlm-1807	25	124	of	of	ADP
ajlm-1807	25	125	patients	patient	NOUN
ajlm-1807	25	126	,	,	PUNCT
ajlm-1807	25	127	such	such	ADJ
ajlm-1807	25	128	as	as	ADP
ajlm-1807	25	129	diabetes	diabetes	NOUN
ajlm-1807	25	130	mellitus	mellitus	NOUN
ajlm-1807	25	131	,	,	PUNCT
ajlm-1807	25	132	malignancies	malignancy	NOUN
ajlm-1807	25	133	,	,	PUNCT
ajlm-1807	25	134	renal	renal	ADJ
ajlm-1807	25	135	failure	failure	NOUN
ajlm-1807	25	136	,	,	PUNCT
ajlm-1807	25	137	burns	burn	NOUN
ajlm-1807	25	138	,	,	PUNCT
ajlm-1807	25	139	and	and	CCONJ
ajlm-1807	25	140	prior	prior	ADJ
ajlm-1807	25	141	hospitalisation.5	hospitalisation.5	NOUN
ajlm-1807	25	142	the	the	DET
ajlm-1807	25	143	mortality	mortality	NOUN
ajlm-1807	25	144	rate	rate	NOUN
ajlm-1807	25	145	from	from	ADP
ajlm-1807	25	146	bloodstream	bloodstream	NOUN
ajlm-1807	25	147	infections	infection	NOUN
ajlm-1807	25	148	ranges	range	VERB
ajlm-1807	25	149	from	from	ADP
ajlm-1807	25	150	4.0	4.0	NUM
ajlm-1807	25	151	%	%	NOUN
ajlm-1807	25	152	to	to	ADP
ajlm-1807	25	153	41.5	41.5	NUM
ajlm-1807	25	154	%	%	NOUN
ajlm-1807	25	155	depending	depend	VERB
ajlm-1807	25	156	on	on	ADP
ajlm-1807	25	157	severity	severity	NOUN
ajlm-1807	25	158	,	,	PUNCT
ajlm-1807	25	159	age	age	NOUN
ajlm-1807	25	160	,	,	PUNCT
ajlm-1807	25	161	sex	sex	NOUN
ajlm-1807	25	162	,	,	PUNCT
ajlm-1807	25	163	and	and	CCONJ
ajlm-1807	25	164	other	other	ADJ
ajlm-1807	25	165	risk	risk	NOUN
ajlm-1807	25	166	factors	factor	NOUN
ajlm-1807	25	167	.	.	PUNCT
ajlm-1807	26	1	infections	infection	NOUN
ajlm-1807	26	2	due	due	ADJ
ajlm-1807	26	3	to	to	ADP
ajlm-1807	26	4	antibiotic	antibiotic	ADJ
ajlm-1807	26	5	-	-	PUNCT
ajlm-1807	26	6	resistant	resistant	ADJ
ajlm-1807	26	7	strains	strain	NOUN
ajlm-1807	26	8	of	of	ADP
ajlm-1807	26	9	bacteria	bacteria	NOUN
ajlm-1807	26	10	present	present	ADJ
ajlm-1807	26	11	with	with	ADP
ajlm-1807	26	12	a	a	DET
ajlm-1807	26	13	significantly	significantly	ADV
ajlm-1807	26	14	higher	high	ADJ
ajlm-1807	26	15	morbidity	morbidity	NOUN
ajlm-1807	26	16	and	and	CCONJ
ajlm-1807	26	17	mortality.6	mortality.6	NOUN
ajlm-1807	26	18	blood	blood	NOUN
ajlm-1807	26	19	culture	culture	NOUN
ajlm-1807	26	20	remains	remain	VERB
ajlm-1807	26	21	the	the	DET
ajlm-1807	26	22	gold	gold	ADJ
ajlm-1807	26	23	standard	standard	NOUN
ajlm-1807	26	24	in	in	ADP
ajlm-1807	26	25	the	the	DET
ajlm-1807	26	26	laboratory	laboratory	NOUN
ajlm-1807	26	27	diagnosis	diagnosis	NOUN
ajlm-1807	26	28	and	and	CCONJ
ajlm-1807	26	29	identification	identification	NOUN
ajlm-1807	26	30	of	of	ADP
ajlm-1807	26	31	bloodstream	bloodstream	NOUN
ajlm-1807	26	32	pathogens	pathogen	NOUN
ajlm-1807	26	33	;	;	PUNCT
ajlm-1807	26	34	however	however	ADV
ajlm-1807	26	35	,	,	PUNCT
ajlm-1807	26	36	bacteria	bacteria	NOUN
ajlm-1807	26	37	are	be	AUX
ajlm-1807	26	38	not	not	PART
ajlm-1807	26	39	isolated	isolate	VERB
ajlm-1807	26	40	in	in	ADP
ajlm-1807	26	41	many	many	ADJ
ajlm-1807	26	42	cases	case	NOUN
ajlm-1807	26	43	of	of	ADP
ajlm-1807	26	44	bsi.7	bsi.7	PROPN
ajlm-1807	26	45	blood	blood	NOUN
ajlm-1807	26	46	culture	culture	NOUN
ajlm-1807	26	47	positivity	positivity	NOUN
ajlm-1807	26	48	rates	rate	NOUN
ajlm-1807	26	49	among	among	ADP
ajlm-1807	26	50	patients	patient	NOUN
ajlm-1807	26	51	with	with	ADP
ajlm-1807	26	52	bsi	bsi	PROPN
ajlm-1807	26	53	in	in	ADP
ajlm-1807	26	54	developing	develop	VERB
ajlm-1807	26	55	countries	country	NOUN
ajlm-1807	26	56	range	range	VERB
ajlm-1807	26	57	from	from	ADP
ajlm-1807	26	58	9.2	9.2	NUM
ajlm-1807	26	59	%	%	NOUN
ajlm-1807	26	60	to	to	ADP
ajlm-1807	26	61	44.0	44.0	NUM
ajlm-1807	26	62	%	%	NOUN
ajlm-1807	26	63	.	.	PUNCT
ajlm-1807	27	1	there	there	PRON
ajlm-1807	27	2	is	be	VERB
ajlm-1807	27	3	a	a	DET
ajlm-1807	27	4	paucity	paucity	NOUN
ajlm-1807	27	5	of	of	ADP
ajlm-1807	27	6	data	datum	NOUN
ajlm-1807	27	7	from	from	ADP
ajlm-1807	27	8	nigeria	nigeria	PROPN
ajlm-1807	27	9	on	on	ADP
ajlm-1807	27	10	bsi	bsi	PROPN
ajlm-1807	27	11	as	as	ADP
ajlm-1807	27	12	a	a	DET
ajlm-1807	27	13	result	result	NOUN
ajlm-1807	27	14	of	of	ADP
ajlm-1807	27	15	a	a	DET
ajlm-1807	27	16	poor	poor	ADJ
ajlm-1807	27	17	surveillance	surveillance	NOUN
ajlm-1807	27	18	system	system	NOUN
ajlm-1807	27	19	for	for	ADP
ajlm-1807	27	20	the	the	DET
ajlm-1807	27	21	associated	associated	ADJ
ajlm-1807	27	22	pathogens	pathogen	NOUN
ajlm-1807	27	23	,	,	PUNCT
ajlm-1807	27	24	thus	thus	ADV
ajlm-1807	27	25	depriving	deprive	VERB
ajlm-1807	27	26	us	we	PRON
ajlm-1807	27	27	of	of	ADP
ajlm-1807	27	28	any	any	DET
ajlm-1807	27	29	useful	useful	ADJ
ajlm-1807	27	30	antibiotic	antibiotic	ADJ
ajlm-1807	27	31	policy	policy	NOUN
ajlm-1807	27	32	or	or	CCONJ
ajlm-1807	27	33	treatment	treatment	NOUN
ajlm-1807	27	34	guidelines	guideline	NOUN
ajlm-1807	27	35	for	for	ADP
ajlm-1807	27	36	these	these	DET
ajlm-1807	27	37	infections.8,9	infections.8,9	PROPN
ajlm-1807	27	38	the	the	DET
ajlm-1807	27	39	few	few	ADJ
ajlm-1807	27	40	studies	study	NOUN
ajlm-1807	27	41	carried	carry	VERB
ajlm-1807	27	42	out	out	ADP
ajlm-1807	27	43	in	in	ADP
ajlm-1807	27	44	nigeria	nigeria	PROPN
ajlm-1807	27	45	on	on	ADP
ajlm-1807	27	46	bsis	bsis	NOUN
ajlm-1807	27	47	were	be	AUX
ajlm-1807	27	48	mainly	mainly	ADV
ajlm-1807	27	49	among	among	ADP
ajlm-1807	27	50	neonates	neonate	NOUN
ajlm-1807	27	51	and	and	CCONJ
ajlm-1807	27	52	younger	young	ADJ
ajlm-1807	27	53	children	child	NOUN
ajlm-1807	27	54	.	.	PUNCT
ajlm-1807	28	1	ogunkunle	ogunkunle	NOUN
ajlm-1807	28	2	et	et	PROPN
ajlm-1807	28	3	al	al	PROPN
ajlm-1807	28	4	.	.	PROPN
ajlm-1807	28	5	,	,	PUNCT
ajlm-1807	28	6	iregbu	iregbu	VERB
ajlm-1807	28	7	et	et	PROPN
ajlm-1807	28	8	al	al	PROPN
ajlm-1807	28	9	.	.	PROPN
ajlm-1807	28	10	,	,	PUNCT
ajlm-1807	28	11	and	and	CCONJ
ajlm-1807	28	12	uzodima	uzodima	PROPN
ajlm-1807	28	13	et	et	PROPN
ajlm-1807	28	14	al	al	PROPN
ajlm-1807	28	15	.	.	PROPN
ajlm-1807	28	16	,	,	PUNCT
ajlm-1807	28	17	all	all	ADV
ajlm-1807	28	18	from	from	ADP
ajlm-1807	28	19	nigeria	nigeria	PRON
ajlm-1807	28	20	,	,	PUNCT
ajlm-1807	28	21	reported	report	VERB
ajlm-1807	28	22	blood	blood	NOUN
ajlm-1807	28	23	culture	culture	NOUN
ajlm-1807	28	24	positivity	positivity	NOUN
ajlm-1807	28	25	rates	rate	NOUN
ajlm-1807	28	26	of	of	ADP
ajlm-1807	28	27	19.0	19.0	NUM
ajlm-1807	28	28	%	%	NOUN
ajlm-1807	28	29	,	,	PUNCT
ajlm-1807	28	30	22.0	22.0	NUM
ajlm-1807	28	31	%	%	NOUN
ajlm-1807	28	32	and	and	CCONJ
ajlm-1807	28	33	35.0	35.0	NUM
ajlm-1807	28	34	%	%	NOUN
ajlm-1807	28	35	,	,	PUNCT
ajlm-1807	28	36	respectively	respectively	ADV
ajlm-1807	28	37	,	,	PUNCT
ajlm-1807	28	38	among	among	ADP
ajlm-1807	28	39	suspected	suspect	VERB
ajlm-1807	28	40	cases	case	NOUN
ajlm-1807	28	41	of	of	ADP
ajlm-1807	28	42	bsi.10,11,12	bsi.10,11,12	ADJ
ajlm-1807	28	43	numerous	numerous	ADJ
ajlm-1807	28	44	bacteria	bacteria	NOUN
ajlm-1807	28	45	have	have	AUX
ajlm-1807	28	46	been	be	AUX
ajlm-1807	28	47	associated	associate	VERB
ajlm-1807	28	48	with	with	ADP
ajlm-1807	28	49	causation	causation	NOUN
ajlm-1807	28	50	of	of	ADP
ajlm-1807	28	51	bsis	bsis	NOUN
ajlm-1807	28	52	including	include	VERB
ajlm-1807	28	53	gram	gram	NOUN
ajlm-1807	28	54	-	-	PUNCT
ajlm-1807	28	55	negative	negative	ADJ
ajlm-1807	28	56	bacteria	bacteria	NOUN
ajlm-1807	28	57	:	:	PUNCT
ajlm-1807	28	58	escherichia	escherichia	NOUN
ajlm-1807	28	59	coli	coli	NOUN
ajlm-1807	28	60	,	,	PUNCT
ajlm-1807	28	61	pseudomonas	pseudomona	NOUN
ajlm-1807	28	62	species	specie	NOUN
ajlm-1807	28	63	(	(	PUNCT
ajlm-1807	28	64	spp	spp	NOUN
ajlm-1807	28	65	.	.	PUNCT
ajlm-1807	28	66	)	)	PUNCT
ajlm-1807	28	67	,	,	PUNCT
ajlm-1807	29	1	klebsiella	klebsiella	PROPN
ajlm-1807	29	2	spp	spp	PROPN
ajlm-1807	29	3	.	.	PROPN
ajlm-1807	29	4	,	,	PUNCT
ajlm-1807	29	5	serratia	serratia	PROPN
ajlm-1807	29	6	spp	spp	PROPN
ajlm-1807	29	7	.	.	PROPN
ajlm-1807	29	8	,	,	PUNCT
ajlm-1807	29	9	salmonella	salmonella	PROPN
ajlm-1807	29	10	spp	spp	NOUN
ajlm-1807	29	11	.	.	PUNCT
ajlm-1807	30	1	and	and	CCONJ
ajlm-1807	30	2	enterobacter	enterobacter	ADJ
ajlm-1807	30	3	spp	spp	NOUN
ajlm-1807	30	4	.	.	PUNCT
ajlm-1807	30	5	;	;	PUNCT
ajlm-1807	30	6	and	and	CCONJ
ajlm-1807	30	7	gram	gram	NOUN
ajlm-1807	30	8	-	-	PUNCT
ajlm-1807	30	9	positive	positive	ADJ
ajlm-1807	30	10	bacteria	bacteria	NOUN
ajlm-1807	30	11	:	:	PUNCT
ajlm-1807	30	12	staphylococcus	staphylococcus	NOUN
ajlm-1807	30	13	spp	spp	NOUN
ajlm-1807	30	14	.	.	PUNCT
ajlm-1807	30	15	,	,	PUNCT
ajlm-1807	30	16	streptococcus	streptococcus	VERB
ajlm-1807	30	17	spp	spp	NOUN
ajlm-1807	30	18	.	.	PUNCT
ajlm-1807	31	1	and	and	CCONJ
ajlm-1807	31	2	enterococcus	enterococcus	NOUN
ajlm-1807	31	3	spp.13,14	spp.13,14	ADV
ajlm-1807	31	4	however	however	ADV
ajlm-1807	31	5	,	,	PUNCT
ajlm-1807	31	6	recent	recent	ADJ
ajlm-1807	31	7	findings	finding	NOUN
ajlm-1807	31	8	suggested	suggest	VERB
ajlm-1807	31	9	an	an	DET
ajlm-1807	31	10	upsurge	upsurge	NOUN
ajlm-1807	31	11	in	in	ADP
ajlm-1807	31	12	bsis	bsis	NOUN
ajlm-1807	31	13	caused	cause	VERB
ajlm-1807	31	14	by	by	ADP
ajlm-1807	31	15	multidrug	multidrug	NOUN
ajlm-1807	31	16	-	-	PUNCT
ajlm-1807	31	17	resistant	resistant	ADJ
ajlm-1807	31	18	bacteria	bacteria	NOUN
ajlm-1807	31	19	,	,	PUNCT
ajlm-1807	31	20	including	include	VERB
ajlm-1807	31	21	the	the	DET
ajlm-1807	31	22	members	member	NOUN
ajlm-1807	31	23	of	of	ADP
ajlm-1807	31	24	the	the	DET
ajlm-1807	31	25	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-1807	31	26	family	family	NOUN
ajlm-1807	31	27	and	and	CCONJ
ajlm-1807	31	28	other	other	ADJ
ajlm-1807	31	29	gram	gram	ADJ
ajlm-1807	31	30	-	-	PUNCT
ajlm-1807	31	31	negative	negative	ADJ
ajlm-1807	31	32	bacteria	bacteria	NOUN
ajlm-1807	31	33	,	,	PUNCT
ajlm-1807	31	34	such	such	ADJ
ajlm-1807	31	35	as	as	ADP
ajlm-1807	31	36	klebsiella	klebsiella	PROPN
ajlm-1807	31	37	spp	spp	PROPN
ajlm-1807	31	38	.	.	PROPN
ajlm-1807	31	39	,	,	PUNCT
ajlm-1807	31	40	pseudomonas	pseudomona	VERB
ajlm-1807	31	41	spp	spp	NOUN
ajlm-1807	31	42	.	.	PROPN
ajlm-1807	31	43	,	,	PUNCT
ajlm-1807	31	44	acinetobacter	acinetobacter	PROPN
ajlm-1807	31	45	spp	spp	NOUN
ajlm-1807	31	46	.	.	PUNCT
ajlm-1807	32	1	and	and	CCONJ
ajlm-1807	32	2	citrobacter	citrobacter	PROPN
ajlm-1807	32	3	spp	spp	PROPN
ajlm-1807	32	4	.	.	PROPN
ajlm-1807	33	1	,	,	PUNCT
ajlm-1807	33	2	most	most	ADJ
ajlm-1807	33	3	of	of	ADP
ajlm-1807	33	4	which	which	PRON
ajlm-1807	33	5	are	be	AUX
ajlm-1807	33	6	extended	extend	VERB
ajlm-1807	33	7	spectrum	spectrum	NOUN
ajlm-1807	33	8	beta	beta	NOUN
ajlm-1807	33	9	-	-	PUNCT
ajlm-1807	33	10	lactamase	lactamase	NOUN
ajlm-1807	33	11	(	(	PUNCT
ajlm-1807	33	12	esbl	esbl	NOUN
ajlm-1807	33	13	)	)	PUNCT
ajlm-1807	33	14	producers	producer	NOUN
ajlm-1807	33	15	,	,	PUNCT
ajlm-1807	33	16	and	and	CCONJ
ajlm-1807	33	17	also	also	ADV
ajlm-1807	33	18	some	some	DET
ajlm-1807	33	19	gram	gram	ADJ
ajlm-1807	33	20	-	-	PUNCT
ajlm-1807	33	21	positive	positive	ADJ
ajlm-1807	33	22	bacteria	bacteria	NOUN
ajlm-1807	33	23	,	,	PUNCT
ajlm-1807	33	24	including	include	VERB
ajlm-1807	33	25	methicillin	methicillin	NOUN
ajlm-1807	33	26	-	-	PUNCT
ajlm-1807	33	27	resistant	resistant	ADJ
ajlm-1807	33	28	staphylococcus	staphylococcus	NOUN
ajlm-1807	33	29	aureus	aureus	NOUN
ajlm-1807	33	30	(	(	PUNCT
ajlm-1807	33	31	mrsa	mrsa	NOUN
ajlm-1807	33	32	)	)	PUNCT
ajlm-1807	33	33	and	and	CCONJ
ajlm-1807	33	34	the	the	DET
ajlm-1807	33	35	vancomycin	vancomycin	NOUN
ajlm-1807	33	36	-	-	PUNCT
ajlm-1807	33	37	resistant	resistant	ADJ
ajlm-1807	33	38	enterococci.15,16	enterococci.15,16	NOUN
ajlm-1807	33	39	the	the	DET
ajlm-1807	33	40	carbapenem	carbapenem	PROPN
ajlm-1807	33	41	antibiotics	antibiotic	NOUN
ajlm-1807	33	42	remain	remain	VERB
ajlm-1807	33	43	the	the	DET
ajlm-1807	33	44	antibiotic	antibiotic	ADJ
ajlm-1807	33	45	agents	agent	NOUN
ajlm-1807	33	46	of	of	ADP
ajlm-1807	33	47	choice	choice	NOUN
ajlm-1807	33	48	in	in	ADP
ajlm-1807	33	49	the	the	DET
ajlm-1807	33	50	management	management	NOUN
ajlm-1807	33	51	of	of	ADP
ajlm-1807	33	52	emerging	emerge	VERB
ajlm-1807	33	53	esbl	esbl	NOUN
ajlm-1807	33	54	-	-	PUNCT
ajlm-1807	33	55	producing	produce	VERB
ajlm-1807	33	56	gram	gram	NOUN
ajlm-1807	33	57	-	-	PUNCT
ajlm-1807	33	58	negative	negative	ADJ
ajlm-1807	33	59	bacteria	bacteria	NOUN
ajlm-1807	33	60	,	,	PUNCT
ajlm-1807	33	61	while	while	SCONJ
ajlm-1807	33	62	vancomycin	vancomycin	PROPN
ajlm-1807	33	63	is	be	AUX
ajlm-1807	33	64	the	the	DET
ajlm-1807	33	65	mainstay	mainstay	NOUN
ajlm-1807	33	66	in	in	ADP
ajlm-1807	33	67	treatment	treatment	NOUN
ajlm-1807	33	68	of	of	ADP
ajlm-1807	33	69	mrsa.17	mrsa.17	PROPN
ajlm-1807	33	70	however	however	ADV
ajlm-1807	33	71	,	,	PUNCT
ajlm-1807	33	72	of	of	ADP
ajlm-1807	33	73	particular	particular	ADJ
ajlm-1807	33	74	concern	concern	NOUN
ajlm-1807	33	75	is	be	AUX
ajlm-1807	33	76	the	the	DET
ajlm-1807	33	77	recent	recent	ADJ
ajlm-1807	33	78	emergence	emergence	NOUN
ajlm-1807	33	79	of	of	ADP
ajlm-1807	33	80	increasing	increase	VERB
ajlm-1807	33	81	resistance	resistance	NOUN
ajlm-1807	33	82	of	of	ADP
ajlm-1807	33	83	some	some	DET
ajlm-1807	33	84	gram	gram	NOUN
ajlm-1807	33	85	-	-	PUNCT
ajlm-1807	33	86	negative	negative	ADJ
ajlm-1807	33	87	bacteria	bacteria	NOUN
ajlm-1807	33	88	to	to	ADP
ajlm-1807	33	89	carbapenems	carbapenem	NOUN
ajlm-1807	33	90	through	through	ADP
ajlm-1807	33	91	the	the	DET
ajlm-1807	33	92	production	production	NOUN
ajlm-1807	33	93	of	of	ADP
ajlm-1807	33	94	enzymes	enzyme	NOUN
ajlm-1807	33	95	,	,	PUNCT
ajlm-1807	33	96	carbapenemases.18	carbapenemases.18	VERB
ajlm-1807	33	97	this	this	DET
ajlm-1807	33	98	trend	trend	NOUN
ajlm-1807	33	99	of	of	ADP
ajlm-1807	33	100	multidrug	multidrug	NOUN
ajlm-1807	33	101	resistance	resistance	NOUN
ajlm-1807	33	102	,	,	PUNCT
ajlm-1807	33	103	especially	especially	ADV
ajlm-1807	33	104	among	among	ADP
ajlm-1807	33	105	the	the	DET
ajlm-1807	33	106	gram	gram	NOUN
ajlm-1807	33	107	-	-	PUNCT
ajlm-1807	33	108	negative	negative	ADJ
ajlm-1807	33	109	bacteria	bacteria	NOUN
ajlm-1807	33	110	causing	cause	VERB
ajlm-1807	33	111	bsis	bsis	NOUN
ajlm-1807	33	112	,	,	PUNCT
ajlm-1807	33	113	has	have	AUX
ajlm-1807	33	114	created	create	VERB
ajlm-1807	33	115	a	a	DET
ajlm-1807	33	116	very	very	ADV
ajlm-1807	33	117	serious	serious	ADJ
ajlm-1807	33	118	therapeutic	therapeutic	ADJ
ajlm-1807	33	119	dilemma	dilemma	NOUN
ajlm-1807	33	120	,	,	PUNCT
ajlm-1807	33	121	especially	especially	ADV
ajlm-1807	33	122	in	in	ADP
ajlm-1807	33	123	the	the	DET
ajlm-1807	33	124	management	management	NOUN
ajlm-1807	33	125	of	of	ADP
ajlm-1807	33	126	intensive	intensive	ADJ
ajlm-1807	33	127	care	care	NOUN
ajlm-1807	33	128	unit	unit	NOUN
ajlm-1807	33	129	patients	patient	NOUN
ajlm-1807	33	130	,	,	PUNCT
ajlm-1807	33	131	since	since	SCONJ
ajlm-1807	33	132	it	it	PRON
ajlm-1807	33	133	leads	lead	VERB
ajlm-1807	33	134	to	to	ADP
ajlm-1807	33	135	fewer	few	ADJ
ajlm-1807	33	136	therapeutic	therapeutic	ADJ
ajlm-1807	33	137	options	option	NOUN
ajlm-1807	33	138	,	,	PUNCT
ajlm-1807	33	139	use	use	NOUN
ajlm-1807	33	140	of	of	ADP
ajlm-1807	33	141	more	more	ADV
ajlm-1807	33	142	expensive	expensive	ADJ
ajlm-1807	33	143	drugs	drug	NOUN
ajlm-1807	33	144	,	,	PUNCT
ajlm-1807	33	145	increased	increase	VERB
ajlm-1807	33	146	hospital	hospital	NOUN
ajlm-1807	33	147	stay	stay	NOUN
ajlm-1807	33	148	,	,	PUNCT
ajlm-1807	33	149	and	and	CCONJ
ajlm-1807	33	150	increased	increase	VERB
ajlm-1807	33	151	morbidity	morbidity	NOUN
ajlm-1807	33	152	and	and	CCONJ
ajlm-1807	33	153	mortality.19	mortality.19	NOUN
ajlm-1807	33	154	bearing	bear	VERB
ajlm-1807	33	155	in	in	ADP
ajlm-1807	33	156	mind	mind	NOUN
ajlm-1807	33	157	this	this	DET
ajlm-1807	33	158	trend	trend	NOUN
ajlm-1807	33	159	of	of	ADP
ajlm-1807	33	160	antibiotic	antibiotic	NOUN
ajlm-1807	33	161	-	-	PUNCT
ajlm-1807	33	162	resistant	resistant	ADJ
ajlm-1807	33	163	bacterial	bacterial	ADJ
ajlm-1807	33	164	agents	agent	NOUN
ajlm-1807	33	165	of	of	ADP
ajlm-1807	33	166	bsis	bsis	NOUN
ajlm-1807	33	167	and	and	CCONJ
ajlm-1807	33	168	the	the	DET
ajlm-1807	33	169	known	know	VERB
ajlm-1807	33	170	fact	fact	NOUN
ajlm-1807	33	171	that	that	SCONJ
ajlm-1807	33	172	antibiotic	antibiotic	ADJ
ajlm-1807	33	173	-	-	PUNCT
ajlm-1807	33	174	resistance	resistance	NOUN
ajlm-1807	33	175	patterns	pattern	NOUN
ajlm-1807	33	176	vary	vary	VERB
ajlm-1807	33	177	with	with	ADP
ajlm-1807	33	178	geographical	geographical	ADJ
ajlm-1807	33	179	locations	location	NOUN
ajlm-1807	33	180	,	,	PUNCT
ajlm-1807	33	181	regular	regular	ADJ
ajlm-1807	33	182	surveillance	surveillance	NOUN
ajlm-1807	33	183	and	and	CCONJ
ajlm-1807	33	184	documentation	documentation	NOUN
ajlm-1807	33	185	of	of	ADP
ajlm-1807	33	186	blood	blood	NOUN
ajlm-1807	33	187	culture	culture	NOUN
ajlm-1807	33	188	isolates	isolate	NOUN
ajlm-1807	33	189	and	and	CCONJ
ajlm-1807	33	190	their	their	PRON
ajlm-1807	33	191	antibiogram	antibiogram	PROPN
ajlm-1807	33	192	is	be	AUX
ajlm-1807	33	193	imperative	imperative	ADJ
ajlm-1807	33	194	in	in	ADP
ajlm-1807	33	195	formulating	formulate	VERB
ajlm-1807	33	196	an	an	DET
ajlm-1807	33	197	antibiotic	antibiotic	ADJ
ajlm-1807	33	198	policy	policy	NOUN
ajlm-1807	33	199	and	and	CCONJ
ajlm-1807	33	200	identifying	identify	VERB
ajlm-1807	33	201	the	the	DET
ajlm-1807	33	202	best	good	ADJ
ajlm-1807	33	203	empirical	empirical	ADJ
ajlm-1807	33	204	antibiotic	antibiotic	ADJ
ajlm-1807	33	205	therapeutic	therapeutic	ADJ
ajlm-1807	33	206	options	option	NOUN
ajlm-1807	33	207	for	for	ADP
ajlm-1807	33	208	different	different	ADJ
ajlm-1807	33	209	scenarios	scenario	NOUN
ajlm-1807	33	210	of	of	ADP
ajlm-1807	33	211	bsis	bsis	NOUN
ajlm-1807	33	212	in	in	ADP
ajlm-1807	33	213	each	each	DET
ajlm-1807	33	214	hospital	hospital	NOUN
ajlm-1807	33	215	environment.20	environment.20	NOUN
ajlm-1807	33	216	this	this	PRON
ajlm-1807	33	217	will	will	AUX
ajlm-1807	33	218	encourage	encourage	VERB
ajlm-1807	33	219	‘	'	PUNCT
ajlm-1807	33	220	rational	rational	ADJ
ajlm-1807	33	221	use	use	NOUN
ajlm-1807	33	222	’	'	PUNCT
ajlm-1807	33	223	of	of	ADP
ajlm-1807	33	224	antibiotics	antibiotic	NOUN
ajlm-1807	33	225	and	and	CCONJ
ajlm-1807	33	226	reduce	reduce	VERB
ajlm-1807	33	227	the	the	DET
ajlm-1807	33	228	tendency	tendency	NOUN
ajlm-1807	33	229	towards	towards	ADP
ajlm-1807	33	230	increasing	increase	VERB
ajlm-1807	33	231	antibiotic	antibiotic	ADJ
ajlm-1807	33	232	-	-	PUNCT
ajlm-1807	33	233	resistance	resistance	NOUN
ajlm-1807	33	234	.	.	PUNCT
ajlm-1807	34	1	there	there	PRON
ajlm-1807	34	2	have	have	AUX
ajlm-1807	34	3	been	be	AUX
ajlm-1807	34	4	random	random	ADJ
ajlm-1807	34	5	reports	report	NOUN
ajlm-1807	34	6	of	of	ADP
ajlm-1807	34	7	multiple	multiple	ADJ
ajlm-1807	34	8	antibiotic	antibiotic	ADJ
ajlm-1807	34	9	-	-	PUNCT
ajlm-1807	34	10	resistant	resistant	ADJ
ajlm-1807	34	11	isolates	isolate	NOUN
ajlm-1807	34	12	causing	cause	VERB
ajlm-1807	34	13	a	a	DET
ajlm-1807	34	14	therapeutic	therapeutic	ADJ
ajlm-1807	34	15	dilemma	dilemma	NOUN
ajlm-1807	34	16	among	among	ADP
ajlm-1807	34	17	patients	patient	NOUN
ajlm-1807	34	18	with	with	ADP
ajlm-1807	34	19	bsis	bsis	NOUN
ajlm-1807	34	20	in	in	ADP
ajlm-1807	34	21	our	our	PRON
ajlm-1807	34	22	hospital	hospital	NOUN
ajlm-1807	34	23	with	with	ADP
ajlm-1807	34	24	occasional	occasional	ADJ
ajlm-1807	34	25	attendant	attendant	ADJ
ajlm-1807	34	26	case	case	NOUN
ajlm-1807	34	27	fatalities	fatality	NOUN
ajlm-1807	34	28	in	in	ADP
ajlm-1807	34	29	the	the	DET
ajlm-1807	34	30	past	past	ADJ
ajlm-1807	34	31	years	year	NOUN
ajlm-1807	34	32	.	.	PUNCT
ajlm-1807	35	1	also	also	ADV
ajlm-1807	35	2	,	,	PUNCT
ajlm-1807	35	3	there	there	PRON
ajlm-1807	35	4	was	be	VERB
ajlm-1807	35	5	no	no	DET
ajlm-1807	35	6	existing	exist	VERB
ajlm-1807	35	7	antibiotic	antibiotic	ADJ
ajlm-1807	35	8	policy	policy	NOUN
ajlm-1807	35	9	or	or	CCONJ
ajlm-1807	35	10	treatment	treatment	NOUN
ajlm-1807	35	11	guideline	guideline	NOUN
ajlm-1807	35	12	for	for	ADP
ajlm-1807	35	13	bsi	bsi	PROPN
ajlm-1807	35	14	management	management	NOUN
ajlm-1807	35	15	in	in	ADP
ajlm-1807	35	16	our	our	PRON
ajlm-1807	35	17	centre	centre	NOUN
ajlm-1807	35	18	,	,	PUNCT
ajlm-1807	35	19	as	as	SCONJ
ajlm-1807	35	20	there	there	PRON
ajlm-1807	35	21	was	be	VERB
ajlm-1807	35	22	poor	poor	ADJ
ajlm-1807	35	23	or	or	CCONJ
ajlm-1807	35	24	non	non	ADJ
ajlm-1807	35	25	-	-	ADJ
ajlm-1807	35	26	existent	existent	ADJ
ajlm-1807	35	27	surveillance	surveillance	NOUN
ajlm-1807	35	28	for	for	ADP
ajlm-1807	35	29	these	these	DET
ajlm-1807	35	30	multiple	multiple	ADJ
ajlm-1807	35	31	antibiotic	antibiotic	ADJ
ajlm-1807	35	32	-	-	PUNCT
ajlm-1807	35	33	resistant	resistant	ADJ
ajlm-1807	35	34	pathogens	pathogen	NOUN
ajlm-1807	35	35	.	.	PUNCT
ajlm-1807	36	1	these	these	DET
ajlm-1807	36	2	factors	factor	NOUN
ajlm-1807	36	3	necessitated	necessitate	VERB
ajlm-1807	36	4	this	this	DET
ajlm-1807	36	5	study	study	NOUN
ajlm-1807	36	6	.	.	PUNCT
ajlm-1807	37	1	the	the	DET
ajlm-1807	37	2	objectives	objective	NOUN
ajlm-1807	37	3	of	of	ADP
ajlm-1807	37	4	this	this	DET
ajlm-1807	37	5	study	study	NOUN
ajlm-1807	37	6	are	be	AUX
ajlm-1807	37	7	:	:	PUNCT
ajlm-1807	37	8	to	to	PART
ajlm-1807	37	9	isolate	isolate	VERB
ajlm-1807	37	10	and	and	CCONJ
ajlm-1807	37	11	identify	identify	VERB
ajlm-1807	37	12	different	different	ADJ
ajlm-1807	37	13	bacterial	bacterial	ADJ
ajlm-1807	37	14	causes	cause	NOUN
ajlm-1807	37	15	of	of	ADP
ajlm-1807	37	16	bsis	bsis	NOUN
ajlm-1807	37	17	;	;	PUNCT
ajlm-1807	37	18	to	to	PART
ajlm-1807	37	19	determine	determine	VERB
ajlm-1807	37	20	the	the	DET
ajlm-1807	37	21	antibiotic	antibiotic	ADJ
ajlm-1807	37	22	susceptibility	susceptibility	NOUN
ajlm-1807	37	23	patterns	pattern	NOUN
ajlm-1807	37	24	of	of	ADP
ajlm-1807	37	25	isolated	isolated	ADJ
ajlm-1807	37	26	bacteria	bacteria	NOUN
ajlm-1807	37	27	;	;	PUNCT
ajlm-1807	37	28	and	and	CCONJ
ajlm-1807	37	29	to	to	PART
ajlm-1807	37	30	suggest	suggest	VERB
ajlm-1807	37	31	the	the	DET
ajlm-1807	37	32	best	good	ADJ
ajlm-1807	37	33	empirical	empirical	ADJ
ajlm-1807	37	34	treatment	treatment	NOUN
ajlm-1807	37	35	of	of	ADP
ajlm-1807	37	36	bsis	bsis	NOUN
ajlm-1807	37	37	in	in	ADP
ajlm-1807	37	38	different	different	ADJ
ajlm-1807	37	39	scenarios	scenario	NOUN
ajlm-1807	37	40	in	in	ADP
ajlm-1807	37	41	the	the	DET
ajlm-1807	37	42	hospital	hospital	NOUN
ajlm-1807	37	43	.	.	PUNCT
ajlm-1807	38	1	methods	method	NOUN
ajlm-1807	38	2	ethical	ethical	ADJ
ajlm-1807	38	3	considerations	consideration	NOUN
ajlm-1807	38	4	ethical	ethical	ADJ
ajlm-1807	38	5	approval	approval	NOUN
ajlm-1807	38	6	(	(	PUNCT
ajlm-1807	38	7	protocol	protocol	NOUN
ajlm-1807	38	8	number	number	NOUN
ajlm-1807	38	9	:	:	PUNCT
ajlm-1807	38	10	erc/2020/10/16/431a	erc/2020/10/16/431a	NOUN
ajlm-1807	38	11	)	)	PUNCT
ajlm-1807	38	12	for	for	ADP
ajlm-1807	38	13	the	the	DET
ajlm-1807	38	14	study	study	NOUN
ajlm-1807	38	15	was	be	AUX
ajlm-1807	38	16	obtained	obtain	VERB
ajlm-1807	38	17	from	from	ADP
ajlm-1807	38	18	the	the	DET
ajlm-1807	38	19	human	human	ADJ
ajlm-1807	38	20	research	research	NOUN
ajlm-1807	38	21	and	and	CCONJ
ajlm-1807	38	22	ethics	ethic	NOUN
ajlm-1807	38	23	committee	committee	NOUN
ajlm-1807	38	24	,	,	PUNCT
ajlm-1807	38	25	federal	federal	ADJ
ajlm-1807	38	26	teaching	teaching	NOUN
ajlm-1807	38	27	hospital	hospital	NOUN
ajlm-1807	38	28	,	,	PUNCT
ajlm-1807	38	29	ido	ido	NOUN
ajlm-1807	38	30	-	-	PUNCT
ajlm-1807	38	31	ekiti	ekiti	PROPN
ajlm-1807	38	32	,	,	PUNCT
ajlm-1807	38	33	nigeria	nigeria	PROPN
ajlm-1807	38	34	.	.	PUNCT
ajlm-1807	39	1	written	write	VERB
ajlm-1807	39	2	informed	informed	ADJ
ajlm-1807	39	3	consent	consent	NOUN
ajlm-1807	39	4	was	be	AUX
ajlm-1807	39	5	also	also	ADV
ajlm-1807	39	6	obtained	obtain	VERB
ajlm-1807	39	7	from	from	ADP
ajlm-1807	39	8	all	all	DET
ajlm-1807	39	9	participants	participant	NOUN
ajlm-1807	39	10	prior	prior	ADV
ajlm-1807	39	11	to	to	ADP
ajlm-1807	39	12	inclusion	inclusion	NOUN
ajlm-1807	39	13	in	in	ADP
ajlm-1807	39	14	the	the	DET
ajlm-1807	39	15	study	study	NOUN
ajlm-1807	39	16	.	.	PUNCT
ajlm-1807	40	1	for	for	ADP
ajlm-1807	40	2	underage	underage	ADJ
ajlm-1807	40	3	participants	participant	NOUN
ajlm-1807	40	4	,	,	PUNCT
ajlm-1807	40	5	consent	consent	NOUN
ajlm-1807	40	6	was	be	AUX
ajlm-1807	40	7	sought	seek	VERB
ajlm-1807	40	8	and	and	CCONJ
ajlm-1807	40	9	obtained	obtain	VERB
ajlm-1807	40	10	from	from	ADP
ajlm-1807	40	11	the	the	DET
ajlm-1807	40	12	parent	parent	NOUN
ajlm-1807	40	13	/	/	SYM
ajlm-1807	40	14	guardian	guardian	NOUN
ajlm-1807	40	15	.	.	PUNCT
ajlm-1807	41	1	participants	participant	NOUN
ajlm-1807	41	2	were	be	AUX
ajlm-1807	41	3	de	de	ADJ
ajlm-1807	41	4	-	-	VERB
ajlm-1807	41	5	identified	identify	VERB
ajlm-1807	41	6	by	by	ADP
ajlm-1807	41	7	encoding	encode	VERB
ajlm-1807	41	8	their	their	PRON
ajlm-1807	41	9	names	name	NOUN
ajlm-1807	41	10	with	with	ADP
ajlm-1807	41	11	research	research	NOUN
ajlm-1807	41	12	numbers	number	NOUN
ajlm-1807	41	13	determined	determine	VERB
ajlm-1807	41	14	based	base	VERB
ajlm-1807	41	15	on	on	ADP
ajlm-1807	41	16	the	the	DET
ajlm-1807	41	17	units	unit	NOUN
ajlm-1807	41	18	from	from	ADP
ajlm-1807	41	19	which	which	PRON
ajlm-1807	41	20	participants	participant	NOUN
ajlm-1807	41	21	were	be	AUX
ajlm-1807	41	22	recruited	recruit	VERB
ajlm-1807	41	23	.	.	PUNCT
ajlm-1807	42	1	study	study	NOUN
ajlm-1807	42	2	design	design	NOUN
ajlm-1807	42	3	and	and	CCONJ
ajlm-1807	42	4	hospital	hospital	NOUN
ajlm-1807	42	5	setting	set	VERB
ajlm-1807	42	6	this	this	DET
ajlm-1807	42	7	cross	cross	ADJ
ajlm-1807	42	8	-	-	ADJ
ajlm-1807	42	9	sectional	sectional	ADJ
ajlm-1807	42	10	study	study	NOUN
ajlm-1807	42	11	was	be	AUX
ajlm-1807	42	12	conducted	conduct	VERB
ajlm-1807	42	13	at	at	ADP
ajlm-1807	42	14	the	the	DET
ajlm-1807	42	15	department	department	PROPN
ajlm-1807	42	16	of	of	ADP
ajlm-1807	42	17	medical	medical	ADJ
ajlm-1807	42	18	microbiology	microbiology	NOUN
ajlm-1807	42	19	and	and	CCONJ
ajlm-1807	42	20	parasitology	parasitology	NOUN
ajlm-1807	42	21	of	of	ADP
ajlm-1807	42	22	federal	federal	ADJ
ajlm-1807	42	23	teaching	teaching	NOUN
ajlm-1807	42	24	hospital	hospital	NOUN
ajlm-1807	42	25	,	,	PUNCT
ajlm-1807	42	26	ido	ido	NOUN
ajlm-1807	42	27	-	-	PUNCT
ajlm-1807	42	28	ekiti	ekiti	PROPN
ajlm-1807	42	29	,	,	PUNCT
ajlm-1807	42	30	a	a	DET
ajlm-1807	42	31	rural	rural	ADJ
ajlm-1807	42	32	southwestern	southwestern	ADJ
ajlm-1807	42	33	nigerian	nigerian	ADJ
ajlm-1807	42	34	teaching	teaching	NOUN
ajlm-1807	42	35	hospital	hospital	NOUN
ajlm-1807	42	36	.	.	PUNCT
ajlm-1807	43	1	the	the	DET
ajlm-1807	43	2	hospital	hospital	NOUN
ajlm-1807	43	3	is	be	AUX
ajlm-1807	43	4	a	a	DET
ajlm-1807	43	5	tertiary	tertiary	ADJ
ajlm-1807	43	6	health	health	NOUN
ajlm-1807	43	7	facility	facility	NOUN
ajlm-1807	43	8	which	which	PRON
ajlm-1807	43	9	serves	serve	VERB
ajlm-1807	43	10	as	as	ADP
ajlm-1807	43	11	a	a	DET
ajlm-1807	43	12	referral	referral	ADJ
ajlm-1807	43	13	centre	centre	NOUN
ajlm-1807	43	14	to	to	ADP
ajlm-1807	43	15	other	other	ADJ
ajlm-1807	43	16	primary	primary	ADJ
ajlm-1807	43	17	and	and	CCONJ
ajlm-1807	43	18	secondary	secondary	ADJ
ajlm-1807	43	19	healthcare	healthcare	NOUN
ajlm-1807	43	20	facilities	facility	NOUN
ajlm-1807	43	21	in	in	ADP
ajlm-1807	43	22	ekiti	ekiti	PROPN
ajlm-1807	43	23	state	state	PROPN
ajlm-1807	43	24	,	,	PUNCT
ajlm-1807	43	25	nigeria	nigeria	PROPN
ajlm-1807	43	26	.	.	PUNCT
ajlm-1807	44	1	it	it	PRON
ajlm-1807	44	2	is	be	AUX
ajlm-1807	44	3	a	a	DET
ajlm-1807	44	4	290	290	NUM
ajlm-1807	44	5	-	-	PUNCT
ajlm-1807	44	6	bed	bed	NOUN
ajlm-1807	44	7	hospital	hospital	NOUN
ajlm-1807	44	8	with	with	ADP
ajlm-1807	44	9	many	many	ADJ
ajlm-1807	44	10	modern	modern	ADJ
ajlm-1807	44	11	facilities	facility	NOUN
ajlm-1807	44	12	for	for	ADP
ajlm-1807	44	13	healthcare	healthcare	NOUN
ajlm-1807	44	14	.	.	PUNCT
ajlm-1807	45	1	study	study	NOUN
ajlm-1807	45	2	population	population	NOUN
ajlm-1807	45	3	and	and	CCONJ
ajlm-1807	45	4	sampling	sample	VERB
ajlm-1807	45	5	method	method	NOUN
ajlm-1807	45	6	using	use	VERB
ajlm-1807	45	7	a	a	DET
ajlm-1807	45	8	simple	simple	ADJ
ajlm-1807	45	9	random	random	ADJ
ajlm-1807	45	10	sampling	sampling	NOUN
ajlm-1807	45	11	technique	technique	NOUN
ajlm-1807	45	12	,	,	PUNCT
ajlm-1807	45	13	a	a	DET
ajlm-1807	45	14	total	total	NOUN
ajlm-1807	45	15	of	of	ADP
ajlm-1807	45	16	177	177	NUM
ajlm-1807	45	17	clinically	clinically	ADV
ajlm-1807	45	18	diagnosed	diagnose	VERB
ajlm-1807	45	19	bsi	bsi	NOUN
ajlm-1807	45	20	patients	patient	NOUN
ajlm-1807	45	21	were	be	AUX
ajlm-1807	45	22	recruited	recruit	VERB
ajlm-1807	45	23	into	into	ADP
ajlm-1807	45	24	the	the	DET
ajlm-1807	45	25	study	study	NOUN
ajlm-1807	45	26	,	,	PUNCT
ajlm-1807	45	27	thus	thus	ADV
ajlm-1807	45	28	a	a	DET
ajlm-1807	45	29	total	total	NOUN
ajlm-1807	45	30	of	of	ADP
ajlm-1807	45	31	177	177	NUM
ajlm-1807	45	32	blood	blood	NOUN
ajlm-1807	45	33	culture	culture	NOUN
ajlm-1807	45	34	samples	sample	NOUN
ajlm-1807	45	35	from	from	ADP
ajlm-1807	45	36	different	different	ADJ
ajlm-1807	45	37	hospital	hospital	NOUN
ajlm-1807	45	38	units	unit	NOUN
ajlm-1807	45	39	were	be	AUX
ajlm-1807	45	40	received	receive	VERB
ajlm-1807	45	41	and	and	CCONJ
ajlm-1807	45	42	investigated	investigate	VERB
ajlm-1807	45	43	at	at	ADP
ajlm-1807	45	44	the	the	DET
ajlm-1807	45	45	medical	medical	ADJ
ajlm-1807	45	46	microbiology	microbiology	NOUN
ajlm-1807	45	47	laboratory	laboratory	NOUN
ajlm-1807	45	48	of	of	ADP
ajlm-1807	45	49	the	the	DET
ajlm-1807	45	50	hospital	hospital	NOUN
ajlm-1807	45	51	between	between	ADP
ajlm-1807	45	52	june	june	PROPN
ajlm-1807	45	53	2020	2020	NUM
ajlm-1807	45	54	and	and	CCONJ
ajlm-1807	45	55	february	february	PROPN
ajlm-1807	45	56	2021	2021	NUM
ajlm-1807	45	57	.	.	PUNCT
ajlm-1807	46	1	patients	patient	NOUN
ajlm-1807	46	2	’	'	PUNCT
ajlm-1807	46	3	clinical	clinical	ADJ
ajlm-1807	46	4	history	history	NOUN
ajlm-1807	46	5	and	and	CCONJ
ajlm-1807	46	6	other	other	ADJ
ajlm-1807	46	7	relevant	relevant	ADJ
ajlm-1807	46	8	details	detail	NOUN
ajlm-1807	46	9	were	be	AUX
ajlm-1807	46	10	recorded	record	VERB
ajlm-1807	46	11	in	in	ADP
ajlm-1807	46	12	a	a	DET
ajlm-1807	46	13	predesigned	predesigned	ADJ
ajlm-1807	46	14	form	form	NOUN
ajlm-1807	46	15	.	.	PUNCT
ajlm-1807	47	1	blood	blood	NOUN
ajlm-1807	47	2	sample	sample	NOUN
ajlm-1807	47	3	collection	collection	NOUN
ajlm-1807	47	4	and	and	CCONJ
ajlm-1807	47	5	processing	process	VERB
ajlm-1807	47	6	a	a	DET
ajlm-1807	47	7	set	set	NOUN
ajlm-1807	47	8	of	of	ADP
ajlm-1807	47	9	two	two	NUM
ajlm-1807	47	10	venous	venous	ADJ
ajlm-1807	47	11	blood	blood	NOUN
ajlm-1807	47	12	samples	sample	NOUN
ajlm-1807	47	13	from	from	ADP
ajlm-1807	47	14	two	two	NUM
ajlm-1807	47	15	different	different	ADJ
ajlm-1807	47	16	sites	site	NOUN
ajlm-1807	47	17	were	be	AUX
ajlm-1807	47	18	collected	collect	VERB
ajlm-1807	47	19	30	30	NUM
ajlm-1807	47	20	minutes	minute	NOUN
ajlm-1807	47	21	apart	apart	ADV
ajlm-1807	47	22	from	from	ADP
ajlm-1807	47	23	each	each	DET
ajlm-1807	47	24	participant	participant	NOUN
ajlm-1807	47	25	with	with	ADP
ajlm-1807	47	26	suspected	suspect	VERB
ajlm-1807	47	27	bsi	bsi	PROPN
ajlm-1807	47	28	,	,	PUNCT
ajlm-1807	47	29	following	follow	VERB
ajlm-1807	47	30	strict	strict	ADJ
ajlm-1807	47	31	aseptic	aseptic	ADJ
ajlm-1807	47	32	precautions	precaution	NOUN
ajlm-1807	47	33	before	before	ADP
ajlm-1807	47	34	commencement	commencement	NOUN
ajlm-1807	47	35	of	of	ADP
ajlm-1807	47	36	antibiotic	antibiotic	ADJ
ajlm-1807	47	37	treatment	treatment	NOUN
ajlm-1807	47	38	.	.	PUNCT
ajlm-1807	48	1	each	each	DET
ajlm-1807	48	2	set	set	NOUN
ajlm-1807	48	3	consisted	consist	VERB
ajlm-1807	48	4	of	of	ADP
ajlm-1807	48	5	8	8	NUM
ajlm-1807	48	6	ml	ml	NOUN
ajlm-1807	48	7	–	–	PUNCT
ajlm-1807	48	8	10	10	NUM
ajlm-1807	48	9	ml	ml	NOUN
ajlm-1807	48	10	of	of	ADP
ajlm-1807	48	11	venous	venous	ADJ
ajlm-1807	48	12	blood	blood	NOUN
ajlm-1807	48	13	from	from	ADP
ajlm-1807	48	14	adults	adult	NOUN
ajlm-1807	48	15	,	,	PUNCT
ajlm-1807	48	16	2	2	NUM
ajlm-1807	48	17	ml	ml	NOUN
ajlm-1807	48	18	of	of	ADP
ajlm-1807	48	19	venous	venous	ADJ
ajlm-1807	48	20	blood	blood	NOUN
ajlm-1807	48	21	from	from	ADP
ajlm-1807	48	22	neonates	neonate	NOUN
ajlm-1807	48	23	and	and	CCONJ
ajlm-1807	48	24	2	2	NUM
ajlm-1807	48	25	ml	ml	NOUN
ajlm-1807	48	26	–	–	PUNCT
ajlm-1807	48	27	5	5	NUM
ajlm-1807	48	28	ml	ml	NOUN
ajlm-1807	48	29	from	from	ADP
ajlm-1807	48	30	other	other	ADJ
ajlm-1807	48	31	paediatric	paediatric	ADJ
ajlm-1807	48	32	patients	patient	NOUN
ajlm-1807	48	33	.	.	PUNCT
ajlm-1807	49	1	blood	blood	NOUN
ajlm-1807	49	2	samples	sample	NOUN
ajlm-1807	49	3	were	be	AUX
ajlm-1807	49	4	immediately	immediately	ADV
ajlm-1807	49	5	inoculated	inoculate	VERB
ajlm-1807	49	6	into	into	ADP
ajlm-1807	49	7	bact	bact	NOUN
ajlm-1807	49	8	/	/	SYM
ajlm-1807	49	9	alert	alert	ADJ
ajlm-1807	49	10	®	®	NOUN
ajlm-1807	49	11	(	(	PUNCT
ajlm-1807	49	12	biomérieux	biomérieux	PROPN
ajlm-1807	49	13	,	,	PUNCT
ajlm-1807	49	14	inc	inc	PROPN
ajlm-1807	49	15	.	.	PROPN
ajlm-1807	49	16	,	,	PUNCT
ajlm-1807	49	17	durham	durham	PROPN
ajlm-1807	49	18	,	,	PUNCT
ajlm-1807	49	19	north	north	PROPN
ajlm-1807	49	20	carolina	carolina	PROPN
ajlm-1807	49	21	,	,	PUNCT
ajlm-1807	49	22	united	united	PROPN
ajlm-1807	49	23	states	states	PROPN
ajlm-1807	49	24	)	)	PUNCT
ajlm-1807	49	25	aerobic	aerobic	ADJ
ajlm-1807	49	26	blood	blood	NOUN
ajlm-1807	49	27	culture	culture	NOUN
ajlm-1807	49	28	bottles	bottle	NOUN
ajlm-1807	49	29	(	(	PUNCT
ajlm-1807	49	30	adult	adult	NOUN
ajlm-1807	49	31	or	or	CCONJ
ajlm-1807	49	32	paediatric	paediatric	ADJ
ajlm-1807	49	33	bottles	bottle	NOUN
ajlm-1807	49	34	,	,	PUNCT
ajlm-1807	49	35	as	as	ADP
ajlm-1807	49	36	necessary	necessary	ADJ
ajlm-1807	49	37	)	)	PUNCT
ajlm-1807	49	38	.	.	PUNCT
ajlm-1807	50	1	these	these	DET
ajlm-1807	50	2	bottles	bottle	NOUN
ajlm-1807	50	3	were	be	AUX
ajlm-1807	50	4	immediately	immediately	ADV
ajlm-1807	50	5	incubated	incubate	VERB
ajlm-1807	50	6	in	in	ADP
ajlm-1807	50	7	a	a	DET
ajlm-1807	50	8	bact	bact	NOUN
ajlm-1807	50	9	/	/	SYM
ajlm-1807	50	10	alert	alert	ADJ
ajlm-1807	50	11	®	®	NOUN
ajlm-1807	50	12	3d	3d	NUM
ajlm-1807	50	13	automated	automate	VERB
ajlm-1807	50	14	blood	blood	NOUN
ajlm-1807	50	15	culture	culture	NOUN
ajlm-1807	50	16	analyser	analyser	NOUN
ajlm-1807	50	17	(	(	PUNCT
ajlm-1807	50	18	biomérieux	biomérieux	PROPN
ajlm-1807	50	19	,	,	PUNCT
ajlm-1807	50	20	inc	inc	PROPN
ajlm-1807	50	21	.	.	PROPN
ajlm-1807	50	22	,	,	PUNCT
ajlm-1807	50	23	durham	durham	PROPN
ajlm-1807	50	24	,	,	PUNCT
ajlm-1807	50	25	north	north	PROPN
ajlm-1807	50	26	caroline	caroline	PROPN
ajlm-1807	50	27	,	,	PUNCT
ajlm-1807	50	28	united	united	PROPN
ajlm-1807	50	29	states	states	PROPN
ajlm-1807	50	30	)	)	PUNCT
ajlm-1807	50	31	.	.	PUNCT
ajlm-1807	51	1	all	all	DET
ajlm-1807	51	2	bact	bact	NOUN
ajlm-1807	51	3	/	/	SYM
ajlm-1807	51	4	alert	alert	ADJ
ajlm-1807	51	5	-	-	PUNCT
ajlm-1807	51	6	positive	positive	ADJ
ajlm-1807	51	7	broths	broth	NOUN
ajlm-1807	51	8	were	be	AUX
ajlm-1807	51	9	immediately	immediately	ADV
ajlm-1807	51	10	brought	bring	VERB
ajlm-1807	51	11	out	out	ADP
ajlm-1807	51	12	for	for	ADP
ajlm-1807	51	13	subculture	subculture	NOUN
ajlm-1807	51	14	onto	onto	ADP
ajlm-1807	51	15	blood	blood	NOUN
ajlm-1807	51	16	agar	agar	NOUN
ajlm-1807	51	17	(	(	PUNCT
ajlm-1807	51	18	oxoid	oxoid	PROPN
ajlm-1807	51	19	,	,	PUNCT
ajlm-1807	51	20	wade	wade	PROPN
ajlm-1807	51	21	road	road	PROPN
ajlm-1807	51	22	,	,	PUNCT
ajlm-1807	51	23	basingstoke	basingstoke	PROPN
ajlm-1807	51	24	,	,	PUNCT
ajlm-1807	51	25	united	united	ADJ
ajlm-1807	51	26	kingdom	kingdom	PROPN
ajlm-1807	51	27	)	)	PUNCT
ajlm-1807	51	28	and	and	CCONJ
ajlm-1807	51	29	macconkey	macconkey	NOUN
ajlm-1807	51	30	agar	agar	NOUN
ajlm-1807	51	31	(	(	PUNCT
ajlm-1807	51	32	oxoid	oxoid	PROPN
ajlm-1807	51	33	,	,	PUNCT
ajlm-1807	51	34	basingstoke	basingstoke	PROPN
ajlm-1807	51	35	,	,	PUNCT
ajlm-1807	51	36	united	united	ADJ
ajlm-1807	51	37	kingdom	kingdom	PROPN
ajlm-1807	51	38	)	)	PUNCT
ajlm-1807	51	39	.	.	PUNCT
ajlm-1807	52	1	for	for	ADP
ajlm-1807	52	2	those	those	DET
ajlm-1807	52	3	bottles	bottle	NOUN
ajlm-1807	52	4	without	without	ADP
ajlm-1807	52	5	positive	positive	ADJ
ajlm-1807	52	6	signals	signal	NOUN
ajlm-1807	52	7	,	,	PUNCT
ajlm-1807	52	8	blind	blind	ADJ
ajlm-1807	52	9	subculture	subculture	NOUN
ajlm-1807	52	10	onto	onto	ADP
ajlm-1807	52	11	blood	blood	NOUN
ajlm-1807	52	12	agar	agar	NOUN
ajlm-1807	52	13	and	and	CCONJ
ajlm-1807	52	14	macconkey	macconkey	NOUN
ajlm-1807	52	15	agar	agar	NOUN
ajlm-1807	52	16	was	be	AUX
ajlm-1807	52	17	done	do	VERB
ajlm-1807	52	18	on	on	ADP
ajlm-1807	52	19	days	day	NOUN
ajlm-1807	52	20	2	2	NUM
ajlm-1807	52	21	,	,	PUNCT
ajlm-1807	52	22	5	5	NUM
ajlm-1807	52	23	and	and	CCONJ
ajlm-1807	52	24	7	7	NUM
ajlm-1807	52	25	of	of	ADP
ajlm-1807	52	26	incubation	incubation	NOUN
ajlm-1807	52	27	.	.	PUNCT
ajlm-1807	53	1	the	the	DET
ajlm-1807	53	2	inoculated	inoculate	VERB
ajlm-1807	53	3	blood	blood	NOUN
ajlm-1807	53	4	agar	agar	NOUN
ajlm-1807	53	5	and	and	CCONJ
ajlm-1807	53	6	macconkey	macconkey	NOUN
ajlm-1807	53	7	agar	agar	NOUN
ajlm-1807	53	8	plates	plate	NOUN
ajlm-1807	53	9	were	be	AUX
ajlm-1807	53	10	incubated	incubate	VERB
ajlm-1807	53	11	at	at	ADP
ajlm-1807	53	12	37	37	NUM
ajlm-1807	53	13	°	°	NOUN
ajlm-1807	53	14	c	c	NOUN
ajlm-1807	53	15	for	for	ADP
ajlm-1807	53	16	18	18	NUM
ajlm-1807	53	17	hours	hour	NOUN
ajlm-1807	53	18	–	–	PUNCT
ajlm-1807	53	19	24	24	NUM
ajlm-1807	53	20	hours	hour	NOUN
ajlm-1807	53	21	.	.	PUNCT
ajlm-1807	54	1	any	any	DET
ajlm-1807	54	2	bacterial	bacterial	ADJ
ajlm-1807	54	3	growth	growth	NOUN
ajlm-1807	54	4	on	on	ADP
ajlm-1807	54	5	agar	agar	NOUN
ajlm-1807	54	6	plates	plate	NOUN
ajlm-1807	54	7	was	be	AUX
ajlm-1807	54	8	identified	identify	VERB
ajlm-1807	54	9	using	use	VERB
ajlm-1807	54	10	colonial	colonial	ADJ
ajlm-1807	54	11	morphology	morphology	NOUN
ajlm-1807	54	12	,	,	PUNCT
ajlm-1807	54	13	gram	gram	NOUN
ajlm-1807	54	14	staining	staining	NOUN
ajlm-1807	54	15	,	,	PUNCT
ajlm-1807	54	16	and	and	CCONJ
ajlm-1807	54	17	conventional	conventional	ADJ
ajlm-1807	54	18	biochemical	biochemical	ADJ
ajlm-1807	54	19	tests	test	NOUN
ajlm-1807	54	20	using	use	VERB
ajlm-1807	54	21	standard	standard	ADJ
ajlm-1807	54	22	laboratory	laboratory	NOUN
ajlm-1807	54	23	protocols.21	protocols.21	NOUN
ajlm-1807	54	24	antibiotic	antibiotic	ADJ
ajlm-1807	54	25	susceptibility	susceptibility	NOUN
ajlm-1807	54	26	testing	testing	NOUN
ajlm-1807	54	27	of	of	ADP
ajlm-1807	54	28	isolated	isolated	ADJ
ajlm-1807	54	29	bacteria	bacteria	NOUN
ajlm-1807	54	30	was	be	AUX
ajlm-1807	54	31	performed	perform	VERB
ajlm-1807	54	32	on	on	ADP
ajlm-1807	54	33	mueller	mueller	PROPN
ajlm-1807	54	34	-	-	PUNCT
ajlm-1807	54	35	hinton	hinton	PROPN
ajlm-1807	54	36	agar	agar	NOUN
ajlm-1807	54	37	(	(	PUNCT
ajlm-1807	54	38	oxoid	oxoid	PROPN
ajlm-1807	54	39	,	,	PUNCT
ajlm-1807	54	40	basingstoke	basingstoke	PROPN
ajlm-1807	54	41	,	,	PUNCT
ajlm-1807	54	42	united	united	ADJ
ajlm-1807	54	43	kingdom	kingdom	PROPN
ajlm-1807	54	44	)	)	PUNCT
ajlm-1807	54	45	using	use	VERB
ajlm-1807	54	46	the	the	DET
ajlm-1807	54	47	modified	modified	ADJ
ajlm-1807	54	48	kirby	kirby	PROPN
ajlm-1807	54	49	-	-	PUNCT
ajlm-1807	54	50	bauer	bauer	PROPN
ajlm-1807	54	51	disc	disc	NOUN
ajlm-1807	54	52	diffusion	diffusion	NOUN
ajlm-1807	54	53	method	method	NOUN
ajlm-1807	54	54	.	.	PUNCT
ajlm-1807	55	1	the	the	DET
ajlm-1807	55	2	results	result	NOUN
ajlm-1807	55	3	were	be	AUX
ajlm-1807	55	4	interpreted	interpret	VERB
ajlm-1807	55	5	as	as	ADP
ajlm-1807	55	6	sensitive	sensitive	ADJ
ajlm-1807	55	7	or	or	CCONJ
ajlm-1807	55	8	resistant	resistant	ADJ
ajlm-1807	55	9	using	use	VERB
ajlm-1807	55	10	the	the	DET
ajlm-1807	55	11	guidelines	guideline	NOUN
ajlm-1807	55	12	of	of	ADP
ajlm-1807	55	13	the	the	DET
ajlm-1807	55	14	clinical	clinical	ADJ
ajlm-1807	55	15	and	and	CCONJ
ajlm-1807	55	16	laboratory	laboratory	NOUN
ajlm-1807	55	17	standard	standard	NOUN
ajlm-1807	55	18	institute.22	institute.22	ADP
ajlm-1807	55	19	the	the	DET
ajlm-1807	55	20	following	follow	VERB
ajlm-1807	55	21	antibiotics	antibiotic	NOUN
ajlm-1807	55	22	were	be	AUX
ajlm-1807	55	23	tested	test	VERB
ajlm-1807	55	24	on	on	ADP
ajlm-1807	55	25	all	all	DET
ajlm-1807	55	26	identified	identify	VERB
ajlm-1807	55	27	isolates	isolate	NOUN
ajlm-1807	55	28	:	:	PUNCT
ajlm-1807	55	29	imipenem	imipenem	PROPN
ajlm-1807	55	30	(	(	PUNCT
ajlm-1807	55	31	10	10	NUM
ajlm-1807	55	32	μg	μg	NOUN
ajlm-1807	55	33	)	)	PUNCT
ajlm-1807	55	34	,	,	PUNCT
ajlm-1807	55	35	meropenem	meropenem	PROPN
ajlm-1807	55	36	(	(	PUNCT
ajlm-1807	55	37	10	10	NUM
ajlm-1807	55	38	μg	μg	NOUN
ajlm-1807	55	39	)	)	PUNCT
ajlm-1807	55	40	,	,	PUNCT
ajlm-1807	55	41	ampicillin	ampicillin	NOUN
ajlm-1807	55	42	/	/	SYM
ajlm-1807	55	43	sulbactam	sulbactam	NOUN
ajlm-1807	55	44	(	(	PUNCT
ajlm-1807	55	45	20/10	20/10	NUM
ajlm-1807	55	46	μg	μg	NOUN
ajlm-1807	55	47	)	)	PUNCT
ajlm-1807	55	48	,	,	PUNCT
ajlm-1807	55	49	gentamicin	gentamicin	NOUN
ajlm-1807	55	50	(	(	PUNCT
ajlm-1807	55	51	10	10	NUM
ajlm-1807	55	52	μg	μg	NOUN
ajlm-1807	55	53	)	)	PUNCT
ajlm-1807	55	54	,	,	PUNCT
ajlm-1807	55	55	ciprofloxacin	ciprofloxacin	NOUN
ajlm-1807	55	56	(	(	PUNCT
ajlm-1807	55	57	5	5	NUM
ajlm-1807	55	58	μg	μg	NOUN
ajlm-1807	55	59	)	)	PUNCT
ajlm-1807	55	60	,	,	PUNCT
ajlm-1807	55	61	ofloxacin	ofloxacin	NOUN
ajlm-1807	55	62	(	(	PUNCT
ajlm-1807	55	63	5	5	NUM
ajlm-1807	55	64	μg	μg	NOUN
ajlm-1807	55	65	)	)	PUNCT
ajlm-1807	55	66	,	,	PUNCT
ajlm-1807	55	67	cefriaxone	cefriaxone	PROPN
ajlm-1807	55	68	(	(	PUNCT
ajlm-1807	55	69	30	30	NUM
ajlm-1807	55	70	μg	μg	NOUN
ajlm-1807	55	71	)	)	PUNCT
ajlm-1807	55	72	,	,	PUNCT
ajlm-1807	55	73	ceftazidime	ceftazidime	NOUN
ajlm-1807	55	74	(	(	PUNCT
ajlm-1807	55	75	30	30	NUM
ajlm-1807	55	76	μg	μg	NOUN
ajlm-1807	55	77	)	)	PUNCT
ajlm-1807	55	78	,	,	PUNCT
ajlm-1807	55	79	amoxycillin	amoxycillin	PROPN
ajlm-1807	55	80	/	/	SYM
ajlm-1807	55	81	clavulanate	clavulanate	PROPN
ajlm-1807	55	82	(	(	PUNCT
ajlm-1807	55	83	20/10	20/10	NUM
ajlm-1807	55	84	μg	μg	NOUN
ajlm-1807	55	85	)	)	PUNCT
ajlm-1807	55	86	,	,	PUNCT
ajlm-1807	55	87	cefixime	cefixime	NOUN
ajlm-1807	55	88	(	(	PUNCT
ajlm-1807	55	89	5	5	NUM
ajlm-1807	55	90	μg	μg	NOUN
ajlm-1807	55	91	)	)	PUNCT
ajlm-1807	55	92	,	,	PUNCT
ajlm-1807	55	93	and	and	CCONJ
ajlm-1807	55	94	ampicillin	ampicillin	NOUN
ajlm-1807	55	95	(	(	PUNCT
ajlm-1807	55	96	10	10	NUM
ajlm-1807	55	97	μg	μg	NOUN
ajlm-1807	55	98	)	)	PUNCT
ajlm-1807	55	99	.	.	PUNCT
ajlm-1807	56	1	all	all	DET
ajlm-1807	56	2	antibiotic	antibiotic	ADJ
ajlm-1807	56	3	discs	disc	NOUN
ajlm-1807	56	4	were	be	AUX
ajlm-1807	56	5	from	from	ADP
ajlm-1807	56	6	oxoidtm	oxoidtm	ADJ
ajlm-1807	56	7	(	(	PUNCT
ajlm-1807	56	8	oxoid	oxoid	PROPN
ajlm-1807	56	9	,	,	PUNCT
ajlm-1807	56	10	wade	wade	PROPN
ajlm-1807	56	11	road	road	PROPN
ajlm-1807	56	12	,	,	PUNCT
ajlm-1807	56	13	basingstoke	basingstoke	PROPN
ajlm-1807	56	14	,	,	PUNCT
ajlm-1807	56	15	united	united	ADJ
ajlm-1807	56	16	kingdom	kingdom	PROPN
ajlm-1807	56	17	)	)	PUNCT
ajlm-1807	56	18	.	.	PUNCT
ajlm-1807	57	1	all	all	DET
ajlm-1807	57	2	gram	gram	NOUN
ajlm-1807	57	3	-	-	PUNCT
ajlm-1807	57	4	negative	negative	ADJ
ajlm-1807	57	5	bacteria	bacteria	NOUN
ajlm-1807	57	6	isolates	isolate	NOUN
ajlm-1807	57	7	were	be	AUX
ajlm-1807	57	8	tested	test	VERB
ajlm-1807	57	9	for	for	ADP
ajlm-1807	57	10	esbl	esbl	NOUN
ajlm-1807	57	11	production	production	NOUN
ajlm-1807	57	12	by	by	ADP
ajlm-1807	57	13	the	the	DET
ajlm-1807	57	14	double	double	ADJ
ajlm-1807	57	15	disc	disc	NOUN
ajlm-1807	57	16	synergy	synergy	NOUN
ajlm-1807	57	17	test	test	NOUN
ajlm-1807	57	18	using	use	VERB
ajlm-1807	57	19	ceftazidime	ceftazidime	NOUN
ajlm-1807	57	20	(	(	PUNCT
ajlm-1807	57	21	30	30	NUM
ajlm-1807	57	22	μg	μg	NOUN
ajlm-1807	57	23	)	)	PUNCT
ajlm-1807	57	24	and	and	CCONJ
ajlm-1807	57	25	ceftazidime	ceftazidime	NOUN
ajlm-1807	57	26	/	/	SYM
ajlm-1807	57	27	clavulanate	clavulanate	NOUN
ajlm-1807	57	28	(	(	PUNCT
ajlm-1807	57	29	30/10	30/10	NUM
ajlm-1807	57	30	μg	μg	NOUN
ajlm-1807	57	31	)	)	PUNCT
ajlm-1807	57	32	discs	disc	NOUN
ajlm-1807	57	33	,	,	PUNCT
ajlm-1807	57	34	while	while	SCONJ
ajlm-1807	57	35	the	the	DET
ajlm-1807	57	36	cefoxitin	cefoxitin	NOUN
ajlm-1807	57	37	disc	disc	NOUN
ajlm-1807	57	38	diffusion	diffusion	NOUN
ajlm-1807	57	39	method	method	NOUN
ajlm-1807	57	40	was	be	AUX
ajlm-1807	57	41	used	use	VERB
ajlm-1807	57	42	to	to	PART
ajlm-1807	57	43	identify	identify	VERB
ajlm-1807	57	44	mrsa.22	mrsa.22	NOUN
ajlm-1807	57	45	all	all	DET
ajlm-1807	57	46	s.	s.	PROPN
ajlm-1807	57	47	aureus	aureus	PROPN
ajlm-1807	57	48	isolated	isolate	VERB
ajlm-1807	57	49	,	,	PUNCT
ajlm-1807	57	50	including	include	VERB
ajlm-1807	57	51	mrsa	mrsa	NOUN
ajlm-1807	57	52	and	and	CCONJ
ajlm-1807	57	53	coagulase	coagulase	NOUN
ajlm-1807	57	54	-	-	PUNCT
ajlm-1807	57	55	negative	negative	ADJ
ajlm-1807	57	56	s.	s.	PROPN
ajlm-1807	57	57	aureus	aureus	PROPN
ajlm-1807	57	58	(	(	PUNCT
ajlm-1807	57	59	cons	con	NOUN
ajlm-1807	57	60	)	)	PUNCT
ajlm-1807	57	61	,	,	PUNCT
ajlm-1807	57	62	were	be	AUX
ajlm-1807	57	63	tested	test	VERB
ajlm-1807	57	64	against	against	ADP
ajlm-1807	57	65	vancomycin	vancomycin	PROPN
ajlm-1807	57	66	using	use	VERB
ajlm-1807	57	67	etest	et	ADJ
ajlm-1807	57	68	®	®	NOUN
ajlm-1807	57	69	(	(	PUNCT
ajlm-1807	57	70	biomérieux	biomérieux	PROPN
ajlm-1807	57	71	,	,	PUNCT
ajlm-1807	57	72	inc	inc	PROPN
ajlm-1807	57	73	.	.	PROPN
ajlm-1807	57	74	,	,	PUNCT
ajlm-1807	57	75	durham	durham	PROPN
ajlm-1807	57	76	,	,	PUNCT
ajlm-1807	57	77	north	north	PROPN
ajlm-1807	57	78	carolina	carolina	PROPN
ajlm-1807	57	79	,	,	PUNCT
ajlm-1807	57	80	united	united	PROPN
ajlm-1807	57	81	states	states	PROPN
ajlm-1807	57	82	)	)	PUNCT
ajlm-1807	57	83	.	.	PUNCT
ajlm-1807	58	1	inclusion	inclusion	NOUN
ajlm-1807	58	2	and	and	CCONJ
ajlm-1807	58	3	exclusion	exclusion	NOUN
ajlm-1807	58	4	criteria	criterion	NOUN
ajlm-1807	58	5	all	all	DET
ajlm-1807	58	6	blood	blood	NOUN
ajlm-1807	58	7	samples	sample	NOUN
ajlm-1807	58	8	of	of	ADP
ajlm-1807	58	9	patients	patient	NOUN
ajlm-1807	58	10	with	with	ADP
ajlm-1807	58	11	suspected	suspect	VERB
ajlm-1807	58	12	bsi	bsi	PROPN
ajlm-1807	58	13	without	without	ADP
ajlm-1807	58	14	a	a	DET
ajlm-1807	58	15	history	history	NOUN
ajlm-1807	58	16	of	of	ADP
ajlm-1807	58	17	antibiotic	antibiotic	ADJ
ajlm-1807	58	18	medication	medication	NOUN
ajlm-1807	58	19	prior	prior	ADV
ajlm-1807	58	20	to	to	ADP
ajlm-1807	58	21	sample	sample	NOUN
ajlm-1807	58	22	collection	collection	NOUN
ajlm-1807	58	23	were	be	AUX
ajlm-1807	58	24	included	include	VERB
ajlm-1807	58	25	,	,	PUNCT
ajlm-1807	58	26	while	while	SCONJ
ajlm-1807	58	27	blood	blood	NOUN
ajlm-1807	58	28	samples	sample	NOUN
ajlm-1807	58	29	of	of	ADP
ajlm-1807	58	30	bsi	bsi	PROPN
ajlm-1807	58	31	patients	patient	NOUN
ajlm-1807	58	32	with	with	ADP
ajlm-1807	58	33	a	a	DET
ajlm-1807	58	34	history	history	NOUN
ajlm-1807	58	35	of	of	ADP
ajlm-1807	58	36	antibiotic	antibiotic	ADJ
ajlm-1807	58	37	medication	medication	NOUN
ajlm-1807	58	38	prior	prior	ADV
ajlm-1807	58	39	to	to	ADP
ajlm-1807	58	40	sample	sample	NOUN
ajlm-1807	58	41	collection	collection	NOUN
ajlm-1807	58	42	were	be	AUX
ajlm-1807	58	43	excluded	exclude	VERB
ajlm-1807	58	44	.	.	PUNCT
ajlm-1807	59	1	data	datum	NOUN
ajlm-1807	59	2	entry	entry	NOUN
ajlm-1807	59	3	and	and	CCONJ
ajlm-1807	59	4	analysis	analysis	NOUN
ajlm-1807	59	5	data	datum	NOUN
ajlm-1807	59	6	were	be	AUX
ajlm-1807	59	7	entered	enter	VERB
ajlm-1807	59	8	into	into	ADP
ajlm-1807	59	9	microsoft	microsoft	PROPN
ajlm-1807	59	10	excel	excel	VERB
ajlm-1807	59	11	2017	2017	NUM
ajlm-1807	59	12	(	(	PUNCT
ajlm-1807	59	13	microsoft	microsoft	PROPN
ajlm-1807	59	14	corporation	corporation	PROPN
ajlm-1807	59	15	,	,	PUNCT
ajlm-1807	59	16	redmond	redmond	PROPN
ajlm-1807	59	17	,	,	PUNCT
ajlm-1807	59	18	washington	washington	PROPN
ajlm-1807	59	19	,	,	PUNCT
ajlm-1807	59	20	united	united	PROPN
ajlm-1807	59	21	states	states	PROPN
ajlm-1807	59	22	)	)	PUNCT
ajlm-1807	59	23	and	and	CCONJ
ajlm-1807	59	24	data	datum	NOUN
ajlm-1807	59	25	analysis	analysis	NOUN
ajlm-1807	59	26	was	be	AUX
ajlm-1807	59	27	done	do	VERB
ajlm-1807	59	28	using	use	VERB
ajlm-1807	59	29	the	the	DET
ajlm-1807	59	30	statistical	statistical	ADJ
ajlm-1807	59	31	package	package	NOUN
ajlm-1807	59	32	for	for	ADP
ajlm-1807	59	33	social	social	ADJ
ajlm-1807	59	34	sciences	science	NOUN
ajlm-1807	59	35	version	version	NOUN
ajlm-1807	59	36	20.0	20.0	NUM
ajlm-1807	59	37	(	(	PUNCT
ajlm-1807	59	38	ibm	ibm	PROPN
ajlm-1807	59	39	corp	corp	PROPN
ajlm-1807	59	40	.	.	PROPN
ajlm-1807	59	41	,	,	PUNCT
ajlm-1807	59	42	armonk	armonk	PROPN
ajlm-1807	59	43	,	,	PUNCT
ajlm-1807	59	44	new	new	PROPN
ajlm-1807	59	45	york	york	PROPN
ajlm-1807	59	46	,	,	PUNCT
ajlm-1807	59	47	united	united	PROPN
ajlm-1807	59	48	states	states	PROPN
ajlm-1807	59	49	)	)	PUNCT
ajlm-1807	59	50	.	.	PUNCT
ajlm-1807	60	1	results	result	NOUN
ajlm-1807	60	2	were	be	AUX
ajlm-1807	60	3	presented	present	VERB
ajlm-1807	60	4	in	in	ADP
ajlm-1807	60	5	tables	table	NOUN
ajlm-1807	60	6	and	and	CCONJ
ajlm-1807	60	7	expressed	express	VERB
ajlm-1807	60	8	as	as	ADP
ajlm-1807	60	9	frequencies	frequency	NOUN
ajlm-1807	60	10	and	and	CCONJ
ajlm-1807	60	11	percentages	percentage	NOUN
ajlm-1807	60	12	.	.	PUNCT
ajlm-1807	61	1	association	association	NOUN
ajlm-1807	61	2	between	between	ADP
ajlm-1807	61	3	variables	variable	NOUN
ajlm-1807	61	4	was	be	AUX
ajlm-1807	61	5	tested	test	VERB
ajlm-1807	61	6	using	use	VERB
ajlm-1807	61	7	chi	chi	ADJ
ajlm-1807	61	8	-	-	PUNCT
ajlm-1807	61	9	square	square	ADJ
ajlm-1807	61	10	and/or	and/or	CCONJ
ajlm-1807	61	11	fisher	fisher	PROPN
ajlm-1807	61	12	’s	’s	PART
ajlm-1807	61	13	exact	exact	ADJ
ajlm-1807	61	14	tests	test	NOUN
ajlm-1807	61	15	,	,	PUNCT
ajlm-1807	61	16	as	as	ADP
ajlm-1807	61	17	appropriate	appropriate	ADJ
ajlm-1807	61	18	.	.	PUNCT
ajlm-1807	62	1	statistical	statistical	ADJ
ajlm-1807	62	2	significance	significance	NOUN
ajlm-1807	62	3	was	be	AUX
ajlm-1807	62	4	accepted	accept	VERB
ajlm-1807	62	5	at	at	ADP
ajlm-1807	62	6	p	p	NOUN
ajlm-1807	62	7	≤	≤	NUM
ajlm-1807	62	8	0.05	0.05	NUM
ajlm-1807	62	9	.	.	PUNCT
ajlm-1807	63	1	results	result	VERB
ajlm-1807	63	2	the	the	DET
ajlm-1807	63	3	age	age	NOUN
ajlm-1807	63	4	range	range	NOUN
ajlm-1807	63	5	of	of	ADP
ajlm-1807	63	6	participants	participant	NOUN
ajlm-1807	63	7	was	be	AUX
ajlm-1807	63	8	4	4	NUM
ajlm-1807	63	9	days	day	NOUN
ajlm-1807	63	10	to	to	ADP
ajlm-1807	63	11	87	87	NUM
ajlm-1807	63	12	years	year	NOUN
ajlm-1807	63	13	(	(	PUNCT
ajlm-1807	63	14	mean	mean	NOUN
ajlm-1807	63	15	:	:	PUNCT
ajlm-1807	63	16	23.29	23.29	NUM
ajlm-1807	63	17	±	±	NUM
ajlm-1807	63	18	26.58	26.58	NUM
ajlm-1807	63	19	years	year	NOUN
ajlm-1807	63	20	)	)	PUNCT
ajlm-1807	63	21	(	(	PUNCT
ajlm-1807	63	22	table	table	NOUN
ajlm-1807	63	23	1	1	NUM
ajlm-1807	63	24	)	)	PUNCT
ajlm-1807	63	25	.	.	PUNCT
ajlm-1807	64	1	of	of	ADP
ajlm-1807	64	2	the	the	DET
ajlm-1807	64	3	177	177	NUM
ajlm-1807	64	4	suspected	suspect	VERB
ajlm-1807	64	5	cases	case	NOUN
ajlm-1807	64	6	of	of	ADP
ajlm-1807	64	7	sepsis	sepsis	NOUN
ajlm-1807	64	8	and	and	CCONJ
ajlm-1807	64	9	other	other	ADJ
ajlm-1807	64	10	bloodstream	bloodstream	NOUN
ajlm-1807	64	11	-	-	PUNCT
ajlm-1807	64	12	related	relate	VERB
ajlm-1807	64	13	infections	infection	NOUN
ajlm-1807	64	14	that	that	PRON
ajlm-1807	64	15	were	be	AUX
ajlm-1807	64	16	investigated	investigate	VERB
ajlm-1807	64	17	,	,	PUNCT
ajlm-1807	64	18	102	102	NUM
ajlm-1807	64	19	(	(	PUNCT
ajlm-1807	64	20	57.6	57.6	NUM
ajlm-1807	64	21	%	%	NOUN
ajlm-1807	64	22	)	)	PUNCT
ajlm-1807	64	23	of	of	ADP
ajlm-1807	64	24	the	the	DET
ajlm-1807	64	25	patients	patient	NOUN
ajlm-1807	64	26	were	be	AUX
ajlm-1807	64	27	male	male	ADJ
ajlm-1807	64	28	,	,	PUNCT
ajlm-1807	64	29	and	and	CCONJ
ajlm-1807	64	30	75	75	NUM
ajlm-1807	64	31	(	(	PUNCT
ajlm-1807	64	32	42.4	42.4	NUM
ajlm-1807	64	33	%	%	NOUN
ajlm-1807	64	34	)	)	PUNCT
ajlm-1807	64	35	were	be	AUX
ajlm-1807	64	36	female	female	ADJ
ajlm-1807	64	37	.	.	PUNCT
ajlm-1807	65	1	there	there	PRON
ajlm-1807	65	2	were	be	VERB
ajlm-1807	65	3	27	27	NUM
ajlm-1807	65	4	(	(	PUNCT
ajlm-1807	65	5	26.5	26.5	NUM
ajlm-1807	65	6	%	%	NOUN
ajlm-1807	65	7	)	)	PUNCT
ajlm-1807	65	8	male	male	ADJ
ajlm-1807	65	9	patients	patient	NOUN
ajlm-1807	65	10	and	and	CCONJ
ajlm-1807	65	11	15	15	NUM
ajlm-1807	65	12	(	(	PUNCT
ajlm-1807	65	13	20.0	20.0	NUM
ajlm-1807	65	14	%	%	NOUN
ajlm-1807	65	15	)	)	PUNCT
ajlm-1807	65	16	female	female	ADJ
ajlm-1807	65	17	patients	patient	NOUN
ajlm-1807	65	18	below	below	ADP
ajlm-1807	65	19	the	the	DET
ajlm-1807	65	20	age	age	NOUN
ajlm-1807	65	21	of	of	ADP
ajlm-1807	65	22	one	one	NUM
ajlm-1807	65	23	month	month	NOUN
ajlm-1807	65	24	(	(	PUNCT
ajlm-1807	65	25	neonates	neonate	NOUN
ajlm-1807	65	26	)	)	PUNCT
ajlm-1807	65	27	,	,	PUNCT
ajlm-1807	65	28	and	and	CCONJ
ajlm-1807	65	29	15	15	NUM
ajlm-1807	65	30	(	(	PUNCT
ajlm-1807	65	31	14.7	14.7	NUM
ajlm-1807	65	32	%	%	NOUN
ajlm-1807	65	33	)	)	PUNCT
ajlm-1807	65	34	male	male	ADJ
ajlm-1807	65	35	patients	patient	NOUN
ajlm-1807	65	36	and	and	CCONJ
ajlm-1807	65	37	23	23	NUM
ajlm-1807	65	38	(	(	PUNCT
ajlm-1807	65	39	30.7	30.7	NUM
ajlm-1807	65	40	%	%	NOUN
ajlm-1807	65	41	)	)	PUNCT
ajlm-1807	65	42	female	female	ADJ
ajlm-1807	65	43	patients	patient	NOUN
ajlm-1807	65	44	older	old	ADJ
ajlm-1807	65	45	than	than	ADP
ajlm-1807	65	46	50	50	NUM
ajlm-1807	65	47	years	year	NOUN
ajlm-1807	65	48	.	.	PUNCT
ajlm-1807	66	1	table	table	NOUN
ajlm-1807	66	2	1	1	NUM
ajlm-1807	66	3	:	:	PUNCT
ajlm-1807	66	4	 	 	SPACE
ajlm-1807	66	5	age	age	NOUN
ajlm-1807	66	6	distribution	distribution	NOUN
ajlm-1807	66	7	of	of	ADP
ajlm-1807	66	8	bloodstream	bloodstream	NOUN
ajlm-1807	66	9	infection	infection	NOUN
ajlm-1807	66	10	study	study	NOUN
ajlm-1807	66	11	participants	participant	NOUN
ajlm-1807	66	12	in	in	ADP
ajlm-1807	66	13	relation	relation	NOUN
ajlm-1807	66	14	to	to	ADP
ajlm-1807	66	15	gender	gender	NOUN
ajlm-1807	66	16	at	at	ADP
ajlm-1807	66	17	the	the	DET
ajlm-1807	66	18	federal	federal	ADJ
ajlm-1807	66	19	teaching	teaching	NOUN
ajlm-1807	66	20	hospital	hospital	NOUN
ajlm-1807	66	21	,	,	PUNCT
ajlm-1807	66	22	ido	ido	NOUN
ajlm-1807	66	23	-	-	PUNCT
ajlm-1807	66	24	ekiti	ekiti	PROPN
ajlm-1807	66	25	,	,	PUNCT
ajlm-1807	66	26	nigeria	nigeria	PROPN
ajlm-1807	66	27	,	,	PUNCT
ajlm-1807	66	28	between	between	ADP
ajlm-1807	66	29	june	june	PROPN
ajlm-1807	66	30	2020	2020	NUM
ajlm-1807	66	31	and	and	CCONJ
ajlm-1807	66	32	february	february	PROPN
ajlm-1807	66	33	2021	2021	NUM
ajlm-1807	66	34	.	.	PUNCT
ajlm-1807	67	1	only	only	ADV
ajlm-1807	67	2	34	34	NUM
ajlm-1807	67	3	(	(	PUNCT
ajlm-1807	67	4	19.2	19.2	NUM
ajlm-1807	67	5	%	%	NOUN
ajlm-1807	67	6	)	)	PUNCT
ajlm-1807	67	7	of	of	ADP
ajlm-1807	67	8	the	the	DET
ajlm-1807	67	9	total	total	ADJ
ajlm-1807	67	10	blood	blood	NOUN
ajlm-1807	67	11	culture	culture	NOUN
ajlm-1807	67	12	broths	broth	NOUN
ajlm-1807	67	13	were	be	AUX
ajlm-1807	67	14	culture	culture	NOUN
ajlm-1807	67	15	-	-	PUNCT
ajlm-1807	67	16	positive	positive	ADJ
ajlm-1807	67	17	for	for	ADP
ajlm-1807	67	18	bacteria	bacteria	NOUN
ajlm-1807	67	19	(	(	PUNCT
ajlm-1807	67	20	table	table	NOUN
ajlm-1807	67	21	2	2	NUM
ajlm-1807	67	22	)	)	PUNCT
ajlm-1807	67	23	.	.	PUNCT
ajlm-1807	68	1	culture	culture	NOUN
ajlm-1807	68	2	positivity	positivity	NOUN
ajlm-1807	68	3	was	be	AUX
ajlm-1807	68	4	highest	high	ADJ
ajlm-1807	68	5	among	among	ADP
ajlm-1807	68	6	neonates	neonate	NOUN
ajlm-1807	68	7	(	(	PUNCT
ajlm-1807	68	8	aged	age	VERB
ajlm-1807	68	9	<	<	X
ajlm-1807	68	10	1	1	NUM
ajlm-1807	68	11	month	month	NOUN
ajlm-1807	68	12	;	;	PUNCT
ajlm-1807	68	13	23.8	23.8	NUM
ajlm-1807	68	14	%	%	NOUN
ajlm-1807	68	15	)	)	PUNCT
ajlm-1807	68	16	and	and	CCONJ
ajlm-1807	68	17	lowest	low	ADJ
ajlm-1807	68	18	among	among	ADP
ajlm-1807	68	19	patients	patient	NOUN
ajlm-1807	68	20	aged	age	VERB
ajlm-1807	68	21	6–17	6–17	ADJ
ajlm-1807	68	22	years	year	NOUN
ajlm-1807	68	23	(	(	PUNCT
ajlm-1807	68	24	12.9	12.9	NUM
ajlm-1807	68	25	%	%	NOUN
ajlm-1807	68	26	)	)	PUNCT
ajlm-1807	68	27	.	.	PUNCT
ajlm-1807	69	1	culture	culture	NOUN
ajlm-1807	69	2	positivity	positivity	NOUN
ajlm-1807	69	3	was	be	AUX
ajlm-1807	69	4	higher	high	ADJ
ajlm-1807	69	5	among	among	ADP
ajlm-1807	69	6	female	female	ADJ
ajlm-1807	69	7	patients	patient	NOUN
ajlm-1807	69	8	(	(	PUNCT
ajlm-1807	69	9	20.0	20.0	NUM
ajlm-1807	69	10	%	%	NOUN
ajlm-1807	69	11	)	)	PUNCT
ajlm-1807	69	12	compared	compare	VERB
ajlm-1807	69	13	to	to	ADP
ajlm-1807	69	14	male	male	ADJ
ajlm-1807	69	15	patients	patient	NOUN
ajlm-1807	69	16	(	(	PUNCT
ajlm-1807	69	17	9.5	9.5	NUM
ajlm-1807	69	18	%	%	NOUN
ajlm-1807	69	19	)	)	PUNCT
ajlm-1807	69	20	aged	aged	ADJ
ajlm-1807	69	21	6–17	6–17	ADJ
ajlm-1807	69	22	years	year	NOUN
ajlm-1807	69	23	,	,	PUNCT
ajlm-1807	69	24	but	but	CCONJ
ajlm-1807	69	25	no	no	DET
ajlm-1807	69	26	significant	significant	ADJ
ajlm-1807	69	27	difference	difference	NOUN
ajlm-1807	69	28	was	be	AUX
ajlm-1807	69	29	seen	see	VERB
ajlm-1807	69	30	(	(	PUNCT
ajlm-1807	69	31	p	p	NOUN
ajlm-1807	69	32	=	=	NOUN
ajlm-1807	69	33	0.57	0.57	NUM
ajlm-1807	69	34	)	)	PUNCT
ajlm-1807	69	35	.	.	PUNCT
ajlm-1807	70	1	no	no	DET
ajlm-1807	70	2	significant	significant	ADJ
ajlm-1807	70	3	difference	difference	NOUN
ajlm-1807	70	4	was	be	AUX
ajlm-1807	70	5	seen	see	VERB
ajlm-1807	70	6	in	in	ADP
ajlm-1807	70	7	the	the	DET
ajlm-1807	70	8	overall	overall	ADJ
ajlm-1807	70	9	isolation	isolation	NOUN
ajlm-1807	70	10	rate	rate	NOUN
ajlm-1807	70	11	between	between	ADP
ajlm-1807	70	12	male	male	ADJ
ajlm-1807	70	13	and	and	CCONJ
ajlm-1807	70	14	female	female	ADJ
ajlm-1807	70	15	patients	patient	NOUN
ajlm-1807	70	16	(	(	PUNCT
ajlm-1807	70	17	p	p	X
ajlm-1807	70	18	=	=	NOUN
ajlm-1807	70	19	0.97	0.97	NUM
ajlm-1807	70	20	)	)	PUNCT
ajlm-1807	70	21	.	.	PUNCT
ajlm-1807	71	1	table	table	NOUN
ajlm-1807	71	2	2	2	NUM
ajlm-1807	71	3	:	:	PUNCT
ajlm-1807	71	4	 	 	SPACE
ajlm-1807	71	5	frequency	frequency	NOUN
ajlm-1807	71	6	of	of	ADP
ajlm-1807	71	7	culture	culture	NOUN
ajlm-1807	71	8	-	-	PUNCT
ajlm-1807	71	9	positive	positive	ADJ
ajlm-1807	71	10	broths	broth	NOUN
ajlm-1807	71	11	by	by	ADP
ajlm-1807	71	12	age	age	NOUN
ajlm-1807	71	13	group	group	NOUN
ajlm-1807	71	14	among	among	ADP
ajlm-1807	71	15	bloodstream	bloodstream	NOUN
ajlm-1807	71	16	infection	infection	NOUN
ajlm-1807	71	17	cases	case	NOUN
ajlm-1807	71	18	at	at	ADP
ajlm-1807	71	19	the	the	DET
ajlm-1807	71	20	federal	federal	ADJ
ajlm-1807	71	21	teaching	teaching	NOUN
ajlm-1807	71	22	hospital	hospital	NOUN
ajlm-1807	71	23	,	,	PUNCT
ajlm-1807	71	24	ido	ido	NOUN
ajlm-1807	71	25	-	-	PUNCT
ajlm-1807	71	26	ekiti	ekiti	PROPN
ajlm-1807	71	27	,	,	PUNCT
ajlm-1807	71	28	nigeria	nigeria	PROPN
ajlm-1807	71	29	,	,	PUNCT
ajlm-1807	71	30	between	between	ADP
ajlm-1807	71	31	june	june	PROPN
ajlm-1807	71	32	2020	2020	NUM
ajlm-1807	71	33	and	and	CCONJ
ajlm-1807	71	34	february	february	PROPN
ajlm-1807	71	35	2021	2021	NUM
ajlm-1807	71	36	.	.	PUNCT
ajlm-1807	72	1	the	the	DET
ajlm-1807	72	2	most	most	ADV
ajlm-1807	72	3	commonly	commonly	ADV
ajlm-1807	72	4	isolated	isolate	VERB
ajlm-1807	72	5	bacteria	bacteria	NOUN
ajlm-1807	72	6	were	be	AUX
ajlm-1807	72	7	e.	e.	PROPN
ajlm-1807	72	8	coli	coli	PROPN
ajlm-1807	72	9	(	(	PUNCT
ajlm-1807	72	10	10/34	10/34	NUM
ajlm-1807	72	11	,	,	PUNCT
ajlm-1807	72	12	29.4	29.4	NUM
ajlm-1807	72	13	%	%	NOUN
ajlm-1807	72	14	)	)	PUNCT
ajlm-1807	72	15	,	,	PUNCT
ajlm-1807	72	16	s.	s.	PROPN
ajlm-1807	72	17	aureus	aureus	PROPN
ajlm-1807	72	18	(	(	PUNCT
ajlm-1807	72	19	8/34	8/34	NUM
ajlm-1807	72	20	,	,	PUNCT
ajlm-1807	72	21	23.5	23.5	NUM
ajlm-1807	72	22	%	%	NOUN
ajlm-1807	72	23	)	)	PUNCT
ajlm-1807	72	24	,	,	PUNCT
ajlm-1807	72	25	and	and	CCONJ
ajlm-1807	72	26	k.	k.	PROPN
ajlm-1807	72	27	aerogenes	aerogenes	PROPN
ajlm-1807	72	28	(	(	PUNCT
ajlm-1807	72	29	7/34	7/34	NUM
ajlm-1807	72	30	,	,	PUNCT
ajlm-1807	72	31	20.6	20.6	NUM
ajlm-1807	72	32	%	%	NOUN
ajlm-1807	72	33	)	)	PUNCT
ajlm-1807	72	34	(	(	PUNCT
ajlm-1807	72	35	table	table	NOUN
ajlm-1807	72	36	3	3	NUM
ajlm-1807	72	37	)	)	PUNCT
ajlm-1807	72	38	.	.	PUNCT
ajlm-1807	73	1	gram	gram	NOUN
ajlm-1807	73	2	-	-	PUNCT
ajlm-1807	73	3	negative	negative	ADJ
ajlm-1807	73	4	bacteria	bacteria	NOUN
ajlm-1807	73	5	species	specie	NOUN
ajlm-1807	73	6	were	be	AUX
ajlm-1807	73	7	the	the	DET
ajlm-1807	73	8	most	most	ADV
ajlm-1807	73	9	commonly	commonly	ADV
ajlm-1807	73	10	isolated	isolate	VERB
ajlm-1807	73	11	(	(	PUNCT
ajlm-1807	73	12	23/34	23/34	NUM
ajlm-1807	73	13	isolates	isolate	NOUN
ajlm-1807	73	14	,	,	PUNCT
ajlm-1807	73	15	67.6	67.6	NUM
ajlm-1807	73	16	%	%	NOUN
ajlm-1807	73	17	)	)	PUNCT
ajlm-1807	73	18	(	(	PUNCT
ajlm-1807	73	19	table	table	NOUN
ajlm-1807	73	20	4	4	NUM
ajlm-1807	73	21	)	)	PUNCT
ajlm-1807	73	22	.	.	PUNCT
ajlm-1807	74	1	gram	gram	NOUN
ajlm-1807	74	2	-	-	PUNCT
ajlm-1807	74	3	negative	negative	ADJ
ajlm-1807	74	4	bacteria	bacteria	NOUN
ajlm-1807	74	5	were	be	AUX
ajlm-1807	74	6	isolated	isolate	VERB
ajlm-1807	74	7	at	at	ADP
ajlm-1807	74	8	a	a	DET
ajlm-1807	74	9	higher	high	ADJ
ajlm-1807	74	10	rate	rate	NOUN
ajlm-1807	74	11	among	among	ADP
ajlm-1807	74	12	neonates	neonate	NOUN
ajlm-1807	74	13	<	<	X
ajlm-1807	74	14	1	1	NUM
ajlm-1807	74	15	month	month	NOUN
ajlm-1807	74	16	(	(	PUNCT
ajlm-1807	74	17	8/42	8/42	NUM
ajlm-1807	74	18	neonates	neonate	NOUN
ajlm-1807	74	19	,	,	PUNCT
ajlm-1807	74	20	19.0	19.0	NUM
ajlm-1807	74	21	%	%	NOUN
ajlm-1807	74	22	)	)	PUNCT
ajlm-1807	74	23	compared	compare	VERB
ajlm-1807	74	24	to	to	ADP
ajlm-1807	74	25	other	other	ADJ
ajlm-1807	74	26	participants	participant	NOUN
ajlm-1807	74	27	older	old	ADJ
ajlm-1807	74	28	than	than	ADP
ajlm-1807	74	29	one	one	NUM
ajlm-1807	74	30	month	month	NOUN
ajlm-1807	74	31	(	(	PUNCT
ajlm-1807	74	32	15/135	15/135	NUM
ajlm-1807	74	33	participants	participant	NOUN
ajlm-1807	74	34	,	,	PUNCT
ajlm-1807	74	35	11.1	11.1	NUM
ajlm-1807	74	36	%	%	NOUN
ajlm-1807	74	37	)	)	PUNCT
ajlm-1807	74	38	but	but	CCONJ
ajlm-1807	74	39	no	no	DET
ajlm-1807	74	40	significant	significant	ADJ
ajlm-1807	74	41	difference	difference	NOUN
ajlm-1807	74	42	was	be	AUX
ajlm-1807	74	43	seen	see	VERB
ajlm-1807	74	44	in	in	ADP
ajlm-1807	74	45	the	the	DET
ajlm-1807	74	46	rate	rate	NOUN
ajlm-1807	74	47	of	of	ADP
ajlm-1807	74	48	isolation	isolation	NOUN
ajlm-1807	74	49	(	(	PUNCT
ajlm-1807	74	50	p	p	NOUN
ajlm-1807	74	51	=	=	NOUN
ajlm-1807	74	52	0.18	0.18	NUM
ajlm-1807	74	53	)	)	PUNCT
ajlm-1807	74	54	.	.	PUNCT
ajlm-1807	75	1	the	the	DET
ajlm-1807	75	2	isolation	isolation	NOUN
ajlm-1807	75	3	rate	rate	NOUN
ajlm-1807	75	4	was	be	AUX
ajlm-1807	75	5	higher	high	ADJ
ajlm-1807	75	6	among	among	ADP
ajlm-1807	75	7	neonates	neonate	NOUN
ajlm-1807	75	8	(	(	PUNCT
ajlm-1807	75	9	10/42	10/42	NUM
ajlm-1807	75	10	neonates	neonate	NOUN
ajlm-1807	75	11	,	,	PUNCT
ajlm-1807	75	12	23.8	23.8	NUM
ajlm-1807	75	13	%	%	NOUN
ajlm-1807	75	14	)	)	PUNCT
ajlm-1807	75	15	compared	compare	VERB
ajlm-1807	75	16	to	to	ADP
ajlm-1807	75	17	other	other	ADJ
ajlm-1807	75	18	participants	participant	NOUN
ajlm-1807	75	19	older	old	ADJ
ajlm-1807	75	20	than	than	ADP
ajlm-1807	75	21	one	one	NUM
ajlm-1807	75	22	month	month	NOUN
ajlm-1807	75	23	(	(	PUNCT
ajlm-1807	75	24	24/135	24/135	NUM
ajlm-1807	75	25	participants	participant	NOUN
ajlm-1807	75	26	,	,	PUNCT
ajlm-1807	75	27	17.8	17.8	NUM
ajlm-1807	75	28	%	%	NOUN
ajlm-1807	75	29	)	)	PUNCT
ajlm-1807	75	30	,	,	PUNCT
ajlm-1807	75	31	but	but	CCONJ
ajlm-1807	75	32	no	no	DET
ajlm-1807	75	33	significant	significant	ADJ
ajlm-1807	75	34	difference	difference	NOUN
ajlm-1807	75	35	was	be	AUX
ajlm-1807	75	36	found	find	VERB
ajlm-1807	75	37	in	in	ADP
ajlm-1807	75	38	the	the	DET
ajlm-1807	75	39	isolation	isolation	NOUN
ajlm-1807	75	40	rate	rate	NOUN
ajlm-1807	75	41	(	(	PUNCT
ajlm-1807	75	42	p	p	X
ajlm-1807	75	43	=	=	NOUN
ajlm-1807	75	44	0.39	0.39	NUM
ajlm-1807	75	45	)	)	PUNCT
ajlm-1807	75	46	.	.	PUNCT
ajlm-1807	76	1	table	table	NOUN
ajlm-1807	76	2	3	3	NUM
ajlm-1807	76	3	:	:	PUNCT
ajlm-1807	76	4	 	 	SPACE
ajlm-1807	76	5	frequency	frequency	NOUN
ajlm-1807	76	6	of	of	ADP
ajlm-1807	76	7	isolates	isolate	NOUN
ajlm-1807	76	8	from	from	ADP
ajlm-1807	76	9	culture	culture	NOUN
ajlm-1807	76	10	-	-	PUNCT
ajlm-1807	76	11	positive	positive	ADJ
ajlm-1807	76	12	broths	broth	NOUN
ajlm-1807	76	13	among	among	ADP
ajlm-1807	76	14	bloodstream	bloodstream	NOUN
ajlm-1807	76	15	infection	infection	NOUN
ajlm-1807	76	16	cases	case	NOUN
ajlm-1807	76	17	by	by	ADP
ajlm-1807	76	18	age	age	NOUN
ajlm-1807	76	19	group	group	NOUN
ajlm-1807	76	20	at	at	ADP
ajlm-1807	76	21	the	the	DET
ajlm-1807	76	22	federal	federal	ADJ
ajlm-1807	76	23	teaching	teaching	NOUN
ajlm-1807	76	24	hospital	hospital	NOUN
ajlm-1807	76	25	,	,	PUNCT
ajlm-1807	76	26	ido	ido	NOUN
ajlm-1807	76	27	-	-	PUNCT
ajlm-1807	76	28	ekiti	ekiti	PROPN
ajlm-1807	76	29	,	,	PUNCT
ajlm-1807	76	30	nigeria	nigeria	PROPN
ajlm-1807	76	31	,	,	PUNCT
ajlm-1807	76	32	between	between	ADP
ajlm-1807	76	33	june	june	PROPN
ajlm-1807	76	34	2020	2020	NUM
ajlm-1807	76	35	and	and	CCONJ
ajlm-1807	76	36	february	february	PROPN
ajlm-1807	76	37	2021	2021	NUM
ajlm-1807	76	38	.	.	PUNCT
ajlm-1807	77	1	table	table	NOUN
ajlm-1807	77	2	4	4	NUM
ajlm-1807	77	3	:	:	PUNCT
ajlm-1807	77	4	 	 	SPACE
ajlm-1807	77	5	comparison	comparison	NOUN
ajlm-1807	77	6	of	of	ADP
ajlm-1807	77	7	gram	gram	NOUN
ajlm-1807	77	8	-	-	PUNCT
ajlm-1807	77	9	positive	positive	ADJ
ajlm-1807	77	10	and	and	CCONJ
ajlm-1807	77	11	gram	gram	NOUN
ajlm-1807	77	12	-	-	PUNCT
ajlm-1807	77	13	negative	negative	ADJ
ajlm-1807	77	14	isolates	isolate	NOUN
ajlm-1807	77	15	from	from	ADP
ajlm-1807	77	16	bloodstream	bloodstream	NOUN
ajlm-1807	77	17	infection	infection	NOUN
ajlm-1807	77	18	cases	case	NOUN
ajlm-1807	77	19	between	between	ADP
ajlm-1807	77	20	neonates	neonate	NOUN
ajlm-1807	77	21	and	and	CCONJ
ajlm-1807	77	22	other	other	ADJ
ajlm-1807	77	23	participants	participant	NOUN
ajlm-1807	77	24	at	at	ADP
ajlm-1807	77	25	the	the	DET
ajlm-1807	77	26	federal	federal	ADJ
ajlm-1807	77	27	teaching	teaching	NOUN
ajlm-1807	77	28	hospital	hospital	NOUN
ajlm-1807	77	29	,	,	PUNCT
ajlm-1807	77	30	ido	ido	NOUN
ajlm-1807	77	31	-	-	NOUN
ajlm-1807	77	32	ekiti	ekiti	PROPN
ajlm-1807	77	33	,	,	PUNCT
ajlm-1807	77	34	nigeria	nigeria	PROPN
ajlm-1807	77	35	,	,	PUNCT
ajlm-1807	77	36	between	between	ADP
ajlm-1807	77	37	june	june	PROPN
ajlm-1807	77	38	2020	2020	NUM
ajlm-1807	77	39	and	and	CCONJ
ajlm-1807	77	40	february	february	PROPN
ajlm-1807	77	41	2021	2021	NUM
ajlm-1807	77	42	.	.	PUNCT
ajlm-1807	78	1	all	all	PRON
ajlm-1807	78	2	(	(	PUNCT
ajlm-1807	78	3	100.0	100.0	NUM
ajlm-1807	78	4	%	%	NOUN
ajlm-1807	78	5	)	)	PUNCT
ajlm-1807	78	6	of	of	ADP
ajlm-1807	78	7	the	the	DET
ajlm-1807	78	8	isolates	isolate	NOUN
ajlm-1807	78	9	were	be	AUX
ajlm-1807	78	10	sensitive	sensitive	ADJ
ajlm-1807	78	11	to	to	ADP
ajlm-1807	78	12	meropenem	meropenem	PROPN
ajlm-1807	78	13	,	,	PUNCT
ajlm-1807	78	14	33/34	33/34	NUM
ajlm-1807	78	15	isolates	isolate	NOUN
ajlm-1807	78	16	(	(	PUNCT
ajlm-1807	78	17	97.1	97.1	NUM
ajlm-1807	78	18	%	%	NOUN
ajlm-1807	78	19	)	)	PUNCT
ajlm-1807	78	20	were	be	AUX
ajlm-1807	78	21	sensitive	sensitive	ADJ
ajlm-1807	78	22	to	to	ADP
ajlm-1807	78	23	imipenem	imipenem	PROPN
ajlm-1807	78	24	,	,	PUNCT
ajlm-1807	78	25	29/34	29/34	NUM
ajlm-1807	78	26	isolates	isolate	NOUN
ajlm-1807	78	27	(	(	PUNCT
ajlm-1807	78	28	85.3	85.3	NUM
ajlm-1807	78	29	%	%	NOUN
ajlm-1807	78	30	)	)	PUNCT
ajlm-1807	78	31	were	be	AUX
ajlm-1807	78	32	sensitive	sensitive	ADJ
ajlm-1807	78	33	to	to	ADP
ajlm-1807	78	34	ceftazidime	ceftazidime	NOUN
ajlm-1807	78	35	,	,	PUNCT
ajlm-1807	78	36	27/34	27/34	NUM
ajlm-1807	78	37	isolates	isolate	NOUN
ajlm-1807	78	38	(	(	PUNCT
ajlm-1807	78	39	79.4	79.4	NUM
ajlm-1807	78	40	%	%	NOUN
ajlm-1807	78	41	)	)	PUNCT
ajlm-1807	78	42	were	be	AUX
ajlm-1807	78	43	sensitive	sensitive	ADJ
ajlm-1807	78	44	to	to	ADP
ajlm-1807	78	45	ciprofloxacin	ciprofloxacin	PROPN
ajlm-1807	78	46	and	and	CCONJ
ajlm-1807	78	47	ofloxacin	ofloxacin	NOUN
ajlm-1807	78	48	,	,	PUNCT
ajlm-1807	78	49	and	and	CCONJ
ajlm-1807	78	50	26/34	26/34	NUM
ajlm-1807	78	51	isolates	isolate	NOUN
ajlm-1807	78	52	(	(	PUNCT
ajlm-1807	78	53	76.5	76.5	NUM
ajlm-1807	78	54	%	%	NOUN
ajlm-1807	78	55	)	)	PUNCT
ajlm-1807	78	56	were	be	AUX
ajlm-1807	78	57	sensitive	sensitive	ADJ
ajlm-1807	78	58	to	to	ADP
ajlm-1807	78	59	gentamicin	gentamicin	NOUN
ajlm-1807	78	60	(	(	PUNCT
ajlm-1807	78	61	table	table	NOUN
ajlm-1807	78	62	5	5	NUM
ajlm-1807	78	63	)	)	PUNCT
ajlm-1807	78	64	.	.	PUNCT
ajlm-1807	79	1	very	very	ADV
ajlm-1807	79	2	poor	poor	ADJ
ajlm-1807	79	3	sensitivity	sensitivity	NOUN
ajlm-1807	79	4	was	be	AUX
ajlm-1807	79	5	observed	observe	VERB
ajlm-1807	79	6	for	for	ADP
ajlm-1807	79	7	ampicillin	ampicillin	NOUN
ajlm-1807	79	8	(	(	PUNCT
ajlm-1807	79	9	11/34	11/34	NUM
ajlm-1807	79	10	isolates	isolate	NOUN
ajlm-1807	79	11	,	,	PUNCT
ajlm-1807	79	12	32.4	32.4	NUM
ajlm-1807	79	13	%	%	NOUN
ajlm-1807	79	14	)	)	PUNCT
ajlm-1807	79	15	and	and	CCONJ
ajlm-1807	79	16	cotrimoxazole	cotrimoxazole	NOUN
ajlm-1807	79	17	(	(	PUNCT
ajlm-1807	79	18	13/34	13/34	NUM
ajlm-1807	79	19	isolates	isolate	NOUN
ajlm-1807	79	20	,	,	PUNCT
ajlm-1807	79	21	38.2	38.2	NUM
ajlm-1807	79	22	%	%	NOUN
ajlm-1807	79	23	)	)	PUNCT
ajlm-1807	79	24	.	.	PUNCT
ajlm-1807	80	1	none	none	NOUN
ajlm-1807	80	2	of	of	ADP
ajlm-1807	80	3	the	the	DET
ajlm-1807	80	4	gram	gram	NOUN
ajlm-1807	80	5	-	-	PUNCT
ajlm-1807	80	6	negative	negative	ADJ
ajlm-1807	80	7	enteric	enteric	ADJ
ajlm-1807	80	8	bacteria	bacteria	NOUN
ajlm-1807	80	9	isolated	isolate	VERB
ajlm-1807	80	10	were	be	AUX
ajlm-1807	80	11	esbl	esbl	NOUN
ajlm-1807	80	12	producers	producer	NOUN
ajlm-1807	80	13	.	.	PUNCT
ajlm-1807	81	1	three	three	NUM
ajlm-1807	81	2	(	(	PUNCT
ajlm-1807	81	3	37.5	37.5	NUM
ajlm-1807	81	4	%	%	NOUN
ajlm-1807	81	5	)	)	PUNCT
ajlm-1807	81	6	of	of	ADP
ajlm-1807	81	7	the	the	DET
ajlm-1807	81	8	eight	eight	NUM
ajlm-1807	81	9	s.	s.	PROPN
ajlm-1807	81	10	aureus	aureus	PROPN
ajlm-1807	81	11	isolated	isolate	VERB
ajlm-1807	81	12	were	be	AUX
ajlm-1807	81	13	mrsa	mrsa	NOUN
ajlm-1807	81	14	.	.	PUNCT
ajlm-1807	82	1	all	all	PRON
ajlm-1807	82	2	of	of	ADP
ajlm-1807	82	3	the	the	DET
ajlm-1807	82	4	isolated	isolated	ADJ
ajlm-1807	82	5	cons	con	NOUN
ajlm-1807	82	6	(	(	PUNCT
ajlm-1807	82	7	3/3	3/3	NUM
ajlm-1807	82	8	isolates	isolate	NOUN
ajlm-1807	82	9	,	,	PUNCT
ajlm-1807	82	10	100	100	NUM
ajlm-1807	82	11	%	%	NOUN
ajlm-1807	82	12	)	)	PUNCT
ajlm-1807	82	13	and	and	CCONJ
ajlm-1807	82	14	s.	s.	PROPN
ajlm-1807	82	15	aureus	aureus	PROPN
ajlm-1807	82	16	(	(	PUNCT
ajlm-1807	82	17	8/8	8/8	NUM
ajlm-1807	82	18	isolates	isolate	NOUN
ajlm-1807	82	19	,	,	PUNCT
ajlm-1807	82	20	100	100	NUM
ajlm-1807	82	21	%	%	NOUN
ajlm-1807	82	22	)	)	PUNCT
ajlm-1807	82	23	,	,	PUNCT
ajlm-1807	82	24	including	include	VERB
ajlm-1807	82	25	the	the	DET
ajlm-1807	82	26	mrsa	mrsa	NOUN
ajlm-1807	82	27	,	,	PUNCT
ajlm-1807	82	28	were	be	AUX
ajlm-1807	82	29	sensitive	sensitive	ADJ
ajlm-1807	82	30	to	to	ADP
ajlm-1807	82	31	vancomycin	vancomycin	PROPN
ajlm-1807	82	32	.	.	PUNCT
ajlm-1807	83	1	table	table	NOUN
ajlm-1807	83	2	5	5	NUM
ajlm-1807	83	3	:	:	PUNCT
ajlm-1807	83	4	 	 	SPACE
ajlm-1807	83	5	antibiotic	antibiotic	ADJ
ajlm-1807	83	6	susceptibility	susceptibility	NOUN
ajlm-1807	83	7	pattern	pattern	NOUN
ajlm-1807	83	8	of	of	ADP
ajlm-1807	83	9	isolates	isolate	NOUN
ajlm-1807	83	10	from	from	ADP
ajlm-1807	83	11	bloodstream	bloodstream	NOUN
ajlm-1807	83	12	infection	infection	NOUN
ajlm-1807	83	13	cases	case	NOUN
ajlm-1807	83	14	at	at	ADP
ajlm-1807	83	15	the	the	DET
ajlm-1807	83	16	federal	federal	ADJ
ajlm-1807	83	17	teaching	teaching	NOUN
ajlm-1807	83	18	hospital	hospital	NOUN
ajlm-1807	83	19	,	,	PUNCT
ajlm-1807	83	20	ido	ido	NOUN
ajlm-1807	83	21	-	-	PUNCT
ajlm-1807	83	22	ekiti	ekiti	PROPN
ajlm-1807	83	23	,	,	PUNCT
ajlm-1807	83	24	nigeria	nigeria	PROPN
ajlm-1807	83	25	,	,	PUNCT
ajlm-1807	83	26	between	between	ADP
ajlm-1807	83	27	june	june	PROPN
ajlm-1807	83	28	2020	2020	NUM
ajlm-1807	83	29	and	and	CCONJ
ajlm-1807	83	30	february	february	PROPN
ajlm-1807	83	31	2021	2021	NUM
ajlm-1807	83	32	.	.	PUNCT
ajlm-1807	84	1	discussion	discussion	NOUN
ajlm-1807	84	2	the	the	DET
ajlm-1807	84	3	low	low	ADJ
ajlm-1807	84	4	culture	culture	NOUN
ajlm-1807	84	5	positivity	positivity	NOUN
ajlm-1807	84	6	rate	rate	NOUN
ajlm-1807	84	7	of	of	ADP
ajlm-1807	84	8	19.2	19.2	NUM
ajlm-1807	84	9	%	%	NOUN
ajlm-1807	84	10	seen	see	VERB
ajlm-1807	84	11	in	in	ADP
ajlm-1807	84	12	this	this	DET
ajlm-1807	84	13	study	study	NOUN
ajlm-1807	84	14	is	be	AUX
ajlm-1807	84	15	similar	similar	ADJ
ajlm-1807	84	16	to	to	ADP
ajlm-1807	84	17	findings	finding	NOUN
ajlm-1807	84	18	in	in	ADP
ajlm-1807	84	19	some	some	DET
ajlm-1807	84	20	previous	previous	ADJ
ajlm-1807	84	21	studies	study	NOUN
ajlm-1807	84	22	.	.	PUNCT
ajlm-1807	85	1	deku	deku	PROPN
ajlm-1807	85	2	et	et	PROPN
ajlm-1807	85	3	al	al	PROPN
ajlm-1807	85	4	.	.	PROPN
ajlm-1807	85	5	reported	report	VERB
ajlm-1807	85	6	a	a	DET
ajlm-1807	85	7	culture	culture	NOUN
ajlm-1807	85	8	positivity	positivity	NOUN
ajlm-1807	85	9	rate	rate	NOUN
ajlm-1807	85	10	of	of	ADP
ajlm-1807	85	11	13.1	13.1	NUM
ajlm-1807	85	12	%	%	NOUN
ajlm-1807	85	13	in	in	ADP
ajlm-1807	85	14	ghana	ghana	PROPN
ajlm-1807	85	15	and	and	CCONJ
ajlm-1807	85	16	gupta	gupta	PROPN
ajlm-1807	85	17	et	et	PROPN
ajlm-1807	85	18	al	al	PROPN
ajlm-1807	85	19	.	.	PROPN
ajlm-1807	85	20	reported	report	VERB
ajlm-1807	85	21	16.5	16.5	NUM
ajlm-1807	85	22	%	%	NOUN
ajlm-1807	85	23	in	in	ADP
ajlm-1807	85	24	north	north	NOUN
ajlm-1807	85	25	india.23,24	india.23,24	X
ajlm-1807	85	26	lower	low	ADJ
ajlm-1807	85	27	rates	rate	NOUN
ajlm-1807	85	28	have	have	AUX
ajlm-1807	85	29	been	be	AUX
ajlm-1807	85	30	reported	report	VERB
ajlm-1807	85	31	in	in	ADP
ajlm-1807	85	32	other	other	ADJ
ajlm-1807	85	33	studies	study	NOUN
ajlm-1807	85	34	:	:	PUNCT
ajlm-1807	85	35	khanal	khanal	NOUN
ajlm-1807	85	36	et	et	PROPN
ajlm-1807	85	37	al	al	PROPN
ajlm-1807	85	38	.	.	PROPN
ajlm-1807	86	1	and	and	CCONJ
ajlm-1807	86	2	gohel	gohel	PROPN
ajlm-1807	86	3	et	et	PROPN
ajlm-1807	86	4	al	al	PROPN
ajlm-1807	86	5	.	.	PROPN
ajlm-1807	86	6	reported	report	VERB
ajlm-1807	86	7	a	a	DET
ajlm-1807	86	8	culture	culture	NOUN
ajlm-1807	86	9	positivity	positivity	NOUN
ajlm-1807	86	10	rate	rate	NOUN
ajlm-1807	86	11	of	of	ADP
ajlm-1807	86	12	10.3	10.3	NUM
ajlm-1807	86	13	%	%	NOUN
ajlm-1807	86	14	and	and	CCONJ
ajlm-1807	86	15	9.2	9.2	NUM
ajlm-1807	86	16	%	%	NOUN
ajlm-1807	86	17	,	,	PUNCT
ajlm-1807	86	18	respectively	respectively	ADV
ajlm-1807	86	19	,	,	PUNCT
ajlm-1807	86	20	from	from	ADP
ajlm-1807	86	21	bsi	bsi	PROPN
ajlm-1807	86	22	cases	case	NOUN
ajlm-1807	86	23	in	in	ADP
ajlm-1807	86	24	india.8,25	india.8,25	PROPN
ajlm-1807	86	25	a	a	DET
ajlm-1807	86	26	higher	high	ADJ
ajlm-1807	86	27	rate	rate	NOUN
ajlm-1807	86	28	of	of	ADP
ajlm-1807	86	29	44.0	44.0	NUM
ajlm-1807	86	30	%	%	NOUN
ajlm-1807	86	31	has	have	AUX
ajlm-1807	86	32	been	be	AUX
ajlm-1807	86	33	reported	report	VERB
ajlm-1807	86	34	by	by	ADP
ajlm-1807	86	35	khanal	khanal	PROPN
ajlm-1807	86	36	et	et	PROPN
ajlm-1807	86	37	al	al	PROPN
ajlm-1807	86	38	.	.	PROPN
ajlm-1807	87	1	in	in	ADP
ajlm-1807	87	2	another	another	DET
ajlm-1807	87	3	prospective	prospective	ADJ
ajlm-1807	87	4	study	study	NOUN
ajlm-1807	87	5	on	on	ADP
ajlm-1807	87	6	patients	patient	NOUN
ajlm-1807	87	7	with	with	ADP
ajlm-1807	87	8	infective	infective	ADJ
ajlm-1807	87	9	endocarditis	endocarditis	NOUN
ajlm-1807	87	10	in	in	ADP
ajlm-1807	87	11	india.9	india.9	PROPN
ajlm-1807	87	12	most	most	ADV
ajlm-1807	87	13	similar	similar	ADJ
ajlm-1807	87	14	studies	study	NOUN
ajlm-1807	87	15	conducted	conduct	VERB
ajlm-1807	87	16	in	in	ADP
ajlm-1807	87	17	nigeria	nigeria	PROPN
ajlm-1807	87	18	and	and	CCONJ
ajlm-1807	87	19	africa	africa	PROPN
ajlm-1807	87	20	focused	focus	VERB
ajlm-1807	87	21	mainly	mainly	ADV
ajlm-1807	87	22	on	on	ADP
ajlm-1807	87	23	neonatal	neonatal	ADJ
ajlm-1807	87	24	and	and	CCONJ
ajlm-1807	87	25	childhood	childhood	NOUN
ajlm-1807	87	26	bsis	bsis	NOUN
ajlm-1807	87	27	,	,	PUNCT
ajlm-1807	87	28	and	and	CCONJ
ajlm-1807	87	29	data	datum	NOUN
ajlm-1807	87	30	on	on	ADP
ajlm-1807	87	31	adult	adult	NOUN
ajlm-1807	87	32	bsis	bsis	NOUN
ajlm-1807	87	33	is	be	AUX
ajlm-1807	87	34	scanty	scanty	ADJ
ajlm-1807	87	35	.	.	PUNCT
ajlm-1807	88	1	of	of	ADP
ajlm-1807	88	2	those	those	DET
ajlm-1807	88	3	studies	study	NOUN
ajlm-1807	88	4	on	on	ADP
ajlm-1807	88	5	neonatal	neonatal	ADJ
ajlm-1807	88	6	bsis	bsis	NOUN
ajlm-1807	88	7	,	,	PUNCT
ajlm-1807	88	8	some	some	PRON
ajlm-1807	88	9	have	have	AUX
ajlm-1807	88	10	reported	report	VERB
ajlm-1807	88	11	similar	similar	ADJ
ajlm-1807	88	12	culture	culture	NOUN
ajlm-1807	88	13	positivity	positivity	NOUN
ajlm-1807	88	14	rates	rate	NOUN
ajlm-1807	88	15	to	to	ADP
ajlm-1807	88	16	the	the	DET
ajlm-1807	88	17	23.8	23.8	NUM
ajlm-1807	88	18	%	%	NOUN
ajlm-1807	88	19	seen	see	VERB
ajlm-1807	88	20	among	among	ADP
ajlm-1807	88	21	neonates	neonate	NOUN
ajlm-1807	88	22	in	in	ADP
ajlm-1807	88	23	this	this	DET
ajlm-1807	88	24	study	study	NOUN
ajlm-1807	88	25	:	:	PUNCT
ajlm-1807	88	26	ogunkunle	ogunkunle	NOUN
ajlm-1807	88	27	et	et	PROPN
ajlm-1807	88	28	al	al	PROPN
ajlm-1807	88	29	.	.	PROPN
ajlm-1807	89	1	(	(	PUNCT
ajlm-1807	89	2	19.0	19.0	NUM
ajlm-1807	89	3	%	%	NOUN
ajlm-1807	89	4	)	)	PUNCT
ajlm-1807	89	5	and	and	CCONJ
ajlm-1807	89	6	iregbu	iregbu	VERB
ajlm-1807	89	7	et	et	PROPN
ajlm-1807	89	8	al	al	PROPN
ajlm-1807	89	9	.	.	PROPN
ajlm-1807	90	1	(	(	PUNCT
ajlm-1807	90	2	22.0	22.0	NUM
ajlm-1807	90	3	%	%	NOUN
ajlm-1807	90	4	)	)	PUNCT
ajlm-1807	91	1	,	,	PUNCT
ajlm-1807	91	2	both	both	CCONJ
ajlm-1807	91	3	in	in	ADP
ajlm-1807	91	4	nigeria	nigeria	PROPN
ajlm-1807	91	5	,	,	PUNCT
ajlm-1807	91	6	while	while	SCONJ
ajlm-1807	91	7	higher	high	ADJ
ajlm-1807	91	8	isolation	isolation	NOUN
ajlm-1807	91	9	rates	rate	NOUN
ajlm-1807	91	10	were	be	AUX
ajlm-1807	91	11	reported	report	VERB
ajlm-1807	91	12	by	by	ADP
ajlm-1807	91	13	sorsa	sorsa	PROPN
ajlm-1807	91	14	in	in	ADP
ajlm-1807	91	15	ethiopia	ethiopia	PROPN
ajlm-1807	91	16	(	(	PUNCT
ajlm-1807	91	17	29.3	29.3	NUM
ajlm-1807	91	18	%	%	NOUN
ajlm-1807	91	19	)	)	PUNCT
ajlm-1807	91	20	,	,	PUNCT
ajlm-1807	92	1	uzodimma	uzodimma	PROPN
ajlm-1807	92	2	et	et	PROPN
ajlm-1807	92	3	al	al	PROPN
ajlm-1807	92	4	.	.	PROPN
ajlm-1807	93	1	in	in	ADP
ajlm-1807	93	2	nigeria	nigeria	PROPN
ajlm-1807	93	3	(	(	PUNCT
ajlm-1807	93	4	35.0	35.0	NUM
ajlm-1807	93	5	%	%	NOUN
ajlm-1807	93	6	)	)	PUNCT
ajlm-1807	93	7	and	and	CCONJ
ajlm-1807	93	8	el	el	PROPN
ajlm-1807	93	9	-	-	PUNCT
ajlm-1807	93	10	din	din	PROPN
ajlm-1807	93	11	et	et	PROPN
ajlm-1807	93	12	al	al	PROPN
ajlm-1807	93	13	.	.	PROPN
ajlm-1807	94	1	in	in	ADP
ajlm-1807	94	2	egypt	egypt	PROPN
ajlm-1807	94	3	(	(	PUNCT
ajlm-1807	94	4	40.7%).10,11,12,26,27	40.7%).10,11,12,26,27	NUM
ajlm-1807	94	5	factors	factor	NOUN
ajlm-1807	94	6	determining	determine	VERB
ajlm-1807	94	7	rate	rate	NOUN
ajlm-1807	94	8	of	of	ADP
ajlm-1807	94	9	culture	culture	NOUN
ajlm-1807	94	10	positivity	positivity	NOUN
ajlm-1807	94	11	include	include	VERB
ajlm-1807	94	12	the	the	DET
ajlm-1807	94	13	methods	method	NOUN
ajlm-1807	94	14	or	or	CCONJ
ajlm-1807	94	15	technique	technique	NOUN
ajlm-1807	94	16	used	use	VERB
ajlm-1807	94	17	in	in	ADP
ajlm-1807	94	18	isolating	isolate	VERB
ajlm-1807	94	19	bacteria	bacteria	NOUN
ajlm-1807	94	20	,	,	PUNCT
ajlm-1807	94	21	volume	volume	NOUN
ajlm-1807	94	22	and	and	CCONJ
ajlm-1807	94	23	the	the	DET
ajlm-1807	94	24	number	number	NOUN
ajlm-1807	94	25	of	of	ADP
ajlm-1807	94	26	blood	blood	NOUN
ajlm-1807	94	27	samples	sample	NOUN
ajlm-1807	94	28	collected	collect	VERB
ajlm-1807	94	29	for	for	ADP
ajlm-1807	94	30	the	the	DET
ajlm-1807	94	31	culture	culture	NOUN
ajlm-1807	94	32	;	;	PUNCT
ajlm-1807	94	33	also	also	ADV
ajlm-1807	94	34	in	in	ADP
ajlm-1807	94	35	addition	addition	NOUN
ajlm-1807	94	36	,	,	PUNCT
ajlm-1807	94	37	prior	prior	ADJ
ajlm-1807	94	38	use	use	NOUN
ajlm-1807	94	39	of	of	ADP
ajlm-1807	94	40	antibiotics	antibiotic	NOUN
ajlm-1807	94	41	before	before	ADP
ajlm-1807	94	42	sample	sample	NOUN
ajlm-1807	94	43	collection	collection	NOUN
ajlm-1807	94	44	will	will	AUX
ajlm-1807	94	45	affect	affect	VERB
ajlm-1807	94	46	the	the	DET
ajlm-1807	94	47	likelihood	likelihood	NOUN
ajlm-1807	94	48	of	of	ADP
ajlm-1807	94	49	culture	culture	NOUN
ajlm-1807	94	50	positivity.28	positivity.28	NOUN
ajlm-1807	94	51	in	in	ADP
ajlm-1807	94	52	this	this	DET
ajlm-1807	94	53	study	study	NOUN
ajlm-1807	94	54	,	,	PUNCT
ajlm-1807	94	55	adequate	adequate	ADJ
ajlm-1807	94	56	volumes	volume	NOUN
ajlm-1807	94	57	of	of	ADP
ajlm-1807	94	58	blood	blood	NOUN
ajlm-1807	94	59	samples	sample	NOUN
ajlm-1807	94	60	were	be	AUX
ajlm-1807	94	61	collected	collect	VERB
ajlm-1807	94	62	before	before	ADP
ajlm-1807	94	63	the	the	DET
ajlm-1807	94	64	commencement	commencement	NOUN
ajlm-1807	94	65	of	of	ADP
ajlm-1807	94	66	antibiotic	antibiotic	ADJ
ajlm-1807	94	67	treatment	treatment	NOUN
ajlm-1807	94	68	,	,	PUNCT
ajlm-1807	94	69	and	and	CCONJ
ajlm-1807	94	70	patients	patient	NOUN
ajlm-1807	94	71	with	with	ADP
ajlm-1807	94	72	history	history	NOUN
ajlm-1807	94	73	of	of	ADP
ajlm-1807	94	74	antibiotic	antibiotic	ADJ
ajlm-1807	94	75	medication	medication	NOUN
ajlm-1807	94	76	prior	prior	ADV
ajlm-1807	94	77	to	to	ADP
ajlm-1807	94	78	sample	sample	NOUN
ajlm-1807	94	79	collection	collection	NOUN
ajlm-1807	94	80	were	be	AUX
ajlm-1807	94	81	excluded	exclude	VERB
ajlm-1807	94	82	from	from	ADP
ajlm-1807	94	83	the	the	DET
ajlm-1807	94	84	study	study	NOUN
ajlm-1807	94	85	,	,	PUNCT
ajlm-1807	94	86	yet	yet	ADV
ajlm-1807	94	87	,	,	PUNCT
ajlm-1807	94	88	prior	prior	ADV
ajlm-1807	94	89	self	self	NOUN
ajlm-1807	94	90	-	-	PUNCT
ajlm-1807	94	91	medication	medication	NOUN
ajlm-1807	94	92	at	at	ADP
ajlm-1807	94	93	home	home	NOUN
ajlm-1807	94	94	or	or	CCONJ
ajlm-1807	94	95	use	use	NOUN
ajlm-1807	94	96	of	of	ADP
ajlm-1807	94	97	antibiotics	antibiotic	NOUN
ajlm-1807	94	98	at	at	ADP
ajlm-1807	94	99	peripheral	peripheral	ADJ
ajlm-1807	94	100	health	health	NOUN
ajlm-1807	94	101	facilities	facility	NOUN
ajlm-1807	94	102	before	before	SCONJ
ajlm-1807	94	103	transfer	transfer	NOUN
ajlm-1807	94	104	to	to	ADP
ajlm-1807	94	105	our	our	PRON
ajlm-1807	94	106	centre	centre	NOUN
ajlm-1807	94	107	could	could	AUX
ajlm-1807	94	108	not	not	PART
ajlm-1807	94	109	be	be	AUX
ajlm-1807	94	110	totally	totally	ADV
ajlm-1807	94	111	ruled	rule	VERB
ajlm-1807	94	112	out	out	ADP
ajlm-1807	94	113	.	.	PUNCT
ajlm-1807	95	1	this	this	PRON
ajlm-1807	95	2	coupled	couple	VERB
ajlm-1807	95	3	with	with	ADP
ajlm-1807	95	4	the	the	DET
ajlm-1807	95	5	fact	fact	NOUN
ajlm-1807	95	6	that	that	SCONJ
ajlm-1807	95	7	some	some	PRON
ajlm-1807	95	8	of	of	ADP
ajlm-1807	95	9	these	these	DET
ajlm-1807	95	10	patients	patient	NOUN
ajlm-1807	95	11	clinically	clinically	ADV
ajlm-1807	95	12	diagnosed	diagnose	VERB
ajlm-1807	95	13	as	as	SCONJ
ajlm-1807	95	14	bsi	bsi	PROPN
ajlm-1807	95	15	may	may	AUX
ajlm-1807	95	16	actually	actually	ADV
ajlm-1807	95	17	have	have	AUX
ajlm-1807	95	18	been	be	AUX
ajlm-1807	95	19	suffering	suffer	VERB
ajlm-1807	95	20	from	from	ADP
ajlm-1807	95	21	other	other	ADJ
ajlm-1807	95	22	conditions	condition	NOUN
ajlm-1807	95	23	mimicking	mimic	VERB
ajlm-1807	95	24	bsi	bsi	NOUN
ajlm-1807	95	25	(	(	PUNCT
ajlm-1807	95	26	and	and	CCONJ
ajlm-1807	95	27	not	not	PART
ajlm-1807	95	28	bsi	bsi	PROPN
ajlm-1807	95	29	)	)	PUNCT
ajlm-1807	95	30	,	,	PUNCT
ajlm-1807	95	31	thus	thus	ADV
ajlm-1807	95	32	accounting	account	VERB
ajlm-1807	95	33	for	for	ADP
ajlm-1807	95	34	the	the	DET
ajlm-1807	95	35	low	low	ADJ
ajlm-1807	95	36	culture	culture	NOUN
ajlm-1807	95	37	positivity	positivity	NOUN
ajlm-1807	95	38	seen	see	VERB
ajlm-1807	95	39	.	.	PUNCT
ajlm-1807	96	1	gram	gram	NOUN
ajlm-1807	96	2	-	-	PUNCT
ajlm-1807	96	3	negative	negative	ADJ
ajlm-1807	96	4	enteric	enteric	ADJ
ajlm-1807	96	5	bacteria	bacteria	NOUN
ajlm-1807	96	6	(	(	PUNCT
ajlm-1807	96	7	67.6	67.6	NUM
ajlm-1807	96	8	%	%	NOUN
ajlm-1807	96	9	)	)	PUNCT
ajlm-1807	96	10	were	be	AUX
ajlm-1807	96	11	the	the	DET
ajlm-1807	96	12	predominant	predominant	ADJ
ajlm-1807	96	13	isolates	isolate	NOUN
ajlm-1807	96	14	in	in	ADP
ajlm-1807	96	15	this	this	DET
ajlm-1807	96	16	study	study	NOUN
ajlm-1807	96	17	,	,	PUNCT
ajlm-1807	96	18	of	of	ADP
ajlm-1807	96	19	which	which	PRON
ajlm-1807	96	20	e.	e.	PROPN
ajlm-1807	96	21	coli	coli	PROPN
ajlm-1807	96	22	(	(	PUNCT
ajlm-1807	96	23	29.4	29.4	NUM
ajlm-1807	96	24	%	%	NOUN
ajlm-1807	96	25	)	)	PUNCT
ajlm-1807	96	26	was	be	AUX
ajlm-1807	96	27	the	the	DET
ajlm-1807	96	28	most	most	ADV
ajlm-1807	96	29	commonly	commonly	ADV
ajlm-1807	96	30	isolated	isolate	VERB
ajlm-1807	96	31	.	.	PUNCT
ajlm-1807	97	1	staphylococcus	staphylococcus	NOUN
ajlm-1807	97	2	aureus	aureus	NOUN
ajlm-1807	97	3	(	(	PUNCT
ajlm-1807	97	4	23.5	23.5	NUM
ajlm-1807	97	5	%	%	NOUN
ajlm-1807	97	6	)	)	PUNCT
ajlm-1807	97	7	and	and	CCONJ
ajlm-1807	97	8	cons	con	NOUN
ajlm-1807	97	9	(	(	PUNCT
ajlm-1807	97	10	8.8	8.8	NUM
ajlm-1807	97	11	%	%	NOUN
ajlm-1807	97	12	)	)	PUNCT
ajlm-1807	97	13	were	be	AUX
ajlm-1807	97	14	the	the	DET
ajlm-1807	97	15	only	only	ADJ
ajlm-1807	97	16	gram	gram	NOUN
ajlm-1807	97	17	-	-	PUNCT
ajlm-1807	97	18	positive	positive	ADJ
ajlm-1807	97	19	bacteria	bacteria	NOUN
ajlm-1807	97	20	isolated	isolate	VERB
ajlm-1807	97	21	.	.	PUNCT
ajlm-1807	98	1	similar	similar	ADJ
ajlm-1807	98	2	findings	finding	NOUN
ajlm-1807	98	3	have	have	AUX
ajlm-1807	98	4	been	be	AUX
ajlm-1807	98	5	reported	report	VERB
ajlm-1807	98	6	by	by	ADP
ajlm-1807	98	7	earlier	early	ADJ
ajlm-1807	98	8	studies	study	NOUN
ajlm-1807	98	9	where	where	SCONJ
ajlm-1807	98	10	gram	gram	NOUN
ajlm-1807	98	11	-	-	PUNCT
ajlm-1807	98	12	negative	negative	ADJ
ajlm-1807	98	13	bacteria	bacteria	NOUN
ajlm-1807	98	14	were	be	AUX
ajlm-1807	98	15	the	the	DET
ajlm-1807	98	16	predominant	predominant	ADJ
ajlm-1807	98	17	isolates	isolate	NOUN
ajlm-1807	98	18	from	from	ADP
ajlm-1807	98	19	cases	case	NOUN
ajlm-1807	98	20	of	of	ADP
ajlm-1807	98	21	bsi.24,28	bsi.24,28	NOUN
ajlm-1807	98	22	however	however	ADV
ajlm-1807	98	23	,	,	PUNCT
ajlm-1807	98	24	some	some	DET
ajlm-1807	98	25	studies	study	NOUN
ajlm-1807	98	26	have	have	AUX
ajlm-1807	98	27	reported	report	VERB
ajlm-1807	98	28	s.	s.	PROPN
ajlm-1807	98	29	aureus	aureus	PROPN
ajlm-1807	98	30	or	or	CCONJ
ajlm-1807	98	31	cons	con	NOUN
ajlm-1807	98	32	as	as	ADP
ajlm-1807	98	33	the	the	DET
ajlm-1807	98	34	most	most	ADV
ajlm-1807	98	35	commonly	commonly	ADV
ajlm-1807	98	36	isolated	isolate	VERB
ajlm-1807	98	37	bacterial	bacterial	ADJ
ajlm-1807	98	38	pathogen	pathogen	NOUN
ajlm-1807	98	39	from	from	ADP
ajlm-1807	98	40	cases	case	NOUN
ajlm-1807	98	41	of	of	ADP
ajlm-1807	98	42	bsi.15,23,25,29,30,31	bsi.15,23,25,29,30,31	PROPN
ajlm-1807	98	43	generally	generally	ADV
ajlm-1807	98	44	,	,	PUNCT
ajlm-1807	98	45	there	there	PRON
ajlm-1807	98	46	is	be	VERB
ajlm-1807	98	47	wide	wide	ADJ
ajlm-1807	98	48	variability	variability	NOUN
ajlm-1807	98	49	in	in	ADP
ajlm-1807	98	50	the	the	DET
ajlm-1807	98	51	pathogens	pathogen	NOUN
ajlm-1807	98	52	isolated	isolate	VERB
ajlm-1807	98	53	from	from	ADP
ajlm-1807	98	54	cases	case	NOUN
ajlm-1807	98	55	of	of	ADP
ajlm-1807	98	56	bsi	bsi	NOUN
ajlm-1807	98	57	in	in	ADP
ajlm-1807	98	58	different	different	ADJ
ajlm-1807	98	59	settings	setting	NOUN
ajlm-1807	98	60	.	.	PUNCT
ajlm-1807	99	1	gram	gram	NOUN
ajlm-1807	99	2	-	-	PUNCT
ajlm-1807	99	3	positive	positive	ADJ
ajlm-1807	99	4	bacteria	bacteria	NOUN
ajlm-1807	99	5	were	be	AUX
ajlm-1807	99	6	the	the	DET
ajlm-1807	99	7	most	most	ADV
ajlm-1807	99	8	common	common	ADJ
ajlm-1807	99	9	cause	cause	NOUN
ajlm-1807	99	10	of	of	ADP
ajlm-1807	99	11	sepsis	sepsis	NOUN
ajlm-1807	99	12	prior	prior	ADV
ajlm-1807	99	13	to	to	ADP
ajlm-1807	99	14	the	the	DET
ajlm-1807	99	15	advent	advent	NOUN
ajlm-1807	99	16	of	of	ADP
ajlm-1807	99	17	antibiotics	antibiotic	NOUN
ajlm-1807	99	18	in	in	ADP
ajlm-1807	99	19	the	the	DET
ajlm-1807	99	20	1950s	1950	NOUN
ajlm-1807	99	21	,	,	PUNCT
ajlm-1807	99	22	but	but	CCONJ
ajlm-1807	99	23	gram	gram	NOUN
ajlm-1807	99	24	-	-	PUNCT
ajlm-1807	99	25	negative	negative	ADJ
ajlm-1807	99	26	bacteria	bacteria	NOUN
ajlm-1807	99	27	became	become	VERB
ajlm-1807	99	28	the	the	DET
ajlm-1807	99	29	most	most	ADV
ajlm-1807	99	30	predominant	predominant	ADJ
ajlm-1807	99	31	after	after	ADP
ajlm-1807	99	32	the	the	DET
ajlm-1807	99	33	introduction	introduction	NOUN
ajlm-1807	99	34	of	of	ADP
ajlm-1807	99	35	antibiotics	antibiotic	NOUN
ajlm-1807	99	36	from	from	ADP
ajlm-1807	99	37	the	the	DET
ajlm-1807	99	38	1960s	1960	NOUN
ajlm-1807	99	39	to	to	ADP
ajlm-1807	99	40	1980s	1980s	NUM
ajlm-1807	99	41	.	.	PUNCT
ajlm-1807	100	1	however	however	ADV
ajlm-1807	100	2	,	,	PUNCT
ajlm-1807	100	3	from	from	ADP
ajlm-1807	100	4	the	the	DET
ajlm-1807	100	5	1980s	1980s	NUM
ajlm-1807	100	6	,	,	PUNCT
ajlm-1807	100	7	gram	gram	NOUN
ajlm-1807	100	8	-	-	PUNCT
ajlm-1807	100	9	positive	positive	ADJ
ajlm-1807	100	10	bacteria	bacteria	NOUN
ajlm-1807	100	11	,	,	PUNCT
ajlm-1807	100	12	most	most	ADV
ajlm-1807	100	13	commonly	commonly	ADV
ajlm-1807	100	14	staphylococcus	staphylococcus	NOUN
ajlm-1807	100	15	spp	spp	NOUN
ajlm-1807	100	16	.	.	PROPN
ajlm-1807	100	17	,	,	PUNCT
ajlm-1807	100	18	were	be	AUX
ajlm-1807	100	19	thought	think	VERB
ajlm-1807	100	20	to	to	PART
ajlm-1807	100	21	cause	cause	VERB
ajlm-1807	100	22	more	more	ADJ
ajlm-1807	100	23	than	than	ADP
ajlm-1807	100	24	50	50	NUM
ajlm-1807	100	25	%	%	NOUN
ajlm-1807	100	26	of	of	ADP
ajlm-1807	100	27	cases	case	NOUN
ajlm-1807	100	28	of	of	ADP
ajlm-1807	100	29	sepsis.32,33	sepsis.32,33	NOUN
ajlm-1807	100	30	in	in	ADP
ajlm-1807	100	31	hospital	hospital	NOUN
ajlm-1807	100	32	patients	patient	NOUN
ajlm-1807	100	33	,	,	PUNCT
ajlm-1807	100	34	there	there	PRON
ajlm-1807	100	35	is	be	VERB
ajlm-1807	100	36	a	a	DET
ajlm-1807	100	37	higher	high	ADJ
ajlm-1807	100	38	chance	chance	NOUN
ajlm-1807	100	39	of	of	ADP
ajlm-1807	100	40	hospital	hospital	NOUN
ajlm-1807	100	41	-	-	PUNCT
ajlm-1807	100	42	selected	select	VERB
ajlm-1807	100	43	gram	gram	NOUN
ajlm-1807	100	44	-	-	PUNCT
ajlm-1807	100	45	negative	negative	ADJ
ajlm-1807	100	46	bacteria	bacteria	NOUN
ajlm-1807	100	47	causing	cause	VERB
ajlm-1807	100	48	bsis	bsis	NOUN
ajlm-1807	100	49	due	due	ADP
ajlm-1807	100	50	to	to	ADP
ajlm-1807	100	51	the	the	DET
ajlm-1807	100	52	instruments	instrument	NOUN
ajlm-1807	100	53	and	and	CCONJ
ajlm-1807	100	54	procedures	procedure	NOUN
ajlm-1807	100	55	carried	carry	VERB
ajlm-1807	100	56	out	out	ADP
ajlm-1807	100	57	on	on	ADP
ajlm-1807	100	58	these	these	DET
ajlm-1807	100	59	patients	patient	NOUN
ajlm-1807	100	60	.	.	PUNCT
ajlm-1807	101	1	this	this	PRON
ajlm-1807	101	2	may	may	AUX
ajlm-1807	101	3	account	account	VERB
ajlm-1807	101	4	for	for	ADP
ajlm-1807	101	5	the	the	DET
ajlm-1807	101	6	preponderance	preponderance	NOUN
ajlm-1807	101	7	of	of	ADP
ajlm-1807	101	8	gram	gram	NOUN
ajlm-1807	101	9	-	-	PUNCT
ajlm-1807	101	10	negative	negative	ADJ
ajlm-1807	101	11	bacteria	bacteria	NOUN
ajlm-1807	101	12	isolates	isolate	NOUN
ajlm-1807	101	13	in	in	ADP
ajlm-1807	101	14	this	this	DET
ajlm-1807	101	15	study	study	NOUN
ajlm-1807	101	16	.	.	PUNCT
ajlm-1807	102	1	predominant	predominant	ADJ
ajlm-1807	102	2	isolation	isolation	NOUN
ajlm-1807	102	3	of	of	ADP
ajlm-1807	102	4	gram	gram	NOUN
ajlm-1807	102	5	-	-	PUNCT
ajlm-1807	102	6	negative	negative	ADJ
ajlm-1807	102	7	enteric	enteric	ADJ
ajlm-1807	102	8	bacteria	bacteria	NOUN
ajlm-1807	102	9	among	among	ADP
ajlm-1807	102	10	neonates	neonate	NOUN
ajlm-1807	102	11	in	in	ADP
ajlm-1807	102	12	this	this	DET
ajlm-1807	102	13	study	study	NOUN
ajlm-1807	102	14	contrasted	contrast	VERB
ajlm-1807	102	15	with	with	ADP
ajlm-1807	102	16	some	some	DET
ajlm-1807	102	17	previous	previous	ADJ
ajlm-1807	102	18	studies	study	NOUN
ajlm-1807	102	19	on	on	ADP
ajlm-1807	102	20	neonatal	neonatal	ADJ
ajlm-1807	102	21	bsis	bsis	NOUN
ajlm-1807	102	22	:	:	PUNCT
ajlm-1807	102	23	ogunkunle	ogunkunle	NOUN
ajlm-1807	102	24	et	et	PROPN
ajlm-1807	102	25	al	al	PROPN
ajlm-1807	102	26	.	.	PROPN
ajlm-1807	102	27	,	,	PUNCT
ajlm-1807	102	28	sorsa	sorsa	PROPN
ajlm-1807	102	29	and	and	CCONJ
ajlm-1807	102	30	el	el	PROPN
ajlm-1807	102	31	-	-	PUNCT
ajlm-1807	102	32	din	din	PROPN
ajlm-1807	102	33	et	et	PROPN
ajlm-1807	102	34	al	al	PROPN
ajlm-1807	102	35	.	.	PROPN
ajlm-1807	103	1	all	all	PRON
ajlm-1807	103	2	reported	report	VERB
ajlm-1807	103	3	gram	gram	NOUN
ajlm-1807	103	4	-	-	PUNCT
ajlm-1807	103	5	positive	positive	ADJ
ajlm-1807	103	6	bacteria	bacteria	NOUN
ajlm-1807	103	7	as	as	ADP
ajlm-1807	103	8	the	the	DET
ajlm-1807	103	9	most	most	ADV
ajlm-1807	103	10	commonly	commonly	ADV
ajlm-1807	103	11	isolated	isolate	VERB
ajlm-1807	103	12	pathogens	pathogen	NOUN
ajlm-1807	103	13	from	from	ADP
ajlm-1807	103	14	cases	case	NOUN
ajlm-1807	103	15	of	of	ADP
ajlm-1807	103	16	neonatal	neonatal	ADJ
ajlm-1807	103	17	bsis.10,26,27	bsis.10,26,27	NOUN
ajlm-1807	103	18	this	this	DET
ajlm-1807	103	19	contrasting	contrasting	ADJ
ajlm-1807	103	20	result	result	NOUN
ajlm-1807	103	21	may	may	AUX
ajlm-1807	103	22	be	be	AUX
ajlm-1807	103	23	because	because	SCONJ
ajlm-1807	103	24	of	of	ADP
ajlm-1807	103	25	the	the	DET
ajlm-1807	103	26	small	small	ADJ
ajlm-1807	103	27	number	number	NOUN
ajlm-1807	103	28	of	of	ADP
ajlm-1807	103	29	neonates	neonate	NOUN
ajlm-1807	103	30	examined	examine	VERB
ajlm-1807	103	31	in	in	ADP
ajlm-1807	103	32	this	this	DET
ajlm-1807	103	33	study	study	NOUN
ajlm-1807	103	34	compared	compare	VERB
ajlm-1807	103	35	to	to	ADP
ajlm-1807	103	36	those	those	DET
ajlm-1807	103	37	other	other	ADJ
ajlm-1807	103	38	studies	study	NOUN
ajlm-1807	103	39	that	that	PRON
ajlm-1807	103	40	focused	focus	VERB
ajlm-1807	103	41	mainly	mainly	ADV
ajlm-1807	103	42	on	on	ADP
ajlm-1807	103	43	neonates	neonate	NOUN
ajlm-1807	103	44	.	.	PUNCT
ajlm-1807	104	1	iregbu	iregbu	PROPN
ajlm-1807	104	2	et	et	PROPN
ajlm-1807	104	3	al	al	PROPN
ajlm-1807	104	4	.	.	PROPN
ajlm-1807	104	5	,	,	PUNCT
ajlm-1807	104	6	however	however	ADV
ajlm-1807	104	7	,	,	PUNCT
ajlm-1807	104	8	reported	report	VERB
ajlm-1807	104	9	isolation	isolation	NOUN
ajlm-1807	104	10	of	of	ADP
ajlm-1807	104	11	gram	gram	NOUN
ajlm-1807	104	12	-	-	PUNCT
ajlm-1807	104	13	positive	positive	ADJ
ajlm-1807	104	14	and	and	CCONJ
ajlm-1807	104	15	gram	gram	NOUN
ajlm-1807	104	16	-	-	PUNCT
ajlm-1807	104	17	negative	negative	ADJ
ajlm-1807	104	18	bacteria	bacteria	NOUN
ajlm-1807	104	19	in	in	ADP
ajlm-1807	104	20	equal	equal	ADJ
ajlm-1807	104	21	proportion	proportion	NOUN
ajlm-1807	104	22	from	from	ADP
ajlm-1807	104	23	cases	case	NOUN
ajlm-1807	104	24	of	of	ADP
ajlm-1807	104	25	neonatal	neonatal	ADJ
ajlm-1807	104	26	bsis	bsis	NOUN
ajlm-1807	104	27	in	in	ADP
ajlm-1807	104	28	abuja	abuja	PROPN
ajlm-1807	104	29	,	,	PUNCT
ajlm-1807	104	30	nigeria.11	nigeria.11	PROPN
ajlm-1807	104	31	all	all	PRON
ajlm-1807	104	32	of	of	ADP
ajlm-1807	104	33	the	the	DET
ajlm-1807	104	34	cons	con	NOUN
ajlm-1807	104	35	and	and	CCONJ
ajlm-1807	104	36	s.	s.	PROPN
ajlm-1807	104	37	aureus	aureus	PROPN
ajlm-1807	104	38	,	,	PUNCT
ajlm-1807	104	39	including	include	VERB
ajlm-1807	104	40	the	the	DET
ajlm-1807	104	41	three	three	NUM
ajlm-1807	104	42	mrsa	mrsa	NOUN
ajlm-1807	104	43	isolated	isolate	VERB
ajlm-1807	104	44	in	in	ADP
ajlm-1807	104	45	this	this	DET
ajlm-1807	104	46	study	study	NOUN
ajlm-1807	104	47	,	,	PUNCT
ajlm-1807	104	48	were	be	AUX
ajlm-1807	104	49	sensitive	sensitive	ADJ
ajlm-1807	104	50	to	to	ADP
ajlm-1807	104	51	vancomycin	vancomycin	PROPN
ajlm-1807	104	52	.	.	PUNCT
ajlm-1807	105	1	resistance	resistance	NOUN
ajlm-1807	105	2	of	of	ADP
ajlm-1807	105	3	cons	con	NOUN
ajlm-1807	105	4	and	and	CCONJ
ajlm-1807	105	5	mrsa	mrsa	NOUN
ajlm-1807	105	6	to	to	ADP
ajlm-1807	105	7	vancomycin	vancomycin	PROPN
ajlm-1807	105	8	is	be	AUX
ajlm-1807	105	9	of	of	ADP
ajlm-1807	105	10	immense	immense	ADJ
ajlm-1807	105	11	challenge	challenge	NOUN
ajlm-1807	105	12	to	to	ADP
ajlm-1807	105	13	the	the	DET
ajlm-1807	105	14	treatment	treatment	NOUN
ajlm-1807	105	15	of	of	ADP
ajlm-1807	105	16	diseases	disease	NOUN
ajlm-1807	105	17	caused	cause	VERB
ajlm-1807	105	18	by	by	ADP
ajlm-1807	105	19	these	these	DET
ajlm-1807	105	20	strains	strain	NOUN
ajlm-1807	105	21	because	because	SCONJ
ajlm-1807	105	22	of	of	ADP
ajlm-1807	105	23	associated	associate	VERB
ajlm-1807	105	24	persistent	persistent	ADJ
ajlm-1807	105	25	infections	infection	NOUN
ajlm-1807	105	26	,	,	PUNCT
ajlm-1807	105	27	vancomycin	vancomycin	PROPN
ajlm-1807	105	28	treatment	treatment	NOUN
ajlm-1807	105	29	failure	failure	NOUN
ajlm-1807	105	30	and	and	CCONJ
ajlm-1807	105	31	a	a	DET
ajlm-1807	105	32	generally	generally	ADV
ajlm-1807	105	33	poor	poor	ADJ
ajlm-1807	105	34	clinical	clinical	ADJ
ajlm-1807	105	35	outcome	outcome	NOUN
ajlm-1807	105	36	.	.	PUNCT
ajlm-1807	106	1	all	all	PRON
ajlm-1807	106	2	of	of	ADP
ajlm-1807	106	3	the	the	DET
ajlm-1807	106	4	isolates	isolate	NOUN
ajlm-1807	106	5	in	in	ADP
ajlm-1807	106	6	this	this	DET
ajlm-1807	106	7	study	study	NOUN
ajlm-1807	106	8	were	be	AUX
ajlm-1807	106	9	sensitive	sensitive	ADJ
ajlm-1807	106	10	to	to	ADP
ajlm-1807	106	11	meropenem	meropenem	PROPN
ajlm-1807	106	12	,	,	PUNCT
ajlm-1807	106	13	and	and	CCONJ
ajlm-1807	106	14	97.1	97.1	NUM
ajlm-1807	106	15	%	%	NOUN
ajlm-1807	106	16	were	be	AUX
ajlm-1807	106	17	sensitive	sensitive	ADJ
ajlm-1807	106	18	to	to	ADP
ajlm-1807	106	19	imipenem	imipenem	PROPN
ajlm-1807	106	20	.	.	PUNCT
ajlm-1807	107	1	these	these	DET
ajlm-1807	107	2	carbapenems	carbapenem	NOUN
ajlm-1807	107	3	represent	represent	VERB
ajlm-1807	107	4	the	the	DET
ajlm-1807	107	5	last	last	ADJ
ajlm-1807	107	6	resort	resort	NOUN
ajlm-1807	107	7	,	,	PUNCT
ajlm-1807	107	8	in	in	ADP
ajlm-1807	107	9	antibiotic	antibiotic	ADJ
ajlm-1807	107	10	treatment	treatment	NOUN
ajlm-1807	107	11	,	,	PUNCT
ajlm-1807	107	12	for	for	SCONJ
ajlm-1807	107	13	most	most	ADJ
ajlm-1807	107	14	facilities	facility	NOUN
ajlm-1807	107	15	in	in	ADP
ajlm-1807	107	16	the	the	DET
ajlm-1807	107	17	less	less	ADV
ajlm-1807	107	18	-	-	PUNCT
ajlm-1807	107	19	developed	develop	VERB
ajlm-1807	107	20	world	world	NOUN
ajlm-1807	107	21	,	,	PUNCT
ajlm-1807	107	22	where	where	SCONJ
ajlm-1807	107	23	newer	new	ADJ
ajlm-1807	107	24	antibiotics	antibiotic	NOUN
ajlm-1807	107	25	are	be	AUX
ajlm-1807	107	26	out	out	ADP
ajlm-1807	107	27	of	of	ADP
ajlm-1807	107	28	reach	reach	NOUN
ajlm-1807	107	29	of	of	ADP
ajlm-1807	107	30	the	the	DET
ajlm-1807	107	31	majority	majority	NOUN
ajlm-1807	107	32	,	,	PUNCT
ajlm-1807	107	33	especially	especially	ADV
ajlm-1807	107	34	for	for	ADP
ajlm-1807	107	35	esbl	esbl	NOUN
ajlm-1807	107	36	-	-	PUNCT
ajlm-1807	107	37	producing	produce	VERB
ajlm-1807	107	38	gram	gram	NOUN
ajlm-1807	107	39	-	-	PUNCT
ajlm-1807	107	40	negative	negative	ADJ
ajlm-1807	107	41	bacteria.17	bacteria.17	ADJ
ajlm-1807	107	42	favourable	favourable	ADJ
ajlm-1807	107	43	sensitivity	sensitivity	NOUN
ajlm-1807	107	44	patterns	pattern	NOUN
ajlm-1807	107	45	were	be	AUX
ajlm-1807	107	46	also	also	ADV
ajlm-1807	107	47	seen	see	VERB
ajlm-1807	107	48	in	in	ADP
ajlm-1807	107	49	this	this	DET
ajlm-1807	107	50	study	study	NOUN
ajlm-1807	107	51	to	to	ADP
ajlm-1807	107	52	other	other	ADJ
ajlm-1807	107	53	antibiotics	antibiotic	NOUN
ajlm-1807	107	54	,	,	PUNCT
ajlm-1807	107	55	including	include	VERB
ajlm-1807	107	56	ceftazidime	ceftazidime	NOUN
ajlm-1807	107	57	(	(	PUNCT
ajlm-1807	107	58	85.3	85.3	NUM
ajlm-1807	107	59	%	%	NOUN
ajlm-1807	107	60	)	)	PUNCT
ajlm-1807	107	61	,	,	PUNCT
ajlm-1807	107	62	ofloxacin	ofloxacin	PROPN
ajlm-1807	107	63	(	(	PUNCT
ajlm-1807	107	64	79.4	79.4	NUM
ajlm-1807	107	65	%	%	NOUN
ajlm-1807	107	66	)	)	PUNCT
ajlm-1807	107	67	,	,	PUNCT
ajlm-1807	107	68	ciprofloxacin	ciprofloxacin	NOUN
ajlm-1807	107	69	(	(	PUNCT
ajlm-1807	107	70	79.4	79.4	NUM
ajlm-1807	107	71	%	%	NOUN
ajlm-1807	107	72	)	)	PUNCT
ajlm-1807	107	73	,	,	PUNCT
ajlm-1807	107	74	and	and	CCONJ
ajlm-1807	107	75	gentamicin	gentamicin	NOUN
ajlm-1807	107	76	(	(	PUNCT
ajlm-1807	107	77	76.5	76.5	NUM
ajlm-1807	107	78	%	%	NOUN
ajlm-1807	107	79	)	)	PUNCT
ajlm-1807	107	80	.	.	PUNCT
ajlm-1807	108	1	the	the	DET
ajlm-1807	108	2	poor	poor	ADJ
ajlm-1807	108	3	sensitivity	sensitivity	NOUN
ajlm-1807	108	4	pattern	pattern	NOUN
ajlm-1807	108	5	seen	see	VERB
ajlm-1807	108	6	with	with	ADP
ajlm-1807	108	7	these	these	DET
ajlm-1807	108	8	isolates	isolate	NOUN
ajlm-1807	108	9	to	to	ADP
ajlm-1807	108	10	cotrimoxazole	cotrimoxazole	NOUN
ajlm-1807	108	11	(	(	PUNCT
ajlm-1807	108	12	32.4	32.4	NUM
ajlm-1807	108	13	%	%	NOUN
ajlm-1807	108	14	)	)	PUNCT
ajlm-1807	108	15	,	,	PUNCT
ajlm-1807	108	16	ampicillin	ampicillin	NOUN
ajlm-1807	108	17	(	(	PUNCT
ajlm-1807	108	18	38.2	38.2	NUM
ajlm-1807	108	19	%	%	NOUN
ajlm-1807	108	20	)	)	PUNCT
ajlm-1807	108	21	,	,	PUNCT
ajlm-1807	108	22	amoxycillin	amoxycillin	NOUN
ajlm-1807	108	23	-	-	PUNCT
ajlm-1807	108	24	clavulanate	clavulanate	NOUN
ajlm-1807	108	25	(	(	PUNCT
ajlm-1807	108	26	64.7	64.7	NUM
ajlm-1807	108	27	%	%	NOUN
ajlm-1807	108	28	)	)	PUNCT
ajlm-1807	108	29	,	,	PUNCT
ajlm-1807	108	30	ampicillin	ampicillin	NOUN
ajlm-1807	108	31	-	-	PUNCT
ajlm-1807	108	32	sulbactam	sulbactam	NOUN
ajlm-1807	108	33	(	(	PUNCT
ajlm-1807	108	34	67.6	67.6	NUM
ajlm-1807	108	35	%	%	NOUN
ajlm-1807	108	36	)	)	PUNCT
ajlm-1807	108	37	and	and	CCONJ
ajlm-1807	108	38	ceftriaxone	ceftriaxone	NOUN
ajlm-1807	108	39	(	(	PUNCT
ajlm-1807	108	40	67.6	67.6	NUM
ajlm-1807	108	41	%	%	NOUN
ajlm-1807	108	42	)	)	PUNCT
ajlm-1807	108	43	is	be	AUX
ajlm-1807	108	44	undoubtedly	undoubtedly	ADV
ajlm-1807	108	45	a	a	DET
ajlm-1807	108	46	result	result	NOUN
ajlm-1807	108	47	of	of	ADP
ajlm-1807	108	48	irrational	irrational	ADJ
ajlm-1807	108	49	antibiotic	antibiotic	ADJ
ajlm-1807	108	50	use	use	NOUN
ajlm-1807	108	51	.	.	PUNCT
ajlm-1807	109	1	some	some	PRON
ajlm-1807	109	2	of	of	ADP
ajlm-1807	109	3	these	these	DET
ajlm-1807	109	4	drugs	drug	NOUN
ajlm-1807	109	5	are	be	AUX
ajlm-1807	109	6	regularly	regularly	ADV
ajlm-1807	109	7	abused	abuse	VERB
ajlm-1807	109	8	by	by	ADP
ajlm-1807	109	9	patients	patient	NOUN
ajlm-1807	109	10	even	even	ADV
ajlm-1807	109	11	without	without	ADP
ajlm-1807	109	12	prescription	prescription	NOUN
ajlm-1807	109	13	while	while	SCONJ
ajlm-1807	109	14	others	other	NOUN
ajlm-1807	109	15	are	be	AUX
ajlm-1807	109	16	indiscriminately	indiscriminately	ADV
ajlm-1807	109	17	used	use	VERB
ajlm-1807	109	18	in	in	ADP
ajlm-1807	109	19	our	our	PRON
ajlm-1807	109	20	health	health	NOUN
ajlm-1807	109	21	facilities	facility	NOUN
ajlm-1807	109	22	,	,	PUNCT
ajlm-1807	109	23	resulting	result	VERB
ajlm-1807	109	24	in	in	ADP
ajlm-1807	109	25	the	the	DET
ajlm-1807	109	26	generation	generation	NOUN
ajlm-1807	109	27	of	of	ADP
ajlm-1807	109	28	resistance	resistance	NOUN
ajlm-1807	109	29	to	to	ADP
ajlm-1807	109	30	these	these	DET
ajlm-1807	109	31	antibiotics	antibiotic	NOUN
ajlm-1807	109	32	.	.	PUNCT
ajlm-1807	110	1	formulation	formulation	NOUN
ajlm-1807	110	2	of	of	ADP
ajlm-1807	110	3	antibiotic	antibiotic	ADJ
ajlm-1807	110	4	policy	policy	NOUN
ajlm-1807	110	5	on	on	ADP
ajlm-1807	110	6	bsis	bsis	NOUN
ajlm-1807	110	7	from	from	ADP
ajlm-1807	110	8	this	this	DET
ajlm-1807	110	9	data	datum	NOUN
ajlm-1807	110	10	and	and	CCONJ
ajlm-1807	110	11	compliance	compliance	NOUN
ajlm-1807	110	12	with	with	ADP
ajlm-1807	110	13	treatment	treatment	NOUN
ajlm-1807	110	14	guidelines	guideline	NOUN
ajlm-1807	110	15	are	be	AUX
ajlm-1807	110	16	of	of	ADP
ajlm-1807	110	17	paramount	paramount	ADJ
ajlm-1807	110	18	importance	importance	NOUN
ajlm-1807	110	19	,	,	PUNCT
ajlm-1807	110	20	not	not	PART
ajlm-1807	110	21	only	only	ADV
ajlm-1807	110	22	to	to	PART
ajlm-1807	110	23	save	save	VERB
ajlm-1807	110	24	patients	patient	NOUN
ajlm-1807	110	25	’	'	PUNCT
ajlm-1807	110	26	lives	live	VERB
ajlm-1807	110	27	,	,	PUNCT
ajlm-1807	110	28	but	but	CCONJ
ajlm-1807	110	29	also	also	ADV
ajlm-1807	110	30	to	to	PART
ajlm-1807	110	31	reduce	reduce	VERB
ajlm-1807	110	32	further	further	ADJ
ajlm-1807	110	33	resistance	resistance	NOUN
ajlm-1807	110	34	generated	generate	VERB
ajlm-1807	110	35	by	by	ADP
ajlm-1807	110	36	bacteria	bacteria	NOUN
ajlm-1807	110	37	to	to	ADP
ajlm-1807	110	38	more	more	ADJ
ajlm-1807	110	39	antibiotics	antibiotic	NOUN
ajlm-1807	110	40	.	.	PUNCT
ajlm-1807	111	1	for	for	ADP
ajlm-1807	111	2	the	the	DET
ajlm-1807	111	3	empirical	empirical	ADJ
ajlm-1807	111	4	treatment	treatment	NOUN
ajlm-1807	111	5	of	of	ADP
ajlm-1807	111	6	bsis	bsis	NOUN
ajlm-1807	111	7	in	in	ADP
ajlm-1807	111	8	this	this	DET
ajlm-1807	111	9	setting	setting	NOUN
ajlm-1807	111	10	,	,	PUNCT
ajlm-1807	111	11	a	a	DET
ajlm-1807	111	12	combination	combination	NOUN
ajlm-1807	111	13	of	of	ADP
ajlm-1807	111	14	ceftazidime	ceftazidime	NOUN
ajlm-1807	111	15	with	with	ADP
ajlm-1807	111	16	gentamicin	gentamicin	NOUN
ajlm-1807	111	17	is	be	AUX
ajlm-1807	111	18	recommended	recommend	VERB
ajlm-1807	111	19	in	in	ADP
ajlm-1807	111	20	children	child	NOUN
ajlm-1807	111	21	less	less	ADJ
ajlm-1807	111	22	than	than	ADP
ajlm-1807	111	23	16	16	NUM
ajlm-1807	111	24	years	year	NOUN
ajlm-1807	111	25	of	of	ADP
ajlm-1807	111	26	age	age	NOUN
ajlm-1807	111	27	,	,	PUNCT
ajlm-1807	111	28	while	while	SCONJ
ajlm-1807	111	29	a	a	DET
ajlm-1807	111	30	combination	combination	NOUN
ajlm-1807	111	31	of	of	ADP
ajlm-1807	111	32	ciprofloxacin	ciprofloxacin	NOUN
ajlm-1807	111	33	/	/	SYM
ajlm-1807	111	34	ofloxacin	ofloxacin	NOUN
ajlm-1807	111	35	with	with	ADP
ajlm-1807	111	36	gentamicin	gentamicin	NOUN
ajlm-1807	111	37	is	be	AUX
ajlm-1807	111	38	recommended	recommend	VERB
ajlm-1807	111	39	in	in	ADP
ajlm-1807	111	40	the	the	DET
ajlm-1807	111	41	older	old	ADJ
ajlm-1807	111	42	age	age	NOUN
ajlm-1807	111	43	-	-	PUNCT
ajlm-1807	111	44	groups	group	NOUN
ajlm-1807	111	45	.	.	PUNCT
ajlm-1807	112	1	these	these	DET
ajlm-1807	112	2	three	three	NUM
ajlm-1807	112	3	antibiotics	antibiotic	NOUN
ajlm-1807	112	4	demonstrated	demonstrate	VERB
ajlm-1807	112	5	favourable	favourable	ADJ
ajlm-1807	112	6	sensitivity	sensitivity	NOUN
ajlm-1807	112	7	patterns	pattern	NOUN
ajlm-1807	112	8	against	against	ADP
ajlm-1807	112	9	most	most	ADJ
ajlm-1807	112	10	bacteria	bacteria	NOUN
ajlm-1807	112	11	isolated	isolate	VERB
ajlm-1807	112	12	in	in	ADP
ajlm-1807	112	13	this	this	DET
ajlm-1807	112	14	study	study	NOUN
ajlm-1807	112	15	;	;	PUNCT
ajlm-1807	112	16	their	their	PRON
ajlm-1807	112	17	combination	combination	NOUN
ajlm-1807	112	18	in	in	ADP
ajlm-1807	112	19	treatment	treatment	NOUN
ajlm-1807	112	20	of	of	ADP
ajlm-1807	112	21	bsis	bsis	NOUN
ajlm-1807	112	22	will	will	AUX
ajlm-1807	112	23	not	not	PART
ajlm-1807	112	24	only	only	ADV
ajlm-1807	112	25	produce	produce	VERB
ajlm-1807	112	26	a	a	DET
ajlm-1807	112	27	synergistic	synergistic	ADJ
ajlm-1807	112	28	effect	effect	NOUN
ajlm-1807	112	29	,	,	PUNCT
ajlm-1807	112	30	but	but	CCONJ
ajlm-1807	112	31	will	will	AUX
ajlm-1807	112	32	also	also	ADV
ajlm-1807	112	33	reduce	reduce	VERB
ajlm-1807	112	34	the	the	DET
ajlm-1807	112	35	rate	rate	NOUN
ajlm-1807	112	36	at	at	ADP
ajlm-1807	112	37	which	which	PRON
ajlm-1807	112	38	isolates	isolate	NOUN
ajlm-1807	112	39	develop	develop	VERB
ajlm-1807	112	40	resistance	resistance	NOUN
ajlm-1807	112	41	to	to	ADP
ajlm-1807	112	42	individual	individual	ADJ
ajlm-1807	112	43	antibiotics	antibiotic	NOUN
ajlm-1807	112	44	.	.	PUNCT
ajlm-1807	113	1	meropenem	meropenem	PROPN
ajlm-1807	113	2	and	and	CCONJ
ajlm-1807	113	3	imipenem	imipenem	PROPN
ajlm-1807	113	4	should	should	AUX
ajlm-1807	113	5	be	be	AUX
ajlm-1807	113	6	reserved	reserve	VERB
ajlm-1807	113	7	for	for	ADP
ajlm-1807	113	8	cases	case	NOUN
ajlm-1807	113	9	not	not	PART
ajlm-1807	113	10	amenable	amenable	ADJ
ajlm-1807	113	11	to	to	ADP
ajlm-1807	113	12	the	the	DET
ajlm-1807	113	13	aforementioned	aforementioned	ADJ
ajlm-1807	113	14	combination	combination	NOUN
ajlm-1807	113	15	therapy	therapy	NOUN
ajlm-1807	113	16	.	.	PUNCT
ajlm-1807	114	1	it	it	PRON
ajlm-1807	114	2	is	be	AUX
ajlm-1807	114	3	advisable	advisable	ADJ
ajlm-1807	114	4	that	that	SCONJ
ajlm-1807	114	5	meropenem	meropenem	PROPN
ajlm-1807	114	6	or	or	CCONJ
ajlm-1807	114	7	imipenem	imipenem	PROPN
ajlm-1807	114	8	should	should	AUX
ajlm-1807	114	9	also	also	ADV
ajlm-1807	114	10	be	be	AUX
ajlm-1807	114	11	used	use	VERB
ajlm-1807	114	12	in	in	ADP
ajlm-1807	114	13	combination	combination	NOUN
ajlm-1807	114	14	with	with	ADP
ajlm-1807	114	15	other	other	ADJ
ajlm-1807	114	16	classes	class	NOUN
ajlm-1807	114	17	of	of	ADP
ajlm-1807	114	18	antibiotics	antibiotic	NOUN
ajlm-1807	114	19	with	with	ADP
ajlm-1807	114	20	a	a	DET
ajlm-1807	114	21	good	good	ADJ
ajlm-1807	114	22	sensitivity	sensitivity	NOUN
ajlm-1807	114	23	profile	profile	NOUN
ajlm-1807	114	24	to	to	ADP
ajlm-1807	114	25	the	the	DET
ajlm-1807	114	26	isolated	isolated	ADJ
ajlm-1807	114	27	pathogen	pathogen	NOUN
ajlm-1807	114	28	,	,	PUNCT
ajlm-1807	114	29	such	such	ADJ
ajlm-1807	114	30	as	as	ADP
ajlm-1807	114	31	gentamicin	gentamicin	NOUN
ajlm-1807	114	32	,	,	PUNCT
ajlm-1807	114	33	to	to	PART
ajlm-1807	114	34	reduce	reduce	VERB
ajlm-1807	114	35	the	the	DET
ajlm-1807	114	36	speed	speed	NOUN
ajlm-1807	114	37	at	at	ADP
ajlm-1807	114	38	which	which	PRON
ajlm-1807	114	39	bacteria	bacteria	NOUN
ajlm-1807	114	40	generate	generate	VERB
ajlm-1807	114	41	resistance	resistance	NOUN
ajlm-1807	114	42	to	to	ADP
ajlm-1807	114	43	these	these	DET
ajlm-1807	114	44	valuable	valuable	ADJ
ajlm-1807	114	45	drugs	drug	NOUN
ajlm-1807	114	46	.	.	PUNCT
ajlm-1807	115	1	in	in	ADP
ajlm-1807	115	2	cases	case	NOUN
ajlm-1807	115	3	of	of	ADP
ajlm-1807	115	4	bsi	bsi	NOUN
ajlm-1807	115	5	due	due	ADP
ajlm-1807	115	6	to	to	ADP
ajlm-1807	115	7	mrsa	mrsa	NOUN
ajlm-1807	115	8	,	,	PUNCT
ajlm-1807	115	9	vancomycin	vancomycin	PROPN
ajlm-1807	115	10	is	be	AUX
ajlm-1807	115	11	the	the	DET
ajlm-1807	115	12	recommended	recommend	VERB
ajlm-1807	115	13	treatment	treatment	NOUN
ajlm-1807	115	14	of	of	ADP
ajlm-1807	115	15	choice	choice	NOUN
ajlm-1807	115	16	in	in	ADP
ajlm-1807	115	17	this	this	DET
ajlm-1807	115	18	setting	setting	NOUN
ajlm-1807	115	19	.	.	PUNCT
ajlm-1807	116	1	limitations	limitation	NOUN
ajlm-1807	116	2	the	the	DET
ajlm-1807	116	3	method	method	NOUN
ajlm-1807	116	4	of	of	ADP
ajlm-1807	116	5	antibiotic	antibiotic	ADJ
ajlm-1807	116	6	sensitivity	sensitivity	NOUN
ajlm-1807	116	7	testing	testing	NOUN
ajlm-1807	116	8	employed	employ	VERB
ajlm-1807	116	9	for	for	ADP
ajlm-1807	116	10	all	all	DET
ajlm-1807	116	11	antibiotics	antibiotic	NOUN
ajlm-1807	116	12	(	(	PUNCT
ajlm-1807	116	13	except	except	SCONJ
ajlm-1807	116	14	vancomycin	vancomycin	PROPN
ajlm-1807	116	15	)	)	PUNCT
ajlm-1807	116	16	tested	test	VERB
ajlm-1807	116	17	against	against	ADP
ajlm-1807	116	18	isolates	isolate	NOUN
ajlm-1807	116	19	in	in	ADP
ajlm-1807	116	20	this	this	DET
ajlm-1807	116	21	study	study	NOUN
ajlm-1807	116	22	was	be	AUX
ajlm-1807	116	23	limited	limit	VERB
ajlm-1807	116	24	to	to	PART
ajlm-1807	116	25	disc	disc	NOUN
ajlm-1807	116	26	diffusion	diffusion	NOUN
ajlm-1807	116	27	sensitivity	sensitivity	NOUN
ajlm-1807	116	28	testing	testing	NOUN
ajlm-1807	116	29	.	.	PUNCT
ajlm-1807	117	1	additional	additional	ADJ
ajlm-1807	117	2	determination	determination	NOUN
ajlm-1807	117	3	of	of	ADP
ajlm-1807	117	4	the	the	DET
ajlm-1807	117	5	minimum	minimum	ADJ
ajlm-1807	117	6	inhibitory	inhibitory	ADJ
ajlm-1807	117	7	concentration	concentration	NOUN
ajlm-1807	117	8	of	of	ADP
ajlm-1807	117	9	the	the	DET
ajlm-1807	117	10	different	different	ADJ
ajlm-1807	117	11	antibiotics	antibiotic	NOUN
ajlm-1807	117	12	which	which	PRON
ajlm-1807	117	13	would	would	AUX
ajlm-1807	117	14	have	have	AUX
ajlm-1807	117	15	supplied	supply	VERB
ajlm-1807	117	16	quantitative	quantitative	ADJ
ajlm-1807	117	17	data	datum	NOUN
ajlm-1807	117	18	on	on	ADP
ajlm-1807	117	19	the	the	DET
ajlm-1807	117	20	susceptibility	susceptibility	NOUN
ajlm-1807	117	21	pattern	pattern	NOUN
ajlm-1807	117	22	of	of	ADP
ajlm-1807	117	23	isolates	isolate	NOUN
ajlm-1807	117	24	to	to	ADP
ajlm-1807	117	25	these	these	DET
ajlm-1807	117	26	antibiotics	antibiotic	NOUN
ajlm-1807	117	27	was	be	AUX
ajlm-1807	117	28	desired	desire	VERB
ajlm-1807	117	29	,	,	PUNCT
ajlm-1807	117	30	but	but	CCONJ
ajlm-1807	117	31	the	the	DET
ajlm-1807	117	32	study	study	NOUN
ajlm-1807	117	33	was	be	AUX
ajlm-1807	117	34	limited	limit	VERB
ajlm-1807	117	35	by	by	ADP
ajlm-1807	117	36	supply	supply	NOUN
ajlm-1807	117	37	of	of	ADP
ajlm-1807	117	38	funds	fund	NOUN
ajlm-1807	117	39	.	.	PUNCT
ajlm-1807	118	1	similarly	similarly	ADV
ajlm-1807	118	2	,	,	PUNCT
ajlm-1807	118	3	due	due	ADP
ajlm-1807	118	4	to	to	ADP
ajlm-1807	118	5	limited	limited	ADJ
ajlm-1807	118	6	funding	funding	NOUN
ajlm-1807	118	7	,	,	PUNCT
ajlm-1807	118	8	we	we	PRON
ajlm-1807	118	9	were	be	AUX
ajlm-1807	118	10	unable	unable	ADJ
ajlm-1807	118	11	to	to	PART
ajlm-1807	118	12	carry	carry	VERB
ajlm-1807	118	13	out	out	ADP
ajlm-1807	118	14	the	the	DET
ajlm-1807	118	15	molecular	molecular	ADJ
ajlm-1807	118	16	characterisation	characterisation	NOUN
ajlm-1807	118	17	of	of	ADP
ajlm-1807	118	18	the	the	DET
ajlm-1807	118	19	resistant	resistant	ADJ
ajlm-1807	118	20	genes	gene	NOUN
ajlm-1807	118	21	among	among	ADP
ajlm-1807	118	22	the	the	DET
ajlm-1807	118	23	mrsa	mrsa	NOUN
ajlm-1807	118	24	isolated	isolate	VERB
ajlm-1807	118	25	.	.	PUNCT
ajlm-1807	119	1	moreover	moreover	ADV
ajlm-1807	119	2	,	,	PUNCT
ajlm-1807	119	3	this	this	DET
ajlm-1807	119	4	study	study	NOUN
ajlm-1807	119	5	involved	involve	VERB
ajlm-1807	119	6	only	only	ADV
ajlm-1807	119	7	our	our	PRON
ajlm-1807	119	8	centre	centre	NOUN
ajlm-1807	119	9	,	,	PUNCT
ajlm-1807	119	10	which	which	PRON
ajlm-1807	119	11	may	may	AUX
ajlm-1807	119	12	have	have	AUX
ajlm-1807	119	13	limited	limit	VERB
ajlm-1807	119	14	the	the	DET
ajlm-1807	119	15	relevance	relevance	NOUN
ajlm-1807	119	16	of	of	ADP
ajlm-1807	119	17	data	datum	NOUN
ajlm-1807	119	18	generated	generate	VERB
ajlm-1807	119	19	as	as	ADP
ajlm-1807	119	20	regards	regard	VERB
ajlm-1807	119	21	antibiotic	antibiotic	ADJ
ajlm-1807	119	22	policy	policy	NOUN
ajlm-1807	119	23	formulation	formulation	NOUN
ajlm-1807	119	24	and	and	CCONJ
ajlm-1807	119	25	determination	determination	NOUN
ajlm-1807	119	26	of	of	ADP
ajlm-1807	119	27	treatment	treatment	NOUN
ajlm-1807	119	28	guideline	guideline	NOUN
ajlm-1807	119	29	for	for	ADP
ajlm-1807	119	30	managing	manage	VERB
ajlm-1807	119	31	bsis	bsis	NOUN
ajlm-1807	119	32	throughout	throughout	ADP
ajlm-1807	119	33	nigeria	nigeria	PROPN
ajlm-1807	119	34	and	and	CCONJ
ajlm-1807	119	35	other	other	ADJ
ajlm-1807	119	36	african	african	ADJ
ajlm-1807	119	37	countries	country	NOUN
ajlm-1807	119	38	,	,	PUNCT
ajlm-1807	119	39	a	a	DET
ajlm-1807	119	40	multicentre	multicentre	NOUN
ajlm-1807	119	41	study	study	NOUN
ajlm-1807	119	42	is	be	AUX
ajlm-1807	119	43	desirable	desirable	ADJ
ajlm-1807	119	44	in	in	ADP
ajlm-1807	119	45	future	future	NOUN
ajlm-1807	119	46	.	.	PUNCT
ajlm-1807	120	1	conclusion	conclusion	NOUN
ajlm-1807	120	2	gram	gram	NOUN
ajlm-1807	120	3	-	-	PUNCT
ajlm-1807	120	4	negative	negative	ADJ
ajlm-1807	120	5	bacteria	bacteria	NOUN
ajlm-1807	120	6	were	be	AUX
ajlm-1807	120	7	predominantly	predominantly	ADV
ajlm-1807	120	8	isolated	isolate	VERB
ajlm-1807	120	9	from	from	ADP
ajlm-1807	120	10	cases	case	NOUN
ajlm-1807	120	11	of	of	ADP
ajlm-1807	120	12	bsi	bsi	PROPN
ajlm-1807	120	13	.	.	PUNCT
ajlm-1807	121	1	isolates	isolate	NOUN
ajlm-1807	121	2	demonstrated	demonstrate	VERB
ajlm-1807	121	3	good	good	ADJ
ajlm-1807	121	4	sensitivity	sensitivity	NOUN
ajlm-1807	121	5	to	to	ADP
ajlm-1807	121	6	meropenem	meropenem	PROPN
ajlm-1807	121	7	,	,	PUNCT
ajlm-1807	121	8	imipenem	imipenem	PROPN
ajlm-1807	121	9	,	,	PUNCT
ajlm-1807	121	10	ceftazidime	ceftazidime	NOUN
ajlm-1807	121	11	,	,	PUNCT
ajlm-1807	121	12	ciprofloxacin	ciprofloxacin	NOUN
ajlm-1807	121	13	/	/	SYM
ajlm-1807	121	14	ofloxacin	ofloxacin	PROPN
ajlm-1807	121	15	,	,	PUNCT
ajlm-1807	121	16	and	and	CCONJ
ajlm-1807	121	17	gentamicin	gentamicin	NOUN
ajlm-1807	121	18	.	.	PUNCT
ajlm-1807	122	1	regular	regular	ADJ
ajlm-1807	122	2	surveillance	surveillance	NOUN
ajlm-1807	122	3	of	of	ADP
ajlm-1807	122	4	isolate	isolate	NOUN
ajlm-1807	122	5	sensitivity	sensitivity	NOUN
ajlm-1807	122	6	patterns	pattern	NOUN
ajlm-1807	122	7	,	,	PUNCT
ajlm-1807	122	8	formulation	formulation	NOUN
ajlm-1807	122	9	of	of	ADP
ajlm-1807	122	10	hospital	hospital	NOUN
ajlm-1807	122	11	antibiotic	antibiotic	ADJ
ajlm-1807	122	12	policies	policy	NOUN
ajlm-1807	122	13	based	base	VERB
ajlm-1807	122	14	on	on	ADP
ajlm-1807	122	15	existing	exist	VERB
ajlm-1807	122	16	data	datum	NOUN
ajlm-1807	122	17	,	,	PUNCT
ajlm-1807	122	18	and	and	CCONJ
ajlm-1807	122	19	compliance	compliance	NOUN
ajlm-1807	122	20	with	with	ADP
ajlm-1807	122	21	treatment	treatment	NOUN
ajlm-1807	122	22	guidelines	guideline	NOUN
ajlm-1807	122	23	will	will	AUX
ajlm-1807	122	24	promote	promote	VERB
ajlm-1807	122	25	rational	rational	ADJ
ajlm-1807	122	26	antibiotic	antibiotic	ADJ
ajlm-1807	122	27	use	use	NOUN
ajlm-1807	122	28	and	and	CCONJ
ajlm-1807	122	29	reduce	reduce	VERB
ajlm-1807	122	30	resistance	resistance	NOUN
ajlm-1807	122	31	generation	generation	NOUN
ajlm-1807	122	32	among	among	ADP
ajlm-1807	122	33	bacteria	bacteria	NOUN
ajlm-1807	122	34	.	.	PUNCT
ajlm-1807	123	1	acknowledgements	acknowledgement	NOUN
ajlm-1807	123	2	competing	compete	VERB
ajlm-1807	123	3	interests	interest	NOUN
ajlm-1807	123	4	the	the	DET
ajlm-1807	123	5	authors	author	NOUN
ajlm-1807	123	6	declare	declare	VERB
ajlm-1807	123	7	that	that	SCONJ
ajlm-1807	123	8	they	they	PRON
ajlm-1807	123	9	have	have	VERB
ajlm-1807	123	10	no	no	DET
ajlm-1807	123	11	financial	financial	ADJ
ajlm-1807	123	12	or	or	CCONJ
ajlm-1807	123	13	personal	personal	ADJ
ajlm-1807	123	14	relationships	relationship	NOUN
ajlm-1807	123	15	that	that	PRON
ajlm-1807	123	16	may	may	AUX
ajlm-1807	123	17	have	have	AUX
ajlm-1807	123	18	inappropriately	inappropriately	ADV
ajlm-1807	123	19	influenced	influence	VERB
ajlm-1807	123	20	them	they	PRON
ajlm-1807	123	21	in	in	ADP
ajlm-1807	123	22	writing	write	VERB
ajlm-1807	123	23	this	this	DET
ajlm-1807	123	24	article	article	NOUN
ajlm-1807	123	25	.	.	PUNCT
ajlm-1807	124	1	authors	author	NOUN
ajlm-1807	124	2	’	’	PART
ajlm-1807	124	3	contributions	contribution	NOUN
ajlm-1807	124	4	o.t.o	o.t.o	ADJ
ajlm-1807	124	5	.	.	PUNCT
ajlm-1807	125	1	was	be	AUX
ajlm-1807	125	2	responsible	responsible	ADJ
ajlm-1807	125	3	for	for	ADP
ajlm-1807	125	4	conceptualisation	conceptualisation	NOUN
ajlm-1807	125	5	of	of	ADP
ajlm-1807	125	6	the	the	DET
ajlm-1807	125	7	study	study	NOUN
ajlm-1807	125	8	,	,	PUNCT
ajlm-1807	125	9	design	design	NOUN
ajlm-1807	125	10	,	,	PUNCT
ajlm-1807	125	11	definition	definition	NOUN
ajlm-1807	125	12	of	of	ADP
ajlm-1807	125	13	intellectual	intellectual	ADJ
ajlm-1807	125	14	content	content	NOUN
ajlm-1807	125	15	,	,	PUNCT
ajlm-1807	125	16	manuscript	manuscript	NOUN
ajlm-1807	125	17	preparation	preparation	NOUN
ajlm-1807	125	18	,	,	PUNCT
ajlm-1807	125	19	data	data	NOUN
ajlm-1807	125	20	collection	collection	NOUN
ajlm-1807	125	21	,	,	PUNCT
ajlm-1807	125	22	statistical	statistical	ADJ
ajlm-1807	125	23	analysis	analysis	NOUN
ajlm-1807	125	24	,	,	PUNCT
ajlm-1807	125	25	and	and	CCONJ
ajlm-1807	125	26	manuscript	manuscript	PROPN
ajlm-1807	125	27	review	review	NOUN
ajlm-1807	125	28	.	.	PUNCT
ajlm-1807	126	1	b.o.o	b.o.o	PROPN
ajlm-1807	126	2	.	.	PUNCT
ajlm-1807	127	1	and	and	CCONJ
ajlm-1807	127	2	a.t.o	a.t.o	PROPN
ajlm-1807	127	3	.	.	PUNCT
ajlm-1807	127	4	were	be	AUX
ajlm-1807	127	5	involved	involve	VERB
ajlm-1807	127	6	in	in	ADP
ajlm-1807	127	7	data	data	NOUN
ajlm-1807	127	8	collection	collection	NOUN
ajlm-1807	127	9	,	,	PUNCT
ajlm-1807	127	10	literature	literature	NOUN
ajlm-1807	127	11	search	search	NOUN
ajlm-1807	127	12	,	,	PUNCT
ajlm-1807	127	13	experimental	experimental	ADJ
ajlm-1807	127	14	studies	study	NOUN
ajlm-1807	127	15	,	,	PUNCT
ajlm-1807	127	16	data	data	NOUN
ajlm-1807	127	17	acquisition	acquisition	NOUN
ajlm-1807	127	18	,	,	PUNCT
ajlm-1807	127	19	manuscript	manuscript	NOUN
ajlm-1807	127	20	,	,	PUNCT
ajlm-1807	127	21	editing	editing	NOUN
ajlm-1807	127	22	,	,	PUNCT
ajlm-1807	127	23	and	and	CCONJ
ajlm-1807	127	24	manuscript	manuscript	PROPN
ajlm-1807	127	25	review	review	NOUN
ajlm-1807	127	26	.	.	PUNCT
ajlm-1807	128	1	o.i.o	o.i.o	PROPN
ajlm-1807	128	2	.	.	PROPN
ajlm-1807	128	3	was	be	AUX
ajlm-1807	128	4	involved	involve	VERB
ajlm-1807	128	5	in	in	ADP
ajlm-1807	128	6	the	the	DET
ajlm-1807	128	7	literature	literature	NOUN
ajlm-1807	128	8	search	search	NOUN
ajlm-1807	128	9	,	,	PUNCT
ajlm-1807	128	10	data	data	NOUN
ajlm-1807	128	11	acquisition	acquisition	NOUN
ajlm-1807	128	12	,	,	PUNCT
ajlm-1807	128	13	manuscript	manuscript	NOUN
ajlm-1807	128	14	editing	editing	NOUN
ajlm-1807	128	15	,	,	PUNCT
ajlm-1807	128	16	and	and	CCONJ
ajlm-1807	128	17	manuscript	manuscript	PROPN
ajlm-1807	128	18	review	review	NOUN
ajlm-1807	128	19	.	.	PUNCT
ajlm-1807	129	1	sources	source	NOUN
ajlm-1807	129	2	of	of	ADP
ajlm-1807	129	3	support	support	NOUN
ajlm-1807	129	4	the	the	DET
ajlm-1807	129	5	study	study	NOUN
ajlm-1807	129	6	was	be	AUX
ajlm-1807	129	7	funded	fund	VERB
ajlm-1807	129	8	by	by	ADP
ajlm-1807	129	9	all	all	DET
ajlm-1807	129	10	four	four	NUM
ajlm-1807	129	11	authors	author	NOUN
ajlm-1807	129	12	.	.	PUNCT
ajlm-1807	130	1	data	datum	NOUN
ajlm-1807	130	2	availability	availability	NOUN
ajlm-1807	130	3	the	the	DET
ajlm-1807	130	4	raw	raw	ADJ
ajlm-1807	130	5	data	datum	NOUN
ajlm-1807	130	6	from	from	ADP
ajlm-1807	130	7	the	the	DET
ajlm-1807	130	8	study	study	NOUN
ajlm-1807	130	9	are	be	AUX
ajlm-1807	130	10	available	available	ADJ
ajlm-1807	130	11	upon	upon	SCONJ
ajlm-1807	130	12	request	request	NOUN
ajlm-1807	130	13	from	from	ADP
ajlm-1807	130	14	the	the	DET
ajlm-1807	130	15	corresponding	corresponding	ADJ
ajlm-1807	130	16	author	author	NOUN
ajlm-1807	130	17	,	,	PUNCT
ajlm-1807	130	18	o.t.o	o.t.o	ADJ
ajlm-1807	130	19	.	.	PUNCT
ajlm-1807	131	1	disclaimer	disclaimer	VERB
ajlm-1807	131	2	the	the	DET
ajlm-1807	131	3	views	view	NOUN
ajlm-1807	131	4	and	and	CCONJ
ajlm-1807	131	5	opinions	opinion	NOUN
ajlm-1807	131	6	expressed	express	VERB
ajlm-1807	131	7	in	in	ADP
ajlm-1807	131	8	the	the	DET
ajlm-1807	131	9	article	article	NOUN
ajlm-1807	131	10	are	be	AUX
ajlm-1807	131	11	those	those	PRON
ajlm-1807	131	12	of	of	ADP
ajlm-1807	131	13	the	the	DET
ajlm-1807	131	14	authors	author	NOUN
ajlm-1807	131	15	and	and	CCONJ
ajlm-1807	131	16	do	do	AUX
ajlm-1807	131	17	not	not	PART
ajlm-1807	131	18	necessarily	necessarily	ADV
ajlm-1807	131	19	reflect	reflect	VERB
ajlm-1807	131	20	the	the	DET
ajlm-1807	131	21	critical	critical	ADJ
ajlm-1807	131	22	policy	policy	NOUN
ajlm-1807	131	23	or	or	CCONJ
ajlm-1807	131	24	position	position	NOUN
ajlm-1807	131	25	of	of	ADP
ajlm-1807	131	26	any	any	DET
ajlm-1807	131	27	affiliated	affiliated	ADJ
ajlm-1807	131	28	agency	agency	NOUN
ajlm-1807	131	29	or	or	CCONJ
ajlm-1807	131	30	authors	author	NOUN
ajlm-1807	131	31	.	.	PUNCT
ajlm-1807	132	1	references	reference	NOUN
ajlm-1807	132	2	diekema	diekema	PROPN
ajlm-1807	132	3	dj	dj	PROPN
ajlm-1807	132	4	,	,	PUNCT
ajlm-1807	132	5	beekman	beekman	PROPN
ajlm-1807	132	6	se	se	PROPN
ajlm-1807	132	7	,	,	PUNCT
ajlm-1807	132	8	chapin	chapin	PROPN
ajlm-1807	132	9	kc	kc	PROPN
ajlm-1807	132	10	,	,	PUNCT
ajlm-1807	132	11	morel	morel	PROPN
ajlm-1807	132	12	ka	ka	PROPN
ajlm-1807	132	13	,	,	PUNCT
ajlm-1807	132	14	munson	munson	PROPN
ajlm-1807	132	15	e	e	PROPN
ajlm-1807	132	16	,	,	PUNCT
ajlm-1807	132	17	doern	doern	NOUN
ajlm-1807	132	18	gv	gv	PROPN
ajlm-1807	132	19	.	.	PUNCT
ajlm-1807	133	1	epidemiology	epidemiology	NOUN
ajlm-1807	133	2	and	and	CCONJ
ajlm-1807	133	3	outcome	outcome	NOUN
ajlm-1807	133	4	of	of	ADP
ajlm-1807	133	5	nosocomial	nosocomial	ADJ
ajlm-1807	133	6	and	and	CCONJ
ajlm-1807	133	7	community	community	NOUN
ajlm-1807	133	8	onset	onset	VERB
ajlm-1807	133	9	bloodstream	bloodstream	NOUN
ajlm-1807	133	10	infection	infection	NOUN
ajlm-1807	133	11	.	.	PUNCT
ajlm-1807	134	1	j	j	PROPN
ajlm-1807	134	2	clin	clin	PROPN
ajlm-1807	134	3	microbiol	microbiol	PROPN
ajlm-1807	134	4	.	.	PUNCT
ajlm-1807	135	1	2003;41(8):3655–3660	2003;41(8):3655–3660	NUM
ajlm-1807	135	2	.	.	PUNCT
ajlm-1807	136	1	https://doi.org/10.1128/jcm.41.8.3655-3660.2003	https://doi.org/10.1128/jcm.41.8.3655-3660.2003	NOUN
ajlm-1807	136	2	report	report	NOUN
ajlm-1807	136	3	on	on	ADP
ajlm-1807	136	4	the	the	DET
ajlm-1807	136	5	burden	burden	NOUN
ajlm-1807	136	6	of	of	ADP
ajlm-1807	136	7	endemic	endemic	ADJ
ajlm-1807	136	8	health	health	NOUN
ajlm-1807	136	9	care	care	NOUN
ajlm-1807	136	10	-	-	PUNCT
ajlm-1807	136	11	associated	associate	VERB
ajlm-1807	136	12	infection	infection	NOUN
ajlm-1807	136	13	worldwide	worldwide	ADV
ajlm-1807	137	1	[	[	X
ajlm-1807	137	2	homepage	homepage	NOUN
ajlm-1807	137	3	on	on	ADP
ajlm-1807	137	4	the	the	DET
ajlm-1807	137	5	internet	internet	NOUN
ajlm-1807	137	6	]	]	PUNCT
ajlm-1807	137	7	.	.	PUNCT
ajlm-1807	138	1	geneva	geneva	PROPN
ajlm-1807	138	2	:	:	PUNCT
ajlm-1807	138	3	world	world	PROPN
ajlm-1807	138	4	health	health	NOUN
ajlm-1807	138	5	organization	organization	NOUN
ajlm-1807	138	6	;	;	PUNCT
ajlm-1807	138	7	2011	2011	NUM
ajlm-1807	138	8	[	[	X
ajlm-1807	138	9	cited	cite	VERB
ajlm-1807	138	10	2021	2021	NUM
ajlm-1807	138	11	oct	oct	NOUN
ajlm-1807	138	12	28	28	NUM
ajlm-1807	138	13	]	]	PUNCT
ajlm-1807	138	14	.	.	PUNCT
ajlm-1807	139	1	available	available	ADJ
ajlm-1807	139	2	from	from	ADP
ajlm-1807	139	3	:	:	PUNCT
ajlm-1807	139	4	https://apps.who.int/iris/handle/10665/80135	https://apps.who.int/iris/handle/10665/80135	NOUN
ajlm-1807	139	5	suetens	sueten	NOUN
ajlm-1807	139	6	c	c	PROPN
ajlm-1807	139	7	,	,	PUNCT
ajlm-1807	139	8	latour	latour	PROPN
ajlm-1807	139	9	k	k	PROPN
ajlm-1807	139	10	,	,	PUNCT
ajlm-1807	139	11	karki	karki	PROPN
ajlm-1807	139	12	t	t	PROPN
ajlm-1807	139	13	,	,	PUNCT
ajlm-1807	139	14	et	et	PROPN
ajlm-1807	139	15	al	al	PROPN
ajlm-1807	139	16	.	.	PUNCT
ajlm-1807	140	1	prevalence	prevalence	NOUN
ajlm-1807	140	2	of	of	ADP
ajlm-1807	140	3	healthcare	healthcare	PROPN
ajlm-1807	140	4	-	-	PUNCT
ajlm-1807	140	5	associated	associate	VERB
ajlm-1807	140	6	infections	infection	NOUN
ajlm-1807	140	7	,	,	PUNCT
ajlm-1807	140	8	estimated	estimate	VERB
ajlm-1807	140	9	incidence	incidence	NOUN
ajlm-1807	140	10	and	and	CCONJ
ajlm-1807	140	11	composite	composite	ADJ
ajlm-1807	140	12	antimicrobial	antimicrobial	ADJ
ajlm-1807	140	13	resistance	resistance	NOUN
ajlm-1807	140	14	index	index	NOUN
ajlm-1807	140	15	in	in	ADP
ajlm-1807	140	16	acute	acute	ADJ
ajlm-1807	140	17	care	care	NOUN
ajlm-1807	140	18	hospitals	hospital	NOUN
ajlm-1807	140	19	and	and	CCONJ
ajlm-1807	140	20	long	long	ADJ
ajlm-1807	140	21	-	-	PUNCT
ajlm-1807	140	22	term	term	NOUN
ajlm-1807	140	23	care	care	NOUN
ajlm-1807	140	24	facilities	facility	NOUN
ajlm-1807	140	25	:	:	PUNCT
ajlm-1807	140	26	results	result	VERB
ajlm-1807	140	27	from	from	ADP
ajlm-1807	140	28	two	two	NUM
ajlm-1807	140	29	european	european	ADJ
ajlm-1807	140	30	point	point	NOUN
ajlm-1807	140	31	prevalence	prevalence	NOUN
ajlm-1807	140	32	surveys	survey	NOUN
ajlm-1807	140	33	,	,	PUNCT
ajlm-1807	140	34	2016	2016	NUM
ajlm-1807	140	35	to	to	ADP
ajlm-1807	140	36	2017	2017	NUM
ajlm-1807	140	37	.	.	PUNCT
ajlm-1807	141	1	euro	euro	NOUN
ajlm-1807	141	2	surveill	surveill	NOUN
ajlm-1807	141	3	.	.	PUNCT
ajlm-1807	142	1	2018;23(46):1800516	2018;23(46):1800516	NUM
ajlm-1807	142	2	.	.	X
ajlm-1807	142	3	https://doi.org/10.2807/1560-7917.es.2018.23.46.1800516	https://doi.org/10.2807/1560-7917.es.2018.23.46.1800516	PROPN
ajlm-1807	142	4	cassini	cassini	PROPN
ajlm-1807	142	5	a	a	NOUN
ajlm-1807	142	6	,	,	PUNCT
ajlm-1807	142	7	colzani	colzani	ADJ
ajlm-1807	142	8	e	e	NOUN
ajlm-1807	142	9	,	,	PUNCT
ajlm-1807	142	10	pini	pini	X
ajlm-1807	142	11	a	a	X
ajlm-1807	142	12	,	,	PUNCT
ajlm-1807	142	13	et	et	PROPN
ajlm-1807	142	14	al	al	PROPN
ajlm-1807	142	15	.	.	PROPN
ajlm-1807	142	16	impact	impact	NOUN
ajlm-1807	142	17	of	of	ADP
ajlm-1807	142	18	infectious	infectious	ADJ
ajlm-1807	142	19	diseases	disease	NOUN
ajlm-1807	142	20	on	on	ADP
ajlm-1807	142	21	population	population	NOUN
ajlm-1807	142	22	health	health	NOUN
ajlm-1807	142	23	using	use	VERB
ajlm-1807	142	24	incidence	incidence	NOUN
ajlm-1807	142	25	-	-	PUNCT
ajlm-1807	142	26	based	base	VERB
ajlm-1807	142	27	disability	disability	NOUN
ajlm-1807	142	28	-	-	PUNCT
ajlm-1807	142	29	adjusted	adjust	VERB
ajlm-1807	142	30	life	life	NOUN
ajlm-1807	142	31	years	year	NOUN
ajlm-1807	142	32	(	(	PUNCT
ajlm-1807	142	33	dalys	daly	NOUN
ajlm-1807	142	34	):	):	PUNCT
ajlm-1807	142	35	results	result	NOUN
ajlm-1807	142	36	from	from	ADP
ajlm-1807	142	37	the	the	DET
ajlm-1807	142	38	burden	burden	NOUN
ajlm-1807	142	39	of	of	ADP
ajlm-1807	142	40	communicable	communicable	NOUN
ajlm-1807	142	41	diseases	disease	NOUN
ajlm-1807	142	42	in	in	ADP
ajlm-1807	142	43	europe	europe	PROPN
ajlm-1807	142	44	study	study	PROPN
ajlm-1807	142	45	,	,	PUNCT
ajlm-1807	142	46	european	european	PROPN
ajlm-1807	142	47	union	union	PROPN
ajlm-1807	142	48	and	and	CCONJ
ajlm-1807	142	49	european	european	ADJ
ajlm-1807	142	50	economic	economic	ADJ
ajlm-1807	142	51	area	area	NOUN
ajlm-1807	142	52	countries	country	NOUN
ajlm-1807	142	53	,	,	PUNCT
ajlm-1807	142	54	2009	2009	NUM
ajlm-1807	142	55	to	to	ADP
ajlm-1807	142	56	2013	2013	NUM
ajlm-1807	142	57	.	.	PUNCT
ajlm-1807	143	1	euro	euro	NOUN
ajlm-1807	143	2	surveill	surveill	NOUN
ajlm-1807	143	3	.	.	PUNCT
ajlm-1807	144	1	2018;23:17	2018;23:17	NUM
ajlm-1807	144	2	-	-	SYM
ajlm-1807	144	3	00454	00454	NUM
ajlm-1807	144	4	.	.	PUNCT
ajlm-1807	145	1	https://doi.org/10.2807/1560-7917.es.2018.23.16.17-00454	https://doi.org/10.2807/1560-7917.es.2018.23.16.17-00454	ADV
ajlm-1807	145	2	sainfer	sainfer	ADJ
ajlm-1807	145	3	a	a	PRON
ajlm-1807	145	4	,	,	PUNCT
ajlm-1807	145	5	bevin	bevin	PROPN
ajlm-1807	145	6	c	c	PROPN
ajlm-1807	145	7	,	,	PUNCT
ajlm-1807	145	8	jianfang	jianfang	PROPN
ajlm-1807	145	9	l	l	PROPN
ajlm-1807	145	10	,	,	PUNCT
ajlm-1807	145	11	elaine	elaine	PROPN
ajlm-1807	145	12	l.	l.	PROPN
ajlm-1807	145	13	prevalence	prevalence	PROPN
ajlm-1807	145	14	and	and	CCONJ
ajlm-1807	145	15	risk	risk	NOUN
ajlm-1807	145	16	factors	factor	NOUN
ajlm-1807	145	17	for	for	ADP
ajlm-1807	145	18	bloodstream	bloodstream	NOUN
ajlm-1807	145	19	infections	infection	NOUN
ajlm-1807	145	20	present	present	ADJ
ajlm-1807	145	21	on	on	ADP
ajlm-1807	145	22	hospital	hospital	NOUN
ajlm-1807	145	23	admission	admission	NOUN
ajlm-1807	145	24	.	.	PUNCT
ajlm-1807	146	1	j	j	PROPN
ajlm-1807	146	2	infect	infect	PROPN
ajlm-1807	146	3	prev	prev	NOUN
ajlm-1807	146	4	.	.	PUNCT
ajlm-1807	147	1	2018;19(1):37–42	2018;19(1):37–42	NUM
ajlm-1807	147	2	.	.	PUNCT
ajlm-1807	148	1	https://doi.org/10.1177/1757177417720998	https://doi.org/10.1177/1757177417720998	AUX
ajlm-1807	148	2	christaki	christaki	PROPN
ajlm-1807	148	3	e	e	NOUN
ajlm-1807	148	4	,	,	PUNCT
ajlm-1807	148	5	giamarellos	giamarello	NOUN
ajlm-1807	148	6	-	-	PUNCT
ajlm-1807	148	7	bourboulis	bourboulis	PROPN
ajlm-1807	148	8	ej	ej	PROPN
ajlm-1807	148	9	.	.	PUNCT
ajlm-1807	149	1	the	the	DET
ajlm-1807	149	2	complex	complex	ADJ
ajlm-1807	149	3	pathogenesis	pathogenesis	NOUN
ajlm-1807	149	4	of	of	ADP
ajlm-1807	149	5	bacteremia	bacteremia	NOUN
ajlm-1807	149	6	:	:	PUNCT
ajlm-1807	149	7	from	from	ADP
ajlm-1807	149	8	antimicrobial	antimicrobial	ADJ
ajlm-1807	149	9	clearance	clearance	NOUN
ajlm-1807	149	10	mechanisms	mechanism	NOUN
ajlm-1807	149	11	to	to	ADP
ajlm-1807	149	12	the	the	DET
ajlm-1807	149	13	genetic	genetic	ADJ
ajlm-1807	149	14	background	background	NOUN
ajlm-1807	149	15	of	of	ADP
ajlm-1807	149	16	the	the	DET
ajlm-1807	149	17	host	host	NOUN
ajlm-1807	149	18	.	.	PUNCT
ajlm-1807	150	1	virulence	virulence	NOUN
ajlm-1807	150	2	.	.	PUNCT
ajlm-1807	151	1	2014;5(1):57–65	2014;5(1):57–65	NUM
ajlm-1807	151	2	.	.	PUNCT
ajlm-1807	152	1	https://doi.org/10.4161/viru.26514	https://doi.org/10.4161/viru.26514	PROPN
ajlm-1807	152	2	paolucci	paolucci	PROPN
ajlm-1807	152	3	m	m	PROPN
ajlm-1807	152	4	,	,	PUNCT
ajlm-1807	152	5	landini	landini	PROPN
ajlm-1807	152	6	mp	mp	PROPN
ajlm-1807	152	7	,	,	PUNCT
ajlm-1807	152	8	sambri	sambri	NOUN
ajlm-1807	152	9	v.	v.	ADP
ajlm-1807	153	1	how	how	SCONJ
ajlm-1807	153	2	can	can	AUX
ajlm-1807	153	3	the	the	DET
ajlm-1807	153	4	microbiologist	microbiologist	NOUN
ajlm-1807	153	5	help	help	VERB
ajlm-1807	153	6	in	in	ADP
ajlm-1807	153	7	diagnosing	diagnose	VERB
ajlm-1807	153	8	neonatal	neonatal	ADJ
ajlm-1807	153	9	sepsis	sepsis	NOUN
ajlm-1807	153	10	?	?	PUNCT
ajlm-1807	154	1	int	int	NOUN
ajlm-1807	154	2	j	j	PROPN
ajlm-1807	154	3	pediatr	pediatr	X
ajlm-1807	154	4	.	.	PUNCT
ajlm-1807	155	1	2012;2012:120139	2012;2012:120139	NUM
ajlm-1807	155	2	.	.	PUNCT
ajlm-1807	156	1	https://doi.org/10.1155/2012/120139	https://doi.org/10.1155/2012/120139	ADJ
ajlm-1807	156	2	gohel	gohel	NOUN
ajlm-1807	156	3	k	k	NOUN
ajlm-1807	156	4	,	,	PUNCT
ajlm-1807	156	5	jojera	jojera	NOUN
ajlm-1807	156	6	a	a	PRON
ajlm-1807	156	7	,	,	PUNCT
ajlm-1807	156	8	soni	soni	PROPN
ajlm-1807	156	9	s	s	PROPN
ajlm-1807	156	10	,	,	PUNCT
ajlm-1807	156	11	gang	gang	NOUN
ajlm-1807	156	12	s	s	PROPN
ajlm-1807	156	13	,	,	PUNCT
ajlm-1807	156	14	sabnis	sabnis	PROPN
ajlm-1807	156	15	r	r	PROPN
ajlm-1807	156	16	,	,	PUNCT
ajlm-1807	156	17	desai	desai	PROPN
ajlm-1807	156	18	m.	m.	PROPN
ajlm-1807	156	19	bacteriological	bacteriological	PROPN
ajlm-1807	156	20	profile	profile	NOUN
ajlm-1807	156	21	and	and	CCONJ
ajlm-1807	156	22	drug	drug	NOUN
ajlm-1807	156	23	resistance	resistance	NOUN
ajlm-1807	156	24	patterns	pattern	NOUN
ajlm-1807	156	25	of	of	ADP
ajlm-1807	156	26	blood	blood	NOUN
ajlm-1807	156	27	culture	culture	NOUN
ajlm-1807	156	28	isolates	isolate	NOUN
ajlm-1807	156	29	in	in	ADP
ajlm-1807	156	30	a	a	DET
ajlm-1807	156	31	tertiary	tertiary	ADJ
ajlm-1807	156	32	care	care	NOUN
ajlm-1807	156	33	nephrourology	nephrourology	PROPN
ajlm-1807	156	34	teaching	teaching	NOUN
ajlm-1807	156	35	institute	institute	PROPN
ajlm-1807	156	36	.	.	PROPN
ajlm-1807	156	37	biomed	biome	VERB
ajlm-1807	156	38	res	re	NOUN
ajlm-1807	156	39	int	int	NOUN
ajlm-1807	156	40	.	.	PUNCT
ajlm-1807	157	1	2014;2014:153747	2014;2014:153747	NUM
ajlm-1807	157	2	.	.	X
ajlm-1807	157	3	https://doi.org/10.1155/2014/153747	https://doi.org/10.1155/2014/153747	PROPN
ajlm-1807	157	4	khanal	khanal	PROPN
ajlm-1807	157	5	b	b	PROPN
ajlm-1807	157	6	,	,	PUNCT
ajlm-1807	157	7	harish	harish	PROPN
ajlm-1807	157	8	bn	bn	PROPN
ajlm-1807	157	9	,	,	PUNCT
ajlm-1807	157	10	sethuraman	sethuraman	PROPN
ajlm-1807	157	11	kr	kr	PROPN
ajlm-1807	157	12	,	,	PUNCT
ajlm-1807	157	13	srinivasan	srinivasan	PROPN
ajlm-1807	157	14	s.	s.	PROPN
ajlm-1807	157	15	infective	infective	PROPN
ajlm-1807	157	16	endocarditis	endocarditis	NOUN
ajlm-1807	157	17	:	:	PUNCT
ajlm-1807	157	18	report	report	NOUN
ajlm-1807	157	19	of	of	ADP
ajlm-1807	157	20	prospective	prospective	ADJ
ajlm-1807	157	21	study	study	NOUN
ajlm-1807	157	22	in	in	ADP
ajlm-1807	157	23	an	an	DET
ajlm-1807	157	24	indian	indian	ADJ
ajlm-1807	157	25	hospital	hospital	NOUN
ajlm-1807	157	26	.	.	PUNCT
ajlm-1807	158	1	trop	trop	PROPN
ajlm-1807	158	2	doct	doct	PROPN
ajlm-1807	158	3	.	.	PUNCT
ajlm-1807	159	1	2002;32(2):83–85	2002;32(2):83–85	X
ajlm-1807	159	2	.	.	PUNCT
ajlm-1807	160	1	https://doi.org/10.1177/004947550203200208	https://doi.org/10.1177/004947550203200208	VERB
ajlm-1807	160	2	ogunkunle	ogunkunle	NOUN
ajlm-1807	160	3	to	to	ADP
ajlm-1807	160	4	,	,	PUNCT
ajlm-1807	160	5	abdulkadir	abdulkadir	ADJ
ajlm-1807	160	6	mb	mb	NOUN
ajlm-1807	160	7	,	,	PUNCT
ajlm-1807	160	8	katibi	katibi	PROPN
ajlm-1807	160	9	os	os	PROPN
ajlm-1807	160	10	,	,	PUNCT
ajlm-1807	160	11	bello	bello	PROPN
ajlm-1807	161	1	so	so	ADV
ajlm-1807	161	2	,	,	PUNCT
ajlm-1807	161	3	raheem	raheem	PROPN
ajlm-1807	161	4	ra	ra	PROPN
ajlm-1807	161	5	,	,	PUNCT
ajlm-1807	161	6	olaosebikan	olaosebikan	PROPN
ajlm-1807	161	7	r.	r.	PROPN
ajlm-1807	161	8	pediatric	pediatric	PROPN
ajlm-1807	161	9	blood	blood	NOUN
ajlm-1807	161	10	culture	culture	NOUN
ajlm-1807	161	11	isolates	isolate	NOUN
ajlm-1807	161	12	and	and	CCONJ
ajlm-1807	161	13	antibiotic	antibiotic	ADJ
ajlm-1807	161	14	sensitivity	sensitivity	NOUN
ajlm-1807	161	15	pattern	pattern	NOUN
ajlm-1807	161	16	in	in	ADP
ajlm-1807	161	17	a	a	DET
ajlm-1807	161	18	nigerian	nigerian	ADJ
ajlm-1807	161	19	tertiary	tertiary	ADJ
ajlm-1807	161	20	hospital	hospital	NOUN
ajlm-1807	161	21	.	.	PUNCT
ajlm-1807	162	1	niger	niger	PROPN
ajlm-1807	162	2	j	j	PROPN
ajlm-1807	162	3	med	med	PROPN
ajlm-1807	162	4	.	.	PUNCT
ajlm-1807	163	1	2020;29(2):261–264	2020;29(2):261–264	NUM
ajlm-1807	163	2	.	.	PUNCT
ajlm-1807	163	3	https://doi.org/10.4103/njm.njm_55_20	https://doi.org/10.4103/njm.njm_55_20	PROPN
ajlm-1807	163	4	iregbu	iregbu	PROPN
ajlm-1807	163	5	kc	kc	PROPN
ajlm-1807	163	6	,	,	PUNCT
ajlm-1807	163	7	olufumilayo	olufumilayo	PROPN
ajlm-1807	163	8	y	y	PROPN
ajlm-1807	163	9	,	,	PUNCT
ajlm-1807	163	10	elegba	elegba	PROPN
ajlm-1807	163	11	oy	oy	PROPN
ajlm-1807	163	12	,	,	PUNCT
ajlm-1807	163	13	babaniyi	babaniyi	NOUN
ajlm-1807	163	14	ib	ib	NOUN
ajlm-1807	163	15	.	.	PUNCT
ajlm-1807	163	16	bacteriological	bacteriological	PROPN
ajlm-1807	163	17	profile	profile	NOUN
ajlm-1807	163	18	of	of	ADP
ajlm-1807	163	19	neonatal	neonatal	ADJ
ajlm-1807	163	20	septicaemia	septicaemia	NOUN
ajlm-1807	163	21	in	in	ADP
ajlm-1807	163	22	a	a	DET
ajlm-1807	163	23	tertiary	tertiary	ADJ
ajlm-1807	163	24	hospital	hospital	NOUN
ajlm-1807	163	25	in	in	ADP
ajlm-1807	163	26	nigeria	nigeria	PROPN
ajlm-1807	163	27	.	.	PUNCT
ajlm-1807	164	1	afr	afr	PROPN
ajlm-1807	164	2	health	health	PROPN
ajlm-1807	164	3	sci	sci	PROPN
ajlm-1807	164	4	.	.	PUNCT
ajlm-1807	165	1	2006;6(3):151–154	2006;6(3):151–154	PROPN
ajlm-1807	165	2	.	.	PUNCT
ajlm-1807	166	1	uzodimma	uzodimma	PROPN
ajlm-1807	166	2	cc	cc	PROPN
ajlm-1807	166	3	,	,	PUNCT
ajlm-1807	166	4	njokanma	njokanma	ADJ
ajlm-1807	166	5	f	f	PROPN
ajlm-1807	166	6	,	,	PUNCT
ajlm-1807	166	7	ojo	ojo	PROPN
ajlm-1807	166	8	o	o	NOUN
ajlm-1807	166	9	,	,	PUNCT
ajlm-1807	166	10	falase	falase	PROPN
ajlm-1807	166	11	m	m	PROPN
ajlm-1807	166	12	,	,	PUNCT
ajlm-1807	166	13	ojo	ojo	PROPN
ajlm-1807	166	14	t.	t.	PROPN
ajlm-1807	166	15	bacterial	bacterial	ADJ
ajlm-1807	166	16	isolates	isolate	NOUN
ajlm-1807	166	17	from	from	ADP
ajlm-1807	166	18	blood	blood	NOUN
ajlm-1807	166	19	cultures	culture	NOUN
ajlm-1807	166	20	of	of	ADP
ajlm-1807	166	21	children	child	NOUN
ajlm-1807	166	22	with	with	ADP
ajlm-1807	166	23	suspected	suspect	VERB
ajlm-1807	166	24	sepsis	sepsis	NOUN
ajlm-1807	166	25	in	in	ADP
ajlm-1807	166	26	an	an	DET
ajlm-1807	166	27	urban	urban	ADJ
ajlm-1807	166	28	hospital	hospital	NOUN
ajlm-1807	166	29	in	in	ADP
ajlm-1807	166	30	lagos	lagos	PROPN
ajlm-1807	166	31	:	:	PUNCT
ajlm-1807	166	32	a	a	DET
ajlm-1807	166	33	prospective	prospective	ADJ
ajlm-1807	166	34	study	study	NOUN
ajlm-1807	166	35	using	use	VERB
ajlm-1807	166	36	bactec	bactec	ADJ
ajlm-1807	166	37	blood	blood	NOUN
ajlm-1807	166	38	culture	culture	NOUN
ajlm-1807	166	39	system	system	NOUN
ajlm-1807	166	40	.	.	PUNCT
ajlm-1807	167	1	internet	internet	NOUN
ajlm-1807	167	2	j	j	PROPN
ajlm-1807	167	3	pediatr	pediatr	ADJ
ajlm-1807	167	4	neonatol	neonatol	NOUN
ajlm-1807	167	5	[	[	X
ajlm-1807	167	6	serial	serial	ADJ
ajlm-1807	167	7	online	online	NOUN
ajlm-1807	167	8	]	]	X
ajlm-1807	167	9	.	.	PUNCT
ajlm-1807	168	1	2013;16:1–8	2013;16:1–8	X
ajlm-1807	168	2	.	.	PUNCT
ajlm-1807	168	3	available	available	ADJ
ajlm-1807	168	4	from	from	ADP
ajlm-1807	168	5	:	:	PUNCT
ajlm-1807	168	6	http://www.ispub.com	http://www.ispub.com	X
ajlm-1807	168	7	ahmed	ahmed	PROPN
ajlm-1807	169	1	d	d	PROPN
ajlm-1807	169	2	,	,	PUNCT
ajlm-1807	169	3	nahid	nahid	PROPN
ajlm-1807	169	4	ma	ma	PROPN
ajlm-1807	169	5	,	,	PUNCT
ajlm-1807	169	6	sami	sami	PROPN
ajlm-1807	169	7	ab	ab	PROPN
ajlm-1807	169	8	,	,	PUNCT
ajlm-1807	169	9	et	et	PROPN
ajlm-1807	169	10	al	al	PROPN
ajlm-1807	169	11	.	.	PUNCT
ajlm-1807	170	1	bacterial	bacterial	ADJ
ajlm-1807	170	2	etiology	etiology	NOUN
ajlm-1807	170	3	of	of	ADP
ajlm-1807	170	4	bloodstream	bloodstream	NOUN
ajlm-1807	170	5	infections	infection	NOUN
ajlm-1807	170	6	and	and	CCONJ
ajlm-1807	170	7	antimicrobial	antimicrobial	ADJ
ajlm-1807	170	8	resistance	resistance	NOUN
ajlm-1807	170	9	in	in	ADP
ajlm-1807	170	10	dhaka	dhaka	PROPN
ajlm-1807	170	11	,	,	PUNCT
ajlm-1807	170	12	bangladesh	bangladesh	PROPN
ajlm-1807	170	13	,	,	PUNCT
ajlm-1807	170	14	2005–2014	2005–2014	NUM
ajlm-1807	170	15	.	.	PUNCT
ajlm-1807	171	1	antimicrob	antimicrob	PROPN
ajlm-1807	171	2	resist	resist	VERB
ajlm-1807	171	3	infect	infect	ADJ
ajlm-1807	171	4	control	control	NOUN
ajlm-1807	171	5	.	.	PUNCT
ajlm-1807	172	1	2017;6:2	2017;6:2	X
ajlm-1807	172	2	.	.	PUNCT
ajlm-1807	173	1	https://doi.org/10.1186/s13756-016-0162-z	https://doi.org/10.1186/s13756-016-0162-z	PROPN
ajlm-1807	173	2	rolston	rolston	PROPN
ajlm-1807	173	3	kv	kv	PROPN
ajlm-1807	173	4	,	,	PUNCT
ajlm-1807	173	5	yadegarynia	yadegarynia	PROPN
ajlm-1807	173	6	d	d	PROPN
ajlm-1807	173	7	,	,	PUNCT
ajlm-1807	173	8	kontoyiannis	kontoyiannis	PROPN
ajlm-1807	173	9	dp	dp	PROPN
ajlm-1807	173	10	,	,	PUNCT
ajlm-1807	173	11	raad	raad	PROPN
ajlm-1807	173	12	ii	ii	PROPN
ajlm-1807	173	13	,	,	PUNCT
ajlm-1807	173	14	ho	ho	PROPN
ajlm-1807	173	15	dh	dh	PROPN
ajlm-1807	173	16	.	.	PUNCT
ajlm-1807	174	1	the	the	DET
ajlm-1807	174	2	spectrum	spectrum	NOUN
ajlm-1807	174	3	of	of	ADP
ajlm-1807	174	4	gram	gram	NOUN
ajlm-1807	174	5	-	-	PUNCT
ajlm-1807	174	6	positive	positive	ADJ
ajlm-1807	174	7	bloodstream	bloodstream	NOUN
ajlm-1807	174	8	infections	infection	NOUN
ajlm-1807	174	9	in	in	ADP
ajlm-1807	174	10	patients	patient	NOUN
ajlm-1807	174	11	with	with	ADP
ajlm-1807	174	12	hematologic	hematologic	NOUN
ajlm-1807	174	13	malignancies	malignancy	NOUN
ajlm-1807	174	14	,	,	PUNCT
ajlm-1807	174	15	and	and	CCONJ
ajlm-1807	174	16	the	the	DET
ajlm-1807	174	17	in	in	ADV
ajlm-1807	174	18	vitro	vitro	X
ajlm-1807	174	19	activity	activity	NOUN
ajlm-1807	174	20	of	of	ADP
ajlm-1807	174	21	various	various	ADJ
ajlm-1807	174	22	quinolones	quinolone	NOUN
ajlm-1807	174	23	against	against	ADP
ajlm-1807	174	24	gram	gram	NOUN
ajlm-1807	174	25	-	-	PUNCT
ajlm-1807	174	26	positive	positive	ADJ
ajlm-1807	174	27	bacteria	bacteria	NOUN
ajlm-1807	174	28	isolated	isolate	VERB
ajlm-1807	174	29	from	from	ADP
ajlm-1807	174	30	cancer	cancer	NOUN
ajlm-1807	174	31	patients	patient	NOUN
ajlm-1807	174	32	.	.	PUNCT
ajlm-1807	175	1	int	int	NOUN
ajlm-1807	175	2	j	j	PROPN
ajlm-1807	175	3	infect	infect	VERB
ajlm-1807	175	4	dis	dis	PROPN
ajlm-1807	175	5	.	.	PUNCT
ajlm-1807	176	1	2006;10(3):223–230	2006;10(3):223–230	X
ajlm-1807	176	2	.	.	PUNCT
ajlm-1807	177	1	https://doi.org/10.1016/j.ijid.2005.05.007	https://doi.org/10.1016/j.ijid.2005.05.007	VERB
ajlm-1807	177	2	rani	rani	PROPN
ajlm-1807	177	3	nv	nv	PROPN
ajlm-1807	177	4	,	,	PUNCT
ajlm-1807	177	5	gopal	gopal	PROPN
ajlm-1807	177	6	k	k	PROPN
ajlm-1807	177	7	,	,	PUNCT
ajlm-1807	177	8	narendra	narendra	PROPN
ajlm-1807	177	9	mv	mv	PROPN
ajlm-1807	177	10	,	,	PUNCT
ajlm-1807	177	11	et	et	PROPN
ajlm-1807	177	12	al	al	PROPN
ajlm-1807	177	13	.	.	PUNCT
ajlm-1807	178	1	a	a	DET
ajlm-1807	178	2	retrospective	retrospective	ADJ
ajlm-1807	178	3	study	study	NOUN
ajlm-1807	178	4	on	on	ADP
ajlm-1807	178	5	blood	blood	NOUN
ajlm-1807	178	6	stream	stream	NOUN
ajlm-1807	178	7	infections	infection	NOUN
ajlm-1807	178	8	and	and	CCONJ
ajlm-1807	178	9	antibiotic	antibiotic	ADJ
ajlm-1807	178	10	susceptibility	susceptibility	NOUN
ajlm-1807	178	11	patterns	pattern	NOUN
ajlm-1807	178	12	in	in	ADP
ajlm-1807	178	13	a	a	DET
ajlm-1807	178	14	tertiary	tertiary	ADJ
ajlm-1807	178	15	care	care	NOUN
ajlm-1807	178	16	teaching	teaching	NOUN
ajlm-1807	178	17	hospital	hospital	NOUN
ajlm-1807	178	18	.	.	PUNCT
ajlm-1807	179	1	int	int	PROPN
ajlm-1807	180	1	j	j	PROPN
ajlm-1807	180	2	pharm	pharm	PROPN
ajlm-1807	180	3	sci	sci	PROPN
ajlm-1807	181	1	[	[	X
ajlm-1807	181	2	serial	serial	ADJ
ajlm-1807	181	3	online	online	NOUN
ajlm-1807	181	4	]	]	PUNCT
ajlm-1807	181	5	.	.	PUNCT
ajlm-1807	182	1	2012	2012	NUM
ajlm-1807	183	1	[	[	X
ajlm-1807	183	2	cited	cite	VERB
ajlm-1807	183	3	2021	2021	NUM
ajlm-1807	183	4	aug	aug	PROPN
ajlm-1807	183	5	16];4:543–548	16];4:543–548	PROPN
ajlm-1807	183	6	.	.	PUNCT
ajlm-1807	183	7	corpus	corpus	PROPN
ajlm-1807	183	8	i	i	PROPN
ajlm-1807	183	9	d	d	PROPN
ajlm-1807	183	10	:	:	PUNCT
ajlm-1807	183	11	251044	251044	NUM
ajlm-1807	183	12	.	.	PUNCT
ajlm-1807	184	1	available	available	ADJ
ajlm-1807	184	2	from	from	ADP
ajlm-1807	184	3	:	:	PUNCT
ajlm-1807	184	4	https://www.semanticscholar.org/paper/a-retrospective-study-on-blood-stream-infections-in-vanitharani-gopal/82b5b8979427f4472293928d6a53e7b528f5c8a9	https://www.semanticscholar.org/paper/a-retrospective-study-on-blood-stream-infections-in-vanitharani-gopal/82b5b8979427f4472293928d6a53e7b528f5c8a9	NOUN
ajlm-1807	184	5	ndugulile	ndugulile	ADJ
ajlm-1807	185	1	f	f	NOUN
ajlm-1807	185	2	,	,	PUNCT
ajlm-1807	185	3	jureen	jureen	PROPN
ajlm-1807	185	4	r	r	NOUN
ajlm-1807	185	5	,	,	PUNCT
ajlm-1807	185	6	harthug	harthug	NOUN
ajlm-1807	185	7	s	s	PART
ajlm-1807	185	8	,	,	PUNCT
ajlm-1807	185	9	urassa	urassa	PROPN
ajlm-1807	185	10	w	w	PROPN
ajlm-1807	185	11	,	,	PUNCT
ajlm-1807	185	12	langeland	langeland	NOUN
ajlm-1807	185	13	n.	n.	PROPN
ajlm-1807	185	14	extended	extend	VERB
ajlm-1807	185	15	spectrum	spectrum	NOUN
ajlm-1807	185	16	β‑lactamases	β‑lactamases	PRON
ajlm-1807	185	17	among	among	ADP
ajlm-1807	185	18	gram‑negative	gram‑negative	ADJ
ajlm-1807	185	19	bacteria	bacteria	NOUN
ajlm-1807	185	20	of	of	ADP
ajlm-1807	185	21	nosocomial	nosocomial	ADJ
ajlm-1807	185	22	origin	origin	NOUN
ajlm-1807	185	23	from	from	ADP
ajlm-1807	185	24	an	an	DET
ajlm-1807	185	25	intensive	intensive	ADJ
ajlm-1807	185	26	care	care	NOUN
ajlm-1807	185	27	unit	unit	NOUN
ajlm-1807	185	28	of	of	ADP
ajlm-1807	185	29	a	a	DET
ajlm-1807	185	30	tertiary	tertiary	ADJ
ajlm-1807	185	31	health	health	NOUN
ajlm-1807	185	32	facility	facility	NOUN
ajlm-1807	185	33	in	in	ADP
ajlm-1807	185	34	tanzania	tanzania	PROPN
ajlm-1807	185	35	.	.	PUNCT
ajlm-1807	186	1	bmc	bmc	PROPN
ajlm-1807	186	2	infect	infect	PROPN
ajlm-1807	186	3	dis	dis	PROPN
ajlm-1807	186	4	.	.	PUNCT
ajlm-1807	186	5	2005;5:86	2005;5:86	NOUN
ajlm-1807	186	6	.	.	PUNCT
ajlm-1807	187	1	https://doi.org/10.1186/1471-2334-5-86	https://doi.org/10.1186/1471-2334-5-86	ADV
ajlm-1807	187	2	vardakas	vardakas	PROPN
ajlm-1807	187	3	kz	kz	PROPN
ajlm-1807	187	4	,	,	PUNCT
ajlm-1807	187	5	tansarli	tansarli	NOUN
ajlm-1807	187	6	gs	gs	NOUN
ajlm-1807	187	7	,	,	PUNCT
ajlm-1807	187	8	rafailidis	rafailidis	NOUN
ajlm-1807	187	9	pi	pi	NOUN
ajlm-1807	187	10	,	,	PUNCT
ajlm-1807	187	11	falagas	falagas	VERB
ajlm-1807	187	12	me	i	PRON
ajlm-1807	187	13	.	.	PUNCT
ajlm-1807	188	1	carbapenems	carbapenem	NOUN
ajlm-1807	188	2	versus	versus	ADP
ajlm-1807	188	3	alternative	alternative	ADJ
ajlm-1807	188	4	antibiotics	antibiotic	NOUN
ajlm-1807	188	5	for	for	ADP
ajlm-1807	188	6	the	the	DET
ajlm-1807	188	7	treatment	treatment	NOUN
ajlm-1807	188	8	of	of	ADP
ajlm-1807	188	9	bacteraemia	bacteraemia	NOUN
ajlm-1807	188	10	due	due	ADP
ajlm-1807	188	11	to	to	ADP
ajlm-1807	188	12	enterobacteriacea	enterobacteriacea	PROPN
ajlm-1807	188	13	producing	produce	VERB
ajlm-1807	188	14	extended	extended	ADJ
ajlm-1807	188	15	spectrum	spectrum	NOUN
ajlm-1807	188	16	beta	beta	ADJ
ajlm-1807	188	17	lactamases	lactamase	NOUN
ajlm-1807	188	18	:	:	PUNCT
ajlm-1807	188	19	a	a	DET
ajlm-1807	188	20	systemic	systemic	ADJ
ajlm-1807	188	21	review	review	NOUN
ajlm-1807	188	22	and	and	CCONJ
ajlm-1807	188	23	meta	meta	NOUN
ajlm-1807	188	24	-	-	PUNCT
ajlm-1807	188	25	analysis	analysis	NOUN
ajlm-1807	188	26	.	.	PUNCT
ajlm-1807	189	1	j	j	PROPN
ajlm-1807	189	2	antimicrob	antimicrob	PROPN
ajlm-1807	189	3	chemother	chemother	PROPN
ajlm-1807	189	4	.	.	PUNCT
ajlm-1807	190	1	2012;67(12):2793–2803	2012;67(12):2793–2803	X
ajlm-1807	190	2	.	.	PUNCT
ajlm-1807	191	1	https://doi.org/10.1093/jac/dks301	https://doi.org/10.1093/jac/dks301	PROPN
ajlm-1807	191	2	codjoe	codjoe	PROPN
ajlm-1807	191	3	fs	fs	PROPN
ajlm-1807	191	4	,	,	PUNCT
ajlm-1807	191	5	donkor	donkor	PROPN
ajlm-1807	191	6	es	es	PROPN
ajlm-1807	191	7	.	.	PUNCT
ajlm-1807	192	1	carbapenem	carbapenem	PROPN
ajlm-1807	192	2	resistance	resistance	PROPN
ajlm-1807	192	3	:	:	PUNCT
ajlm-1807	192	4	a	a	DET
ajlm-1807	192	5	review	review	NOUN
ajlm-1807	192	6	.	.	PUNCT
ajlm-1807	193	1	med	med	PROPN
ajlm-1807	193	2	sci	sci	PROPN
ajlm-1807	193	3	(	(	PUNCT
ajlm-1807	193	4	basel	basel	PROPN
ajlm-1807	193	5	)	)	PUNCT
ajlm-1807	193	6	.	.	PUNCT
ajlm-1807	194	1	2017;6:1	2017;6:1	NUM
ajlm-1807	194	2	.	.	PUNCT
ajlm-1807	195	1	https://doi.org/10.3390/medsci6010001	https://doi.org/10.3390/medsci6010001	PROPN
ajlm-1807	195	2	howard	howard	PROPN
ajlm-1807	195	3	dh	dh	PROPN
ajlm-1807	195	4	.	.	PUNCT
ajlm-1807	196	1	the	the	DET
ajlm-1807	196	2	global	global	ADJ
ajlm-1807	196	3	impact	impact	NOUN
ajlm-1807	196	4	of	of	ADP
ajlm-1807	196	5	drug	drug	NOUN
ajlm-1807	196	6	resistance	resistance	NOUN
ajlm-1807	196	7	.	.	PUNCT
ajlm-1807	197	1	clin	clin	PROPN
ajlm-1807	197	2	infect	infect	PROPN
ajlm-1807	197	3	dis	dis	PROPN
ajlm-1807	197	4	.	.	PUNCT
ajlm-1807	198	1	2003;36(suppl_1):s4	2003;36(suppl_1):s4	ADJ
ajlm-1807	198	2	–	–	PUNCT
ajlm-1807	198	3	s10	s10	NOUN
ajlm-1807	198	4	.	.	PUNCT
ajlm-1807	199	1	https://doi.org/10.1086/344656	https://doi.org/10.1086/344656	PROPN
ajlm-1807	200	1	jadhav	jadhav	PROPN
ajlm-1807	200	2	s	s	PROPN
ajlm-1807	200	3	,	,	PUNCT
ajlm-1807	200	4	gandham	gandham	PROPN
ajlm-1807	200	5	n	n	CCONJ
ajlm-1807	200	6	,	,	PUNCT
ajlm-1807	200	7	paul	paul	PROPN
ajlm-1807	200	8	r	r	PROPN
ajlm-1807	200	9	,	,	PUNCT
ajlm-1807	200	10	misra	misra	PROPN
ajlm-1807	200	11	rn	rn	PROPN
ajlm-1807	200	12	.	.	PROPN
ajlm-1807	200	13	bacteriological	bacteriological	PROPN
ajlm-1807	200	14	profile	profile	NOUN
ajlm-1807	200	15	of	of	ADP
ajlm-1807	200	16	septicaemia	septicaemia	NOUN
ajlm-1807	200	17	and	and	CCONJ
ajlm-1807	200	18	antimicrobial	antimicrobial	ADJ
ajlm-1807	200	19	susceptibility	susceptibility	NOUN
ajlm-1807	200	20	of	of	ADP
ajlm-1807	200	21	isolates	isolate	NOUN
ajlm-1807	200	22	from	from	ADP
ajlm-1807	200	23	tertiary	tertiary	ADJ
ajlm-1807	200	24	care	care	NOUN
ajlm-1807	200	25	hospital	hospital	NOUN
ajlm-1807	200	26	in	in	ADP
ajlm-1807	200	27	india	india	PROPN
ajlm-1807	200	28	.	.	PUNCT
ajlm-1807	201	1	res	res	PROPN
ajlm-1807	201	2	j	j	PROPN
ajlm-1807	201	3	pharm	pharm	PROPN
ajlm-1807	201	4	biol	biol	PROPN
ajlm-1807	201	5	chem	chem	NOUN
ajlm-1807	201	6	sci	sci	PROPN
ajlm-1807	202	1	[	[	X
ajlm-1807	202	2	serial	serial	ADJ
ajlm-1807	202	3	online	online	NOUN
ajlm-1807	202	4	]	]	PUNCT
ajlm-1807	202	5	.	.	PUNCT
ajlm-1807	203	1	2012	2012	NUM
ajlm-1807	204	1	[	[	X
ajlm-1807	204	2	cited	cite	VERB
ajlm-1807	204	3	2021	2021	NUM
ajlm-1807	204	4	sept	sept	PROPN
ajlm-1807	204	5	22];3(4):1100–1108	22];3(4):1100–1108	NUM
ajlm-1807	204	6	.	.	PUNCT
ajlm-1807	205	1	available	available	ADJ
ajlm-1807	205	2	from	from	ADP
ajlm-1807	205	3	:	:	PUNCT
ajlm-1807	205	4	https://www.researchgate.net/publication/286817962	https://www.researchgate.net/publication/286817962	PROPN
ajlm-1807	205	5	collee	collee	PROPN
ajlm-1807	205	6	,	,	PUNCT
ajlm-1807	205	7	j.g	j.g	PROPN
ajlm-1807	205	8	.	.	PROPN
ajlm-1807	205	9	,	,	PUNCT
ajlm-1807	205	10	miles	miles	PROPN
ajlm-1807	205	11	,	,	PUNCT
ajlm-1807	205	12	r.s	r.s	PROPN
ajlm-1807	205	13	.	.	PROPN
ajlm-1807	205	14	and	and	CCONJ
ajlm-1807	205	15	watt	watt	NOUN
ajlm-1807	205	16	,	,	PUNCT
ajlm-1807	205	17	b.	b.	PROPN
ajlm-1807	205	18	tests	test	NOUN
ajlm-1807	205	19	for	for	ADP
ajlm-1807	205	20	the	the	DET
ajlm-1807	205	21	identification	identification	NOUN
ajlm-1807	205	22	of	of	ADP
ajlm-1807	205	23	bacteria	bacteria	NOUN
ajlm-1807	205	24	.	.	PUNCT
ajlm-1807	206	1	in	in	ADP
ajlm-1807	206	2	:	:	PUNCT
ajlm-1807	206	3	collee	collee	PROPN
ajlm-1807	206	4	,	,	PUNCT
ajlm-1807	206	5	j.g	j.g	PROPN
ajlm-1807	206	6	.	.	PROPN
ajlm-1807	206	7	,	,	PUNCT
ajlm-1807	206	8	marmion	marmion	PROPN
ajlm-1807	206	9	,	,	PUNCT
ajlm-1807	206	10	b.p	b.p	PROPN
ajlm-1807	206	11	.	.	PROPN
ajlm-1807	206	12	,	,	PUNCT
ajlm-1807	206	13	fraser	fraser	PROPN
ajlm-1807	206	14	,	,	PUNCT
ajlm-1807	206	15	a.g	a.g	PROPN
ajlm-1807	206	16	.	.	PROPN
ajlm-1807	206	17	and	and	CCONJ
ajlm-1807	206	18	simmons	simmon	NOUN
ajlm-1807	206	19	,	,	PUNCT
ajlm-1807	206	20	a.	a.	NOUN
ajlm-1807	206	21	,	,	PUNCT
ajlm-1807	206	22	eds	eds	PROPN
ajlm-1807	206	23	.	.	PROPN
ajlm-1807	206	24	,	,	PUNCT
ajlm-1807	206	25	mackie	mackie	PROPN
ajlm-1807	206	26	&	&	CCONJ
ajlm-1807	206	27	mccartney	mccartney	PROPN
ajlm-1807	206	28	practical	practical	PROPN
ajlm-1807	206	29	medical	medical	ADJ
ajlm-1807	206	30	microbiology	microbiology	NOUN
ajlm-1807	206	31	,	,	PUNCT
ajlm-1807	206	32	14th	14th	NUM
ajlm-1807	206	33	edition	edition	NOUN
ajlm-1807	206	34	,	,	PUNCT
ajlm-1807	206	35	churchill	churchill	PROPN
ajlm-1807	206	36	livingstone	livingstone	PROPN
ajlm-1807	206	37	,	,	PUNCT
ajlm-1807	206	38	new	new	PROPN
ajlm-1807	206	39	york	york	PROPN
ajlm-1807	206	40	,	,	PUNCT
ajlm-1807	206	41	1996	1996	NUM
ajlm-1807	206	42	;	;	PUNCT
ajlm-1807	206	43	p.	p.	PROPN
ajlm-1807	206	44	131–151	131–151	NUM
ajlm-1807	206	45	.	.	PUNCT
ajlm-1807	207	1	clinical	clinical	ADJ
ajlm-1807	207	2	and	and	CCONJ
ajlm-1807	207	3	laboratory	laboratory	NOUN
ajlm-1807	207	4	standard	standard	PROPN
ajlm-1807	207	5	institute	institute	PROPN
ajlm-1807	207	6	.	.	PUNCT
ajlm-1807	208	1	performance	performance	NOUN
ajlm-1807	208	2	standards	standard	NOUN
ajlm-1807	208	3	for	for	ADP
ajlm-1807	208	4	antimicrobial	antimicrobial	ADJ
ajlm-1807	208	5	susceptibility	susceptibility	NOUN
ajlm-1807	208	6	testing	testing	NOUN
ajlm-1807	208	7	:	:	PUNCT
ajlm-1807	208	8	twenty	twenty	NUM
ajlm-1807	208	9	-	-	PUNCT
ajlm-1807	208	10	fourth	fourth	ADJ
ajlm-1807	208	11	informational	informational	ADJ
ajlm-1807	208	12	supplement	supplement	NOUN
ajlm-1807	209	1	[	[	X
ajlm-1807	209	2	homepage	homepage	NOUN
ajlm-1807	209	3	on	on	ADP
ajlm-1807	209	4	the	the	DET
ajlm-1807	209	5	internet	internet	NOUN
ajlm-1807	209	6	]	]	PUNCT
ajlm-1807	209	7	.	.	PUNCT
ajlm-1807	210	1	clsi	clsi	ADJ
ajlm-1807	210	2	document	document	NOUN
ajlm-1807	210	3	m100-s27.wayne	m100-s27.wayne	NOUN
ajlm-1807	210	4	,	,	PUNCT
ajlm-1807	210	5	pa	pa	NOUN
ajlm-1807	210	6	:	:	PUNCT
ajlm-1807	210	7	clinical	clinical	ADJ
ajlm-1807	210	8	and	and	CCONJ
ajlm-1807	210	9	laboratory	laboratory	NOUN
ajlm-1807	210	10	standards	standard	NOUN
ajlm-1807	210	11	institute	institute	PROPN
ajlm-1807	210	12	;	;	PUNCT
ajlm-1807	210	13	2014	2014	NUM
ajlm-1807	211	1	[	[	X
ajlm-1807	211	2	cited	cite	VERB
ajlm-1807	211	3	2021	2021	NUM
ajlm-1807	211	4	sept	sept	PROPN
ajlm-1807	211	5	26	26	NUM
ajlm-1807	211	6	]	]	PUNCT
ajlm-1807	211	7	.	.	PUNCT
ajlm-1807	212	1	available	available	ADJ
ajlm-1807	212	2	from	from	ADP
ajlm-1807	212	3	:	:	PUNCT
ajlm-1807	212	4	https://www.nih.org.pk	https://www.nih.org.pk	NOUN
ajlm-1807	212	5	deku	deku	PROPN
ajlm-1807	212	6	jg	jg	PROPN
ajlm-1807	212	7	,	,	PUNCT
ajlm-1807	212	8	dakorah	dakorah	PROPN
ajlm-1807	212	9	mp	mp	PROPN
ajlm-1807	212	10	,	,	PUNCT
ajlm-1807	212	11	lokpo	lokpo	PROPN
ajlm-1807	212	12	sy	sy	PROPN
ajlm-1807	212	13	,	,	PUNCT
ajlm-1807	212	14	et	et	PROPN
ajlm-1807	212	15	al	al	PROPN
ajlm-1807	212	16	.	.	PUNCT
ajlm-1807	213	1	the	the	DET
ajlm-1807	213	2	epidemiology	epidemiology	NOUN
ajlm-1807	213	3	of	of	ADP
ajlm-1807	213	4	bloodstream	bloodstream	NOUN
ajlm-1807	213	5	infections	infection	NOUN
ajlm-1807	213	6	and	and	CCONJ
ajlm-1807	213	7	antimicrobial	antimicrobial	ADJ
ajlm-1807	213	8	susceptibility	susceptibility	NOUN
ajlm-1807	213	9	patterns	pattern	NOUN
ajlm-1807	213	10	:	:	PUNCT
ajlm-1807	213	11	a	a	DET
ajlm-1807	213	12	nine	nine	NUM
ajlm-1807	213	13	-	-	PUNCT
ajlm-1807	213	14	year	year	NOUN
ajlm-1807	213	15	retrospective	retrospective	ADJ
ajlm-1807	213	16	study	study	NOUN
ajlm-1807	213	17	at	at	ADP
ajlm-1807	213	18	st	st	PROPN
ajlm-1807	213	19	.	.	PROPN
ajlm-1807	213	20	dominic	dominic	PROPN
ajlm-1807	213	21	hospital	hospital	PROPN
ajlm-1807	213	22	,	,	PUNCT
ajlm-1807	213	23	akwatia	akwatia	NOUN
ajlm-1807	213	24	,	,	PUNCT
ajlm-1807	213	25	ghana	ghana	PROPN
ajlm-1807	213	26	.	.	PUNCT
ajlm-1807	214	1	j	j	PROPN
ajlm-1807	214	2	trop	trop	X
ajlm-1807	214	3	med	med	PROPN
ajlm-1807	214	4	.	.	PUNCT
ajlm-1807	215	1	2019;2019:6750864	2019;2019:6750864	NUM
ajlm-1807	215	2	.	.	PUNCT
ajlm-1807	216	1	https://doi.org/10.1155/2019/6750864	https://doi.org/10.1155/2019/6750864	PROPN
ajlm-1807	216	2	gupta	gupta	PROPN
ajlm-1807	216	3	s	s	PROPN
ajlm-1807	216	4	,	,	PUNCT
ajlm-1807	216	5	kashyap	kashyap	PROPN
ajlm-1807	216	6	b.	b.	PROPN
ajlm-1807	216	7	bacteriological	bacteriological	PROPN
ajlm-1807	216	8	profile	profile	NOUN
ajlm-1807	216	9	and	and	CCONJ
ajlm-1807	216	10	antibiogram	antibiogram	NUM
ajlm-1807	216	11	of	of	ADP
ajlm-1807	216	12	blood	blood	NOUN
ajlm-1807	216	13	culture	culture	NOUN
ajlm-1807	216	14	isolates	isolate	NOUN
ajlm-1807	216	15	from	from	ADP
ajlm-1807	216	16	a	a	DET
ajlm-1807	216	17	tertiary	tertiary	ADJ
ajlm-1807	216	18	care	care	NOUN
ajlm-1807	216	19	hospital	hospital	NOUN
ajlm-1807	216	20	of	of	ADP
ajlm-1807	216	21	north	north	PROPN
ajlm-1807	216	22	india	india	PROPN
ajlm-1807	216	23	.	.	PUNCT
ajlm-1807	217	1	trop	trop	PROPN
ajlm-1807	217	2	j	j	PROPN
ajlm-1807	217	3	med	med	PROPN
ajlm-1807	217	4	res	re	NOUN
ajlm-1807	217	5	.	.	PUNCT
ajlm-1807	218	1	2016;19(2):94–99	2016;19(2):94–99	NUM
ajlm-1807	218	2	.	.	PUNCT
ajlm-1807	219	1	https://doi.org/10.4103/1119-0388.185426	https://doi.org/10.4103/1119-0388.185426	PROPN
ajlm-1807	219	2	khanal	khanal	ADJ
ajlm-1807	219	3	lk	lk	PROPN
ajlm-1807	219	4	.	.	PROPN
ajlm-1807	219	5	bacteriological	bacteriological	ADJ
ajlm-1807	219	6	profile	profile	NOUN
ajlm-1807	219	7	of	of	ADP
ajlm-1807	219	8	blood	blood	NOUN
ajlm-1807	219	9	culture	culture	NOUN
ajlm-1807	219	10	and	and	CCONJ
ajlm-1807	219	11	antibiogram	antibiogram	PROPN
ajlm-1807	219	12	of	of	ADP
ajlm-1807	219	13	the	the	DET
ajlm-1807	219	14	bacterial	bacterial	ADJ
ajlm-1807	219	15	isolates	isolate	NOUN
ajlm-1807	219	16	in	in	ADP
ajlm-1807	219	17	a	a	DET
ajlm-1807	219	18	tertiary	tertiary	ADJ
ajlm-1807	219	19	care	care	NOUN
ajlm-1807	219	20	hospital	hospital	NOUN
ajlm-1807	219	21	.	.	PUNCT
ajlm-1807	220	1	int	int	PROPN
ajlm-1807	220	2	j	j	PROPN
ajlm-1807	220	3	health	health	PROPN
ajlm-1807	220	4	sci	sci	PROPN
ajlm-1807	220	5	res	re	NOUN
ajlm-1807	220	6	[	[	X
ajlm-1807	220	7	serial	serial	ADJ
ajlm-1807	220	8	online	online	NOUN
ajlm-1807	220	9	]	]	PUNCT
ajlm-1807	220	10	.	.	PUNCT
ajlm-1807	221	1	2020	2020	NUM
ajlm-1807	222	1	[	[	X
ajlm-1807	222	2	cited	cite	VERB
ajlm-1807	222	3	2021	2021	NUM
ajlm-1807	222	4	nov	nov	NOUN
ajlm-1807	222	5	28];10(8):10–14	28];10(8):10–14	NUM
ajlm-1807	222	6	.	.	PUNCT
ajlm-1807	223	1	available	available	ADJ
ajlm-1807	223	2	from	from	ADP
ajlm-1807	223	3	:	:	PUNCT
ajlm-1807	223	4	https://www.ijhsr.org/ijhsr_vol.10_issue.8_a_aug2020/3.pdf	https://www.ijhsr.org/ijhsr_vol.10_issue.8_a_aug2020/3.pdf	NUM
ajlm-1807	223	5	sorsa	sorsa	ADJ
ajlm-1807	223	6	a.	a.	NOUN
ajlm-1807	223	7	epidemiology	epidemiology	NOUN
ajlm-1807	223	8	of	of	ADP
ajlm-1807	223	9	neonatal	neonatal	ADJ
ajlm-1807	223	10	sepsis	sepsis	NOUN
ajlm-1807	223	11	and	and	CCONJ
ajlm-1807	223	12	associated	associated	ADJ
ajlm-1807	223	13	factors	factor	NOUN
ajlm-1807	223	14	implicated	implicate	VERB
ajlm-1807	223	15	:	:	PUNCT
ajlm-1807	223	16	observational	observational	ADJ
ajlm-1807	223	17	study	study	NOUN
ajlm-1807	223	18	at	at	ADP
ajlm-1807	223	19	neonatal	neonatal	ADJ
ajlm-1807	223	20	intensive	intensive	ADJ
ajlm-1807	223	21	care	care	NOUN
ajlm-1807	223	22	unit	unit	NOUN
ajlm-1807	223	23	of	of	ADP
ajlm-1807	223	24	arsi	arsi	ADJ
ajlm-1807	223	25	university	university	NOUN
ajlm-1807	223	26	teaching	teaching	NOUN
ajlm-1807	223	27	and	and	CCONJ
ajlm-1807	223	28	referral	referral	ADJ
ajlm-1807	223	29	hospital	hospital	NOUN
ajlm-1807	223	30	,	,	PUNCT
ajlm-1807	223	31	south	south	PROPN
ajlm-1807	223	32	east	east	PROPN
ajlm-1807	223	33	ethiopia	ethiopia	PROPN
ajlm-1807	223	34	.	.	PUNCT
ajlm-1807	224	1	ethiop	ethiop	PROPN
ajlm-1807	224	2	j	j	PROPN
ajlm-1807	224	3	health	health	PROPN
ajlm-1807	224	4	sci	sci	PROPN
ajlm-1807	224	5	.	.	PUNCT
ajlm-1807	225	1	2019;29(3):333–342	2019;29(3):333–342	X
ajlm-1807	225	2	.	.	PUNCT
ajlm-1807	226	1	https://doi.org/10.4314/ejhs.v29i3.5	https://doi.org/10.4314/ejhs.v29i3.5	PROPN
ajlm-1807	226	2	shehab	shehab	PROPN
ajlm-1807	226	3	el	el	PROPN
ajlm-1807	226	4	-	-	PROPN
ajlm-1807	226	5	din	din	VERB
ajlm-1807	226	6	em	em	PRON
ajlm-1807	226	7	,	,	PUNCT
ajlm-1807	226	8	el	el	PROPN
ajlm-1807	226	9	-	-	ADJ
ajlm-1807	226	10	sokkary	sokkary	ADJ
ajlm-1807	226	11	mm	mm	PROPN
ajlm-1807	226	12	,	,	PUNCT
ajlm-1807	226	13	bassiouny	bassiouny	PROPN
ajlm-1807	226	14	mr	mr	PROPN
ajlm-1807	226	15	,	,	PUNCT
ajlm-1807	226	16	hassan	hassan	PROPN
ajlm-1807	226	17	r.	r.	PROPN
ajlm-1807	226	18	epidemiology	epidemiology	PROPN
ajlm-1807	226	19	of	of	ADP
ajlm-1807	226	20	neonatal	neonatal	ADJ
ajlm-1807	226	21	sepsis	sepsis	NOUN
ajlm-1807	226	22	and	and	CCONJ
ajlm-1807	226	23	implicated	implicate	VERB
ajlm-1807	226	24	pathogens	pathogen	NOUN
ajlm-1807	226	25	:	:	PUNCT
ajlm-1807	226	26	a	a	DET
ajlm-1807	226	27	study	study	NOUN
ajlm-1807	226	28	from	from	ADP
ajlm-1807	226	29	egypt	egypt	PROPN
ajlm-1807	226	30	.	.	PUNCT
ajlm-1807	227	1	biomed	biome	VERB
ajlm-1807	227	2	res	re	NOUN
ajlm-1807	227	3	int	int	NOUN
ajlm-1807	227	4	.	.	PUNCT
ajlm-1807	228	1	2015;2015:509484	2015;2015:509484	NOUN
ajlm-1807	228	2	.	.	PUNCT
ajlm-1807	229	1	https://doi.org/10.1155/2015/509484	https://doi.org/10.1155/2015/509484	PROPN
ajlm-1807	229	2	lee	lee	PROPN
ajlm-1807	229	3	a	a	PRON
ajlm-1807	229	4	,	,	PUNCT
ajlm-1807	229	5	mirrett	mirrett	NOUN
ajlm-1807	229	6	s	s	PROPN
ajlm-1807	229	7	,	,	PUNCT
ajlm-1807	229	8	reller	reller	NOUN
ajlm-1807	229	9	lb	lb	PROPN
ajlm-1807	229	10	,	,	PUNCT
ajlm-1807	230	1	weinstein	weinstein	PROPN
ajlm-1807	230	2	mp	mp	PROPN
ajlm-1807	230	3	.	.	PROPN
ajlm-1807	230	4	detection	detection	NOUN
ajlm-1807	230	5	of	of	ADP
ajlm-1807	230	6	bloodstream	bloodstream	NOUN
ajlm-1807	230	7	infections	infection	NOUN
ajlm-1807	230	8	in	in	ADP
ajlm-1807	230	9	adults	adult	NOUN
ajlm-1807	230	10	:	:	PUNCT
ajlm-1807	230	11	how	how	SCONJ
ajlm-1807	230	12	many	many	ADJ
ajlm-1807	230	13	blood	blood	NOUN
ajlm-1807	230	14	cultures	culture	NOUN
ajlm-1807	230	15	are	be	AUX
ajlm-1807	230	16	needed	need	VERB
ajlm-1807	230	17	?	?	PUNCT
ajlm-1807	231	1	j	j	PROPN
ajlm-1807	231	2	clin	clin	PROPN
ajlm-1807	231	3	microbiol	microbiol	PROPN
ajlm-1807	231	4	.	.	PUNCT
ajlm-1807	232	1	2007;45(11):3546–3548	2007;45(11):3546–3548	NUM
ajlm-1807	232	2	.	.	PUNCT
ajlm-1807	233	1	https://doi.org/10.1128/jcm.01555-07	https://doi.org/10.1128/jcm.01555-07	PROPN
ajlm-1807	233	2	reddy	reddy	PROPN
ajlm-1807	233	3	ea	ea	PROPN
ajlm-1807	233	4	,	,	PUNCT
ajlm-1807	233	5	shaw	shaw	PROPN
ajlm-1807	233	6	av	av	PROPN
ajlm-1807	233	7	,	,	PUNCT
ajlm-1807	233	8	crump	crump	PROPN
ajlm-1807	233	9	ja	ja	PROPN
ajlm-1807	233	10	.	.	PROPN
ajlm-1807	233	11	community	community	PROPN
ajlm-1807	233	12	acquired	acquire	VERB
ajlm-1807	233	13	bloodstream	bloodstream	NOUN
ajlm-1807	233	14	infections	infection	NOUN
ajlm-1807	233	15	in	in	ADP
ajlm-1807	233	16	africa	africa	PROPN
ajlm-1807	233	17	:	:	PUNCT
ajlm-1807	233	18	a	a	DET
ajlm-1807	233	19	systematic	systematic	ADJ
ajlm-1807	233	20	review	review	NOUN
ajlm-1807	233	21	and	and	CCONJ
ajlm-1807	233	22	meta	meta	ADJ
ajlm-1807	233	23	-	-	PUNCT
ajlm-1807	233	24	analysis	analysis	NOUN
ajlm-1807	233	25	.	.	PUNCT
ajlm-1807	234	1	lancet	lancet	PROPN
ajlm-1807	234	2	infect	infect	PROPN
ajlm-1807	234	3	dis	dis	PROPN
ajlm-1807	234	4	.	.	PUNCT
ajlm-1807	235	1	2010;10(6):417–432	2010;10(6):417–432	X
ajlm-1807	235	2	.	.	PUNCT
ajlm-1807	235	3	https://doi.org/10.1016/s1473-3099(10)70072-4	https://doi.org/10.1016/s1473-3099(10)70072-4	PROPN
ajlm-1807	235	4	mia	mia	PROPN
ajlm-1807	235	5	ar	ar	PROPN
ajlm-1807	235	6	,	,	PUNCT
ajlm-1807	235	7	zerin	zerin	PROPN
ajlm-1807	235	8	t.	t.	PROPN
ajlm-1807	235	9	antibiogram	antibiogram	PROPN
ajlm-1807	235	10	of	of	ADP
ajlm-1807	235	11	blood	blood	NOUN
ajlm-1807	235	12	culture	culture	NOUN
ajlm-1807	235	13	isolates	isolate	NOUN
ajlm-1807	235	14	of	of	ADP
ajlm-1807	235	15	patients	patient	NOUN
ajlm-1807	235	16	from	from	ADP
ajlm-1807	235	17	a	a	DET
ajlm-1807	235	18	hospital	hospital	NOUN
ajlm-1807	235	19	in	in	ADP
ajlm-1807	235	20	dhaka	dhaka	PROPN
ajlm-1807	235	21	,	,	PUNCT
ajlm-1807	235	22	bangladesh	bangladesh	PROPN
ajlm-1807	235	23	.	.	PUNCT
ajlm-1807	236	1	matrix	matrix	NOUN
ajlm-1807	236	2	sci	sci	PROPN
ajlm-1807	236	3	med	med	PROPN
ajlm-1807	236	4	.	.	PUNCT
ajlm-1807	237	1	2020;4(1):1–5	2020;4(1):1–5	X
ajlm-1807	237	2	.	.	PUNCT
ajlm-1807	238	1	https://doi.org/10.4103/mtsm.mtsm_4_19	https://doi.org/10.4103/mtsm.mtsm_4_19	PROPN
ajlm-1807	238	2	sangita	sangita	PROPN
ajlm-1807	238	3	km	km	PROPN
ajlm-1807	238	4	,	,	PUNCT
ajlm-1807	238	5	tomar	tomar	ADJ
ajlm-1807	238	6	r	r	PROPN
ajlm-1807	238	7	,	,	PUNCT
ajlm-1807	238	8	saha	saha	PROPN
ajlm-1807	238	9	nk	nk	PROPN
ajlm-1807	238	10	.	.	PROPN
ajlm-1807	238	11	bacteriological	bacteriological	PROPN
ajlm-1807	238	12	profile	profile	NOUN
ajlm-1807	238	13	and	and	CCONJ
ajlm-1807	238	14	antibiogram	antibiogram	NUM
ajlm-1807	238	15	of	of	ADP
ajlm-1807	238	16	blood	blood	NOUN
ajlm-1807	238	17	culture	culture	NOUN
ajlm-1807	238	18	isolates	isolate	NOUN
ajlm-1807	238	19	from	from	ADP
ajlm-1807	238	20	a	a	DET
ajlm-1807	238	21	tertiary	tertiary	ADJ
ajlm-1807	238	22	care	care	NOUN
ajlm-1807	238	23	hospital	hospital	NOUN
ajlm-1807	238	24	.	.	PUNCT
ajlm-1807	239	1	int	int	PROPN
ajlm-1807	239	2	j	j	PROPN
ajlm-1807	239	3	med	med	PROPN
ajlm-1807	239	4	sci	sci	PROPN
ajlm-1807	239	5	innov	innov	PROPN
ajlm-1807	239	6	res	re	NOUN
ajlm-1807	239	7	[	[	X
ajlm-1807	239	8	serial	serial	ADJ
ajlm-1807	239	9	online	online	NOUN
ajlm-1807	239	10	]	]	PUNCT
ajlm-1807	239	11	.	.	PUNCT
ajlm-1807	240	1	2019;4(6):187–192	2019;4(6):187–192	X
ajlm-1807	240	2	.	.	PUNCT
ajlm-1807	240	3	available	available	ADJ
ajlm-1807	240	4	from	from	ADP
ajlm-1807	240	5	:	:	PUNCT
ajlm-1807	240	6	http://www.ijmsir.com	http://www.ijmsir.com	X
ajlm-1807	240	7	polat	polat	PROPN
ajlm-1807	240	8	g	g	PROPN
ajlm-1807	240	9	,	,	PUNCT
ajlm-1807	240	10	ugan	ugan	ADJ
ajlm-1807	240	11	ra	ra	PROPN
ajlm-1807	240	12	,	,	PUNCT
ajlm-1807	240	13	cadirci	cadirci	ADJ
ajlm-1807	240	14	e	e	NOUN
ajlm-1807	240	15	,	,	PUNCT
ajlm-1807	240	16	halici	halici	PROPN
ajlm-1807	240	17	z.	z.	PROPN
ajlm-1807	240	18	sepsis	sepsis	NOUN
ajlm-1807	240	19	and	and	CCONJ
ajlm-1807	240	20	septic	septic	ADJ
ajlm-1807	240	21	shock	shock	NOUN
ajlm-1807	240	22	:	:	PUNCT
ajlm-1807	240	23	current	current	ADJ
ajlm-1807	240	24	treatment	treatment	NOUN
ajlm-1807	240	25	strategies	strategy	NOUN
ajlm-1807	240	26	and	and	CCONJ
ajlm-1807	240	27	new	new	ADJ
ajlm-1807	240	28	approaches	approach	NOUN
ajlm-1807	240	29	.	.	PUNCT
ajlm-1807	241	1	eurasian	eurasian	PROPN
ajlm-1807	241	2	j	j	PROPN
ajlm-1807	241	3	med	med	PROPN
ajlm-1807	241	4	.	.	PUNCT
ajlm-1807	242	1	2017;49(1):53–58	2017;49(1):53–58	NUM
ajlm-1807	242	2	.	.	PUNCT
ajlm-1807	243	1	https://doi.org/10.5152/eurasianjmed.2017.17062	https://doi.org/10.5152/eurasianjmed.2017.17062	PROPN
ajlm-1807	243	2	martins	martin	VERB
ajlm-1807	243	3	gs	gs	NOUN
ajlm-1807	243	4	.	.	PUNCT
ajlm-1807	243	5	sepsis	sepsis	NOUN
ajlm-1807	243	6	,	,	PUNCT
ajlm-1807	243	7	severe	severe	ADJ
ajlm-1807	243	8	sepsis	sepsis	NOUN
ajlm-1807	243	9	and	and	CCONJ
ajlm-1807	243	10	septic	septic	ADJ
ajlm-1807	243	11	shock	shock	NOUN
ajlm-1807	243	12	:	:	PUNCT
ajlm-1807	243	13	changes	change	NOUN
ajlm-1807	243	14	in	in	ADP
ajlm-1807	243	15	incidence	incidence	NOUN
ajlm-1807	243	16	,	,	PUNCT
ajlm-1807	243	17	pathogens	pathogen	NOUN
ajlm-1807	243	18	and	and	CCONJ
ajlm-1807	243	19	outcomes	outcome	NOUN
ajlm-1807	243	20	.	.	PUNCT
ajlm-1807	244	1	expert	expert	NOUN
ajlm-1807	244	2	rev	rev	VERB
ajlm-1807	244	3	anti	anti	ADJ
ajlm-1807	244	4	infect	infect	VERB
ajlm-1807	244	5	ther	ther	ADV
ajlm-1807	244	6	.	.	PUNCT
ajlm-1807	245	1	2012;10(6):701–706	2012;10(6):701–706	X
ajlm-1807	245	2	.	.	PROPN
ajlm-1807	245	3	https://doi.org/10.1586/eri.12.50	https://doi.org/10.1586/eri.12.50	PROPN